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RESUME EN FRANÇAIS ET MOTS CLES FRANÇAIS
Les gènes homéotiques EizgraiÏed-1 (En-1) et EngraiÏed-2 (En-2) sont d’importants
régulateurs du développement du système nerveux central chez la souris. Leur
implication dans le développement de la glande mammaire et leur contribution à la
transformation de ce tissu demeurent inconnu. Le travail présenté dans cette thèse
explore une approche de gène candidat afin de répondre aux questions suivantes: (i) Est-
ce que ces gènes sont impliqués dans le développement du tissu mammaire? (ii) Est-ce
que ces gènes participent à la transformation néoplasique du sein chez l’humain? Mes
résultats démontrent que bien que l’expression d’EngraiÏed-2 n’est pas détectable dans
le tissu mammaire murin au cours du développement fétal et chez la souris adulte, le
gène paralogue En-1 lui est fortement exprimé dans l’épithélium mammaire de souris
pré-pubaires. Mes travaux démontrent aussi que les souris chez qui le gène En-] est
inactivé par recombinaison homologue présente une glande mammaire anormale
caractérisée par une rareté d’arborisation des canaux mammaires. Des expériences de
transplantations de glandes mammaires isolées de souris En-] mutantes confirment que
ces observations sont probablement le résultat d’un défaut intrinsèque à l’arbre
mammaire mutant. Ces études démontrent donc pour la première fois l’expression
spatio-temporel d’Engrailed-] dans la glande mammaire de souris et suggèrent un rôle
important pour ce gène dans le développement mammaire. Mes travaux ont aussi
démontrés que EN2 (mais pas EN]) est exprimé de façon ectopiquc dans environ 8% des
cancer mammaires humains et chez près de la moitié des lignées cellulaires malignes. La
sur-expression d’EN2 induit la transformation mammaire chez deux lignées non-
transformées in vitro et la genèse d’adénocarcinomes in vivo. Des études d’interférence à
l’ARN (RNAi) ont démontré qu’EN2 est requis pour la prolifération de cellules
transformées humaines. De plus, des analyses par micro-puces effectuées chez 2 lignées
cellulaires chez qui les niveaux d’EN2 furent expérimentalement modifiés ont permis
d’identifions des gènes cibles potentiels de cette protéine. Ces résultats suggèrent
qu’EN2 est impliqué dans la transformation du tissu mammaire humain et d’ENl
contribue au développement de ce tissu.
Mots clés: Engraited, homéodomaine, glande mammaire, cancer du sein, oncogène,
morphogénèse ductale, transplantation, puberté, RNAi, micro-puce
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RESUME EN ANGLAIS ET MOTS CLES ANGLAIS
The homeobox genes Engrailed-] (En-1) and Engrailed-2 (En-2) occupy a prominent
position in the developmental regulatory hierarchy and have been studied extensively in
embryonic development, yet have received little attention with respect to mammary
gland organogenesis and cancer. The studies presented in this thesis are the resuit of a
candidate gene approach where the expression and potential role of these homeodomain
containing proteins were investigated in the developing mammary gland and in breast
tumors. While En-2 was neyer detected at any developmental timepoint in normal mouse
or human breast tissue, we have defined the developmentally regulated expression of
En-] in the mammary epithelium of the prepubertal and early pubertal mouse manimary
gland. Moreover, using En-] mutant mice, we provide evidence that loss of En-1
function in the female rnammary gland resuits in severely impaired ductal growth.
Pubertal En-] nuli mammary glands revealed a primitive ductal rudiment devoid of
terminal end buds (TEBs), reminiscent of a prepubertal mammary gland, while a fully
developed ductal system was seen in En-1 heterozygous and wildtype sibÏings. En-1 nuil
mammary epithelium transplanted into surgically cleared fat pads of syngeneic hosts
displayed limited ductal outgrowth and a decrease in side branching. These studies
demonstrate a unique spatio-temporal pattern of En-1 expression in mammary tissue and
suggest a potential role for En-1 in the initial growth and morphogenesis of the epithelial
ductal system during the onset of puberty. We also show that EN2 (but flot EN]) is
ectopically expressed in a subgroup of human breast turnors and in a large proportion of
breast cancer cdl unes and that its ectopic expression readily transforms mammary
epithelial cells in vitro and promotes adenocarcinoma formation in vii’o. RNA
interference studies show that EN2 expression is required for the maintenance of the
transformed phenotype of human breast tumor ceils. Moreover, microarray analysis of
both gain-of-function and loss-of-function of EN2 in two breast cancer ceil lines
provided initial insight into putative EN2 responsive targets. These studies reveal that En
genes have not only acquired a role in the postnatal development of the mouse
mammary gland, but in addition, they have evolved to contribute to brcast
tumorigenesis.
Mots clés: Engraited, homeobox, mammary gland, breast cancer, oncogene, ductal
morphogenesis, transplantation, puberty, RNAi, microarray
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1CHAPITRE 1
INTRODUCTION
Investigating a Potential Role for EngraiÏed Genes in Mammary Gland
Development and Tumorigenesis
2The present Ph.D. thesis, consisting of five chapters, describes the expression, ftmction
and initial mechanistic insights of action ofEngraiÏed-] (En-1) and Engi-ailed-2 (En-2)
in normal mammary gland development and mammaiy tumorigenesis.
Chapter I is a titerature review which shah both encompass the most relevant studies
from other groups to gain a further appreciation of this field and help identify the
underlying motivation behind the research contained herein and is subdivided into six
sections. The first section briefly describes Homeobox genes in development, leading to
the second section, which specifically describes the EngraiÏed homeobox gene family.
The third section outlines the different stages of mouse mammary gland development
and imparts how the mouse is an invaluable model with which to investigate genes
involved in mammary gland development. The fourth section highhights the role of
excmplary homeobox genes in the developing mammary gland whule the flfth section
summarizes the role of certain homeobox genes in cancer, with an emphasis in their
potential involvement in breast cancer. The sixth section introduces the area of human
hreast cancer in general. The Introduction was written by Nicole Martin under the
supervision ofDr. Guy Sauvageau.
31.1 Homeobox genes in embryonic development
1.1.1 Homeobox genes are key developmental regulators
Homeobox genes comprise a large family of transcriptional regulatory proteins that are
involved in a wide range of essentiai biological processes from embryonic development
to terminal differentiation. They are defined by the presence of a 180-hp DNA sequence
motif designated the homeobox. The homeobox was initialiy characterized as a sequence
motif that was shared among Drosophita Homeotic genes (the HOM-C complex). The
homeobox is now known to be evolutionarily conserved among many genes with over
1,000 homeobox genes having been identifled in severai species, ranging from hydra to
humans as weii as fungi and plants . A vast extent of what is presentiy known about
homeobox genes and their corresponding functions is the culmination of decades of
research that started witli dissecting Drosophita development and genetics. The HOM-C
genes in Drosophila were originaliy identified as part of a hierarchy of genes that
control embryonic development and play key roles in the determination and maintenance
of cell fate and ccli identity. Mutations in these DrosophiÏa HOM-C or homeotic genes
resuit in the conversion of one hody part or segment to the likeness or identity of
another, and led to die coinïng of the terni ‘homeotic transformation’. Other classes of
genes in this hierarchy, such as the gap, pair-ruied and segment polarity genes, which in
turn play essential roles in the determination and maintenance of ceil fate and pattern
formation in the developing Drosophila embryo, also contain members that are
homeobox genes.
In mammals, homeobox genes reign over the specification of the overail body plan and
are known to play crucial roles in a variety of developmental processes encompassing
central nervous system and skeletal development, limb and digit specification, and
organogenesis. The HOM-C genes are in many respects still considered to be the
prototype homeobox genes and while they represent only a subset of ail known or
predicted homeobox genes, their counterparts in mammais, the HOX genes, are arnong
the most extensively studied family among vertebrate homeobox genes. Over
evolutionary time, the number of homeobox genes lias increased and their functions
4have been reengineered to meet the demands of increasingly diverse developmental
processes. b date, it is estimated that the human genome contains at least 200 known or
predicted homeobox genes, of which only 39 are members of the HOX family 2 1i
mammals, mutations in homeobox genes can cause dramatic developmental defects
including Ioss of specific structures as well as classical homeotic transformations. Some
homeobox genes appear to have ce!! autonomous functions in differentiation and ce!!
cycle contro! while others appear to have non-celi autonomous fonctions such as pattem
formation and mediation ofreciprocal tissue interactions .
1.1.2 The homeodomain encodes a helix-turn-helix DNA-binding domain
The high!y consewed 180-bp homeobox DNA sequence encodes the homeodomain, a
60 amino acid long DNA-binding domain that folds into three c-helices and a flexible
N-termina! arm. Helices 2 and 3 form a he!ix-turn-helix motif that is the hallmark ofa!!
homeodomain-containing proteins. The third a helix, also known as the recognition
helix, contacts specific bases in the major groove while the N-termina! extension
contacts specific bases in the minor groove. The original 2.8 À reso!ution structure ofthe
engrailed homeodomain-DNA complex was the first crystal structure to reveal how thïs
motif recognized DNA . A!though there is considerable variation in the primary
sequence of the homeobox, the consensus amino acids, which are invariant among ail
horneodomains, maintain the overal! fo!d and DNA-docking arrangement in the three
dimensiona! structure of the homeodomain (fig. 1.1).
Evolutionaiy re!ationships and family c!assifications of homeobox genes are based on
the leve! of simi!arity among their respective homeodomains and subsequent!y, by
comparative analyses of amino acid sequences both amino-terminal and carboxy!
terminal to the homeodomain, which vaiy considerably ftom protein to protein. These
families vary in size from the relatively !arge ones, such as the HOX family, that
comprises 39 members, to the small families, such as the Engrailed fami!y, which only
has two members. The a.a. sequence diversity among homeodomain proteins is believed
5to contribute to their distinct functional properties, by generating distinct DNA-binding
specificities, promoting unique protein-protein interactions, and other mechanisrns.
Fig. 1.1 The highly conserved tlwee-dimensionai helix-tum-helix structure encoded by
the homeodomain is the hallmark of ail homeodomain-containing proteins. The Ieft
image depicts the DrosophiÏa engraiied homeodomain-DNA compiex where the 3 Œ
helices and the extended N-terminal arm of the engrailed homeodomain are shown in
blue. The right image shows the complementary 2.2 Â resolution structure of the
Drosophita engrailed horneodomain bound to its optimal DNA site. DNA is depicted in
blue and the protein backbone is depicted in red with Œ-helices represented by cylinders.
Residue 5 is the first amino acid that could be reiiably modeied from the crystai structure
while the other numbers indicate helix termini. Adapted from Fraenkel E., Rould M.A.,
Chambers K.A. and Pabo C.O. (199$) JMoÏ Bio!. 284:351-361.
1.1.3 Homeoproteins are transcriptional regulators
In accordance with their role as transcnptional regulators, homeobox genes encode
transcription factors, which are predominantly localized in the nucleus where they have
been shown to function as activators, repressors or both. These homeoproteins are
thought to instruct the ceil as to which genetic program they should further implement,
6depending on which step these ceils have reached in the course of their development, or
in response to developmental cues. Although it is widely accepted that the binding
promiscuity of homeoproteins in vitro vs. their highly selective functions in vii’o, reflects
their requirernent for cofactors, relatively few examples exist in which bona fide target
genes have been identified and are regulated by specific homeobox genes in vivo. It is
now thought that the functional specificities of homeoproteins are dictated by several
tiers of regulation, including post-transcriptional controls, nuclear-cytoplasmic transport
and protein-protein interactions. For example, PBX andlor MEIS members bind DNA
cooperatively with HOX family members in vitro, which represents one mechanism that
confers specificity 5.6•
Although individual homeobox genes display unique expression patterns and specific
biological functions, homeobox gene families can be distinguished by certain general
features of their expression pattems and functional properties, as well as by their
sequence similarities. For example, HOX gene expression is generally restricted to
undifferentiated andlor proliferative celis during embryogenesis in patterns that reftect
their biological functions and that specify positional information . Other homeobox
genes have spatial and temporal expression patterns that are consistent with roles in
regulating epithelial-mesenchymal interactions that are required for tissue patterning
during embryogenesis . By contrast, the tissue-specific expression patterns of other
classes of homeobox genes in differentiated adult tissues are consistent with their
functions as positive effectors of differentiation and homeostasis .
1.2 Engrailed homeobox gene family
1.2.1 Engraited genes represent one of the smaller families of homeobox genes
The Engrailed genes are widely regarded as devclopmental genes. They are involved in
pattern formation, neurogenesis, and neuronal differentiation 10,1 ],12 In Drosophila, the
gene engrailed (en), which belongs to the segment polarity class of genes, was first
discovered as a spontaneously occurring mutation, which led to a homeotic
transformation 13 Anterior transformations and ceil death occurs in the posterior
7compartment of each segment in en mutants, and most mutants die as larvae with
severely affected segmentation patterns 14 DrosophiÏa en is involved in regulating a
number of key patteming processes, including segmentation of the epidermis and
neurogenesis, and is an integral member of the highly complex cascade of
developmentaÏ cues, which resuits in a fully developed fruit fty 13
The high degree of conservation among the Engraited gene family led to the rapid
cloning of homologs from several species . The ancestral Drosophila en gene bas
undergone gene duplication to generate two Engrailed orthologs in vertebrates.
However, genome duplication led to four EngraiÏed orthoiogs in Zebrafish, based on
their homology to the mouse En-1 and En-2 genes 16
1.2.2 Moiecular structure and properties of Engrailed proteins
Although individual members of homeoprotein families often share littie sequence
similarity outside of the homeobox, particular protein families such as Engrailed have
additional conserved domains, which contribute to their distinct functional properties.
Comparison of Engrailed homologs identified across several species revealed that ail En
proteins have short stretches of conserved regions outside of the homeodomain 17 There
are five distinct subregions within Engrailed proteins, designated EH 1—5 for Engrailed
homology regions, where 1 through 5 refers to their N- to C-terminal positions 18 (Fig.
1.2). The EH4 domain is the largest and most conserved region and encompasses the
homeodornain. The other domains are involved in proteïn-protein interactions. The EH1
and EH5 domains play a roie in active repression of transcription where the repressor
function of Eh in vivo is dependent upon its association with Groucho 19•
EH3 was defined as a region containing basic amino acids and whose primary sequence
was the least conserved across species, although it is well conserved within cadi
vertebrate class. In contrast, EH2 is 100% conserved across ail species, with tic
exception of tic ftatworm where 17 of tic 19 amino acids are identical. Together, the
EH2 and EH3 domains mediate interactions with PBX proteins . EH2 and EH3 are
similar to the hexapeptide motif and the adjacent linker region in HOX proteins,
$respectively, which are also 5’ of the horneodomain and are responsible for mediating
cooperative DNA binding interactions with PBX homeoproteins 20 This interaction has
a significant impact on the affinity of the Engrailed proteins to DNA, can redirect them
to different targets, and can determine whether they act as activators or repressors of
transcription
There is n conserved phosphorylation site N-terminal to E1-12, which is post
translationally modified by serine/threonine kinase 2 in insects and vertebrates 24 The
phosphorylation of this site may also modulate the secretion of Engrailed protein in
mammalian ceits 25 Despite being a transcription factor, which are predominantly
localized in the nucleus, a small proportion of intracellular Engrailed protein (less then
5%) is actually found associated with membrane vesicles 26 becornes secreted, and is
intemalized by cells 24,27 This occurs despite the protein lacking a classical secretion
signal and depends on a short region in the horneodomain that is essential for nuclear
export and extracellular release ofthe protein, in addition to the phosphorylation site 28
EHI P EH2 EH3 EH4 EH5
N-I I L
Groucho Pbx Homeodomain Repression
binding domain binding domain domain
fig. 1.2 Molecular structure ofthe Engrailed protein farnily. The five highly conserved
subregions designated EH1-EH5 for Engrailed homology regions l-5 are numerically
based on their N- to C- terminal positions, and are designated as colored boxes within
the full-length grey protein. The fourth and largest region, EH4, represents the
horneodomain and is depicted as a red box. The letter P in the pink circle designates the
conserved phosphorylation site N-terminal to EH2, which is putatively involved in
modulating the secretion ofEngrailed proteins in mammalian celis.
9However, outside these regions of homoiogy, En proteins share littie identity across the
phyla. At the protein level, the sequence differences between homologs and paralogs are
significant. Whereas the homeobox domain is highly conserved, often reaching 90%
amongst two different phyla, the sequence hornology drops below 30% for the
remaining portion of the protein. This is evident where mouse En-1 shares greater amino
acid (a.a.) sequence identity with the human homolog ENY than with the mouse En-2
paralog. Overali, mouse En-Ï and human EN1 share 95% identity with each other while
mouse En-1 and En-2 proteins share approxirnately 55% a.a. identity with each other
and approx 35% a.a. identity with Drosophila en. Sirnilarly, human and mouse en-2
share 90% amino acid sequence identity with each other. The En-1 class is distinguished
by the proline and alanine rich regions N-terminal to EH2 in ail En-1 proteins whule ail
En-2 proteins contain a unique serine ricli region. The 2 vertebrate En protein classes
can be further distinguished by fine conserved amino acïds C-terminal to EH5 that are
specific for either the En-1 or En-2 class.
1.2.3 En-1 and En-2 in mouse development
In the mouse, En-] expression is first detected at the one-somite stage around 8.5 days
post coitum (dpc) in ceils of the anterior neural folds. En-2 expression, which occurs in a
similar region, is first detected at the five-somite stage, but does not fully overlap with
En-1 expression until approximately $ somites have formed 29 En-2 continues to be
expressed, along with En-], within the neural plate during condensation of the first
somites and in overlapping domains in the mid-hindbrain region during embryonic
development j. At 9.5 dpc, En-1 expression is also detected in a rostral-to-caudal
pattern in two ventrolateral stripes along the hindbrain and spinal cord, in the
dermomyatome of the somites, as well as in the ventral ectoderm of the limb buds, and
additional En-] expression is later detected in the compact ceils of the somite-derived
sclerotome 30 Indicative of their domains of expression during embryonic development,
En-1 and En-2 are required for midbrain and cerebellum development and En-1 also
plays a crucial role in dorsal/ventral patteming of the limbs and skeleton.
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In the adult mouse, both En-1 and En-2 are coordinately expressed in groups of motor
nuclei in the pons region and substantia nigra that are involved in motor control. In
addition, En-2 is uniquely expressed in the granule and molecular layers of the
cerebellar ceils while En-] is uniquely expressed in the postnatal limbs 31• Their
continuing expression in the nervous system into adulthood is thought to reflect an
additional function in maintaining the integrity of the central nervous system The
emergence of two En paralogs during evolution suggests that each gene likely serves a
unique role by regulating the expression of distinct target genes in specific celi types.
This notion is substantiated by the finding that unique phenotypes are associated with
the disruption of individual En genes in mice.
Mice homozygous for En-] mutations die within a day of birth and have multiple
abnormalities. The En-1 ‘itiM (hd, homeobox deletion) mutants have a striking absence of
the mid-hindbrain tissue that is apparent from 9.5 dpc onwards that results in the loss of
the third and fourth cranial nerves and most of the cerebellum and colliculi 31 In
addition, En-1 mutants have abnormally shaped forelimbs and exhibit skeletal defects in
the 13th rib and sternum. Mutant forelimb paws are grossly deformed showing
occasional ectopic ventral digits, truncations, and fusion of the digits, splaying outwards
of the digits, supernumerary digits and a delay in ossification of the digits. The newborn
mutants exhibited truncated sternums and a delay in ossification, as well as
misalignment of the ribs and abnormal sternum ossification patterns. At birth, these
mutants were readily distinguishable due to their forelimb abnormalities and by 12 hours
after birth, it was obvious that these mutants were flot feeding as evidenced by the lack
of rnilk in their stomachs 31• The mutants could move theirjaws and limbs so the Jack of
feeding was attributed to a probable Jack of appropriate innervation from the CNS for
feeding due to the deletion of brain tissue.
Phenotypic studies initially focused on newborns because En-] mutants die shortly
after birth but subsequent analysis of viable mice homozygous for two other En-]
mutant alleles, En-1 dki/Uki (Drosophila en knock-in) and En-1 2ki/2k1 (En-2 knock-in), and
of rare En-1 ““ mice surviving to three weeks of age, showed the functional
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importance of En-1 in specifying postnatal ventral limb structures. Around 3-4 weeks of
age, the above mutant limbs develop dorsally restricted hyperpigmentation and nail-like
differentiation on the ventral epidermis, ectopic ventral hairs, and occasional ectopic
ventral digits that emanate from the base of the proximal mutant paw pad 32• The Eu-1
mutant brain defect provides evidence that patterning of the nervous system in mammais
involves a phase of regionally controlled proliferation of cell precursors Mice lacking
En-] function have a loss of midbrain and cerebellar structures that derive from the En
]-expressing brain region, suggesting that En-1 is required for the specification,
survival, and differentiation of these neural precursors 31 In contrast, loss of En-1
function in the ventral ectoderm of the developing limb does flot lead to loss of En-]
expressing ectodermal ceils, but instead results in an alteration of ventral ectoderm and
mesoderm cell fate and limb patterning 32•
Mice homozygous for En-2 mutations are viable but exhibit a distinct cerebellar
phenotype where the mutant cerebellum exhibits a one-third reduction of the normal size
and displays a specific alteration in the folding pattern lie En-2 mutant phenotype is
milder than the En-1 mutant phenotype and is restricted to the brain. During postnatal
development of the cerebellum, En-2 is required for the production of some of the
cerebellar cdl precursors and for patterning and fusing of the fissures It is thought
that the milder mid-hindbrain phenotype seen in En-2 mutants is due to the fact that En-
1 and En-2 share partially redundant functions in the brain where En-] is expressed
earlier than En-2 in the celis that will eventually express En-2.
1.2.4 Conservation of protein function among the Engrailed family
Despite the large sequence differences within the Engrailed family outside of the five
conserved regions, the biochemical conservation of these genes is striking. Substituting
mouse En-2 coding sequences in place of mouse En-1 coding sequences by gene
targeting led to viable and fertile animais with a complete rescue of the brain defects,
skeletal abnormalities and the embryonic limb patteming of the otherwise lethal En-1
null mutant 17 En-1 replaced with En-2 revealed that the two En proteins in the mouse
have retained common biochemical functions throughout evolution since mouse En-2
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can substitute for En-1, both in the neural tube where it is normally expressed as well as
in regions such as the limbs, that normally express oniy E,?-] 17 The complete rescue of
the newbom En-] mutant phenotype suggested that the two paralogs were redundant and
almost functionally equivalent. The main functional differences revealed by the nul!
mutants for the two paralogs were thought to anse from the divergence in temporal and
spatial expression rather than through divergence in biochemical function
Accordingly, the more severe deletion ofmid-hindbrain structures in En-1 nul! mutants,
in comparison to En-2 null mutants, was thought to be due to the lack of En ftinction in
the anterior neural folds between the one- and eight-somite stages, before En-2 is
expressed.
However, when surviving En-1 2ki/2k aduit mutants were analyzed, it became evident that
although En-2 can rescue the embryonic limb defects of En-] hd/hd mutants, it cannot
rescue the postnatal patterning defects of En-] hd%icl mutant limbs. En-] 2kt/2ki mice
developed the hyperpigmentation and ventral nail-like structures of En-] 1’M mutants 3-
4 weeks after birth 36 This is a direct demonstration in mammals that the regulation of
essential steps during embryogenesis has been conserved by the two paralogs, but the
fact that En-2 cannot rescue the postnatal limb abnormalities shows that En-1 bas
acquired some novel functions during evolution above those that are seemingly
redundant with En-2.
The same replacement experiment was repeated by replacing the mouse En-] coding
sequences with DrosophiÏa en coding sequences and clearly demonstrated the functional
homology across phyla, when the ortholog from an invertebrate was able to substitute
for a mammalian gene throughout the development of a highly ordered structure, the
brain 36 The resulting mice were viable and fertile, further demonstrating the
biochemical conservation over hundreds of millions of years of evolution. Mice
expressing DrosophiÏa en in place of En-] results in a near complete rescue of the lethal
En-] mutant brain defect and most skeletal abnormalities, reveating a common
underlying molecular mechanism to their diverse developmental activities. in contrast,
surviving adult En-1 dk,/dki mice demonstrated that expression of DrosophiÏa en cannot
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ftmctionally replace En-1 in the dorsal/ventrai patteming of the iimbs during cither
embryonic or postnatal development 36•
Although neither En-2 nor en are capable of rescuing the postnatal iimb abnormalities
that develop in rare En-1 1dM mutants that survive, these studies demonstrate that the
biochemical activity utilized in mouse to mediate brain development has been retained
by Engraiied proteins across the phyla, and indicate that during evolution vertebrate En
proteins have acquired two unique functions during embiyonic and postnatal iimb
developrnent and that only En-1 can carry out the latter 36
Ail En proteins share 5 conserved domains (EH1-EH5), and coding sequences in the
non-conserved regions of Drosophila en could have evolved a functionai domain
required for vertebrate limb development, which became further speciaiized in En-1
afier the second En gene (En-2) was formed by duplication 18 The ftmctional differences
between the 3 En proteins may refiect the inabiiity of en and En-2 to interact with the
full repertoire of En-1 accessory proteins, possibiy resuiting in aitered DNA binding
affinities for selective targets.
1.2.5 Engrailed k a target of the Wnt pathway
Several upstream regulators that activate, repress or maintain engraiÏed expression in the
developing Drosoph lia embryo have been identified, and similarly, several direct and
indirect targets of engrailed regulation have been identified in Drosoph lia but very few
mammalian regulators or targets ofEngraiÏed-1 andlor Engraiied-2 have been identified.
It has been shown, however, that the maintenance of En-1 expression during cmbiyonic
developrnent by the Wnt signaling pathway has been conserved from files to mice
Genetic analysis of Drosophita development indicates that wingless (Wnt-1 homolog)
signaling in the epidermis is required for the maintenance of engrailed expression in
adjacent celis In Wnt-] mouse embryos, initial En-] and En-2 expression is normal,
79but subsequent expression of both are lost
-
. In addition, compound En-1 x En-2
mutants have a similar phenotype to that of Wnt-F’ mutants where the midbrain and
anterior hindbrain fail to develop The functional link between En-1 and Wnt-1 was
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best shown when En-] expression, under the control of the Wnt-] enhancer, was
sufficient to rescue the early rnidbrain and anterior hindbrain phenotypes in Wnt-T’
embryos s”. Wnt-] encodes a secreted growth factor that initiates a signaling cascade,
which resuits in transcriptional activation mediated byfi-catenin[Tcf complexes 40•
1.3 Mouse Mammary Gland Development
The mammary gland forms as an appendage of the skin and lias its evolutionary origin in
skin glands 41 All mammary glands reside just underneath the skin but the number and
location vary among different classes of mammals. For example, only one pair of
mammary glands develops in the thoracic region in humans whereas mice possess five
ventral pairs of mammary glands (Fig. 1.4). The mammary gland consists of two main
components. The epithelial component or parenchyma refers to the epithelial system
composed of ducts and milk-producing alveolar ceils within the gland. This extensive
ductal system is embedded in the surrounding stromal component, which refers to tlie
fatty connective tissue of the mammary gland that supports the epithelial component.
Adipocytes account for the majority of celis in the stromal compartment, but fibroblasts,
celis of the hernatopoiefic system, blood vessels and neurons also reside in the fat pad 41•
The epitliclial celis form the branclied system of ducts that cliannel into a main primary
duct, whicli opens up to the body surface through the nipple. A large proportion of
epithelial ceils within the mammary gland are luminal secretory celis, which undergo
functional differentiation during pregnancy to produce milk, which is then secreted into
the inner lumen of the ducts. Basal myoepithelial cells surround the ductal system and
these contractile ceils facilitate the detivery of milk from the milk secreting cells to the
nipple during lactation.
Unlike most mammalian organs, which develop primarily embryonically, the mammary
gland is established during fetal development but the majority of expansion and
development occurs postnatally 42• The structural and functional development of the
gland involves the influence of hormones and growth factors like estrogen, progesterone
and prolactin and development of the gland itself can be divided into roughly six distinct
stages; embryonic, postnatal, puberty, pregnancy, lactation and involution (Fig. 1.5).
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Fig. 1.4 Location of the five pairs of visible ventral nipples and corresponding
rnammary glands just under the skin in the female mouse. The nipples are shown in red
and the mammary fat pad is shown in pink (the rnammary epithelial tree within the fatty
stroma is not depicted here). The adipose stroma of the gland provides a frame of
support as well as a substrate within which the rnammary epithelial tree can grow and
function. The first 3 mammary glands are in the thoracic region while the 4t11 and 5th
mammary glands are in the abdominal region. The 4th (inguinal) mammary gland is the
most accessible and thus, is the gland of choice in most experirnental manipulations. The
4th
mammary gland also contains a central lymph node (shown in purpÏe), which serves
as a convenient reference point. Adapted from DeOme K.B. et al. (1959) J. Nati. Cancer
Inst. 78:515-525.
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fig. 1.5 Distinct stages within mamrnary gLand development. The linear portion of the
diagram represents the protiferative expansion and morphogenesis that takes place in the
embryonic and virgin female. The circular portion ofthe diagram represents the cycle of
proliferative expansion and morphogenesis, functional differentiation and eventual
remodeling accornpanied with each pregnancy. Adapted from Lewis M.T. (2000) Breast
CancerRes. 2:158-169.
1.3.1 Formation and differentiation of the embryonic mammary gland
The mammary epithelium is an ectodenrial derivative and therefore, the first distinction
that must be made is the differentiation ofthe presumptive inammaiy epithelium from
tissue that can also differentiate to form skin, hair follicles or other ectodermally derived
structures. The future mammary anlage begins to differentiate from the ectodenn at day
10 of gestation (E 10) with the establishment of the mammary streaks, two lines of
1$
epidermalÏy denved thickened epithelium that extend from the anterior to the posterior
Iimb bud, symmetrically displaced off the ventral midiine of the embryo. These streaks
represent the first morphological evidence of mammary pattem formation and
differentiation before sexual differentiation of the gonads. The mammary anlage is first
visible as small placodes which define the nipple region around El 1.5 and then appears
as five pairs of small epithelial buds on the ventral side of the embryo on E12 that
enlarge to form bulb-like structures by F14. During embryonic developrnent the
mammary epithelium is associated with two types of mesenchyme; the mammary
mesenchyme that is directly attached to the epidermal bud and the future mammary fat
pad that is located below the epithelial bud in the deeper mesenchyme and consists of
preadipocytes (fig. 1.6). The mammary mesenchyme consists of several layers of
concentrically organized fibroblasts, which surround the epithelial bud and are more
densely packed than the dermal cells while the mammary fat pad appears at E14 as
undifferentiated mesenchyme and is required for future mammary epithelial
morphogenesis.
The ccli identity of mammary epithelium is clearly estabiished as early as E 12.5 as
shown by the capability of these epithelial buds at this stage to generate a ductal tree
when transplanted into a cleared fat pad of a syngeneic host. Marnmary rudiments are
formed in both sexes but the sexual phenotype of the rnammary gland is determined
between E13 and F14. During this period the gland displays responsiveness to steroid
hormones and is influenced by signais from the surrounding mesenchyme. In male
embryos testosterone acts on the dense mesenchyme surrounding the epithelial
mammary rudiment, which results in the subsequent detachment of the gland from the
epidermis. In females the rnammary buds continue to grow and reciprocal interactions
between the mammaiy bud and the mammary mesenchyme take place, which are crucial
for elongation of the mammary bud. As the mammary bud elongates to form a primary
sprout, it reaches and invades the second mesenchyme, the future mammary fat pad by
E 16. The primary sprotit then undergoes a srnall amount of branching morphogenesis,
which leads to the mdimentary ductal epithelial tree of the neonatal female.
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Fig. 1.6 The inguinal (#4) mouse mammary gland depicted at different developmental
stages. The adipose strorna of the mammary fat pad is shown in pink while the
marnrnary epithelial system is depicted in red. The central lymph node, which serves as
a convenient reference point to evaluate ductal outgrowth in the #4 mammary gland. is
shown in purpie. The embryonic rnarnmary epithelial bud is sulTounded by rnammary
Iymph node
primary duct
nipple
Embryonic d14 Birth
si
Early Puberty Mature Virgin
alveolar
structure
Pregnancy day 9 Lactation day 4
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mesenchyme (yellow) while the future mammary fat pad lies below (pink). In the
newborn mouse, the few rndimentary ducts emanate from a central primary duct that is
connected to the nipple. At this stage, the mdimentary ductal system is proximal to the
nipple and occupies littie space in the mammary fat pad. Rapid and invasive ductal
elongation and branching commence with puberty and terminal end buds (TEBs) start to
become visible. The ductal pattern of the mammary epithelial tree is created by the
bifurcation and penetration of these TEBs through the underlying stromal fat pad. The
growing ductal system reaches the central lymph node around 4 ½ weeks, and continues
growïng until the ducts have reached the peripheral limits of the mammary fat pad
around 6-8 weeks of age. Additional branching occurs in the postpubescent immature
virgin and at 10-12 weeks the mammary gland reaches sexual maturity and ductal
elongation ceases and TEBs regress to leave a branched system of ducts. Proliferation of
mammary secretory epithelium during pregnancy leads to the formation of
lobuloalveolar structures, which resemble grape-like clusters. At parturition the
mammary fat pad is completely filled with secretory alveolar structures and milk
proteins are secreted in large arnounts by the secretory epithelial celis.
1.3.2 Relatively growth quiescent prepubescent mammary gland development
At birth, the mammary epithelial tree consists of 15-20 rudimentary branches emanating
from a central primary duct, which is connected to the nipple (Fig 1.6). The rudimentary
system of small ducts present in the newborn female occupies only a small portion of the
mammary fat pad in the vicinity of the nipple. During the first three weeks of postnatal
life, before the onset of gonadal hormone secretion, the marnmary ducts are in fact
slowly elongating and branching into the underlying fatty stroma at a rate that is in pace
with the overall growth of the entire animal.
1.3.3 Proliferation and morphogenesis in pubescent mammary gland development
Functional development of the mammary gland proceeds in distinct stages that mostly
coincide with the hormonal influences of puberty and pregnancy. Around 3-4 weeks of
age, ovarian hormones stimulate accelerated and invasive ductal extension and
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branching whereby the growth rate of the epithelial ductal system now exceeds the
overail growth rate of the animal. Estrogen, atong with other hormones, plays a critical
role in the expansion and morphogenesis of the growing ductal system.
The onset of puberty also coincides with the appearance of large club-shaped TEBs,
highly proliferative and active structures found at the tips of the growing ductal
branches. It is during the early pubertal developmental stage (3-7 weeks of age) when
the TEBs are most prominent (Fig 1 .6). These TEBs are influenced by systemic steroid
hormones and aid the ducts in linear growth as well as the regulation of branching
pafferns. The ductal pattem of the mammary epithelial trec is created by the bifurcation
and penetrating extension of these TEBs through the underlying stromal fat pad. The
TEB is a specialized structure, comprising a solid mass of epithelial celis, which is
composed oftwo distinct relatively undifferentiated ccli types. Actively proliferating cap
celis make up the outerrnost layer of the end bud and interact with the sunounding
stroma though a thin basal lamina as the subtending duct is formed while body ceils
(about 6-10 layers thick), f111 the interior ofthe end bud. As the ducts elongate and the
TEBs move forward, it is thought that the inner body ceils are the precursors of luminal
epithelial celis and give risc to the inner luminal epitheliat ceil layer of the subtending
duct and the outer cap cells are the precursors ofmyoepithelial ceils and give rise to the
outer rnyoepithelial cell layer of the newly formed portion of the duct. Myoepithelial
ceils are contractile ceils that form a sleeve around the primary ducts and become
discontinuous around secondary and tertiaiy ducts and the TEBs themselves. Luminal
epithelial ceils are generally used to refer to the non-myoepithelial component of the
mammary epithelium system and these ceils line the lumen, the space within the centre
ofthe mammary ducts.
Dichotomous branching of the growing ductal system occurs at the site of TEBs as they
penetrate the underlying fat pad while monopodial branching of ducts occurs by budding
from the body ofthe existing ducts. Ductal morphogenesis and iimer lumen formation is
accomplished by a highly regulated process of both cdl proliferation and death in the
1FB. It has been demonstrated that apoptosis is an important mechanism in ductal
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morphogenesis dunng puberty and occurs in the middle of the mass of body celis and
adjacent developing luminal cells to generate the ductal lumen While a variety of ce!!
types have been identified and their developmental capacities have begun to be explored,
very little is known about how these cet! lineages and fates are established at this
pubertal stage.
The growing ductal system reaches the central lymph node around 4 ,4 weeks, and
continues growing until the ducts have reached the peripheral limits of the mamrnaiy fat
pad around 6-8 weeks of age, at which time few TEBs rernain. Additional branching
occurs in the postpubescent immature virgin and at 10-12 weeks the mammaiy gland
reaches sexual maturity and ductal elongation ceases and TEBs regress to leave a
branched system of differentiated ducts. The fully differentiated mature mammary ducts
can now serve as channels for milk transport during lactation and consist of a
discontinuous outer lining of myoepithelial cells lined by a single layer of luminal
epithelial ceils. The gland becornes essentially quiescent in the mature virgin except for
bnef periods during the ovulation cycle and the ducts will remain relatively quiescent as
long as the mature female remains a virgin.
1.3.4 Alveo]ar growth and secretory differeutiation during pregnancy
Another phase of rapid proliferation takes place during pregnancy where 50% of the
overali growth of the gland takes place from pregnancy day 12 until parturition.
Hormonal changes during pregnancy initiate this cyctical phase of development which
leads to a dramatic transition from a predominantly ductal morphology to a
predominantly lobuloalveolar gland morphology. During pregnancy, the gland cornes
under the influences of estrogen, progesterone and other placental hormones. New ductal
outgrowth occurs from the lateral walls of the ducts and side buds increase in nurnber. In
addition, lobuloalveolar progenitor ceils located in the ducts, mostly at the terminal ends
of the ducts, proliferate and undergo alveolar development to form alveotar buds which
differentiate to fom grape cluster-like structures containing lobuloalveolar units (Fig
1.6). Ibis vast expansion of the mammary epithelium fils in rnost of the fatty stroma
between the ducts. The alveoli are composed of a web like network of myoepithelial
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ceils on their outer surface surrounding columnar epithelial cells facing the lumen, the
space in the centre of the alveoli where milk is initially secreted.
These morphological changes that the alveolar epithelium undergoes are accompanied
by the development of secretory epithelial ceils within the alveoli that acquire the ability
to produce milk proteins by midpregnancy. The capability to produce milk proteins
represents the first stage in the transition to lactogenesis but the secretion of these milk
proteins is inhibited during pregnancy. At parturition, secretory function is no longer
inhibited and milk proteins are secreted in large amounts by the secretory epithelial
cells, which represents the second and final stage in the transition to lactogenesis.
Lobuloalveolar development and proliferation occur during pregnancy and resuit in the
complete fihling of the fat pad by parturition while functional differentiation of the
secretory epithelium coincides with parturition and lactation. Cell division occurs in
both the alveolar and ductal celi populations throughout pregnancy and continues into
the mid stage of lactation. Pregnancy terms vary slightly between 1$-21 days in different
mouse strains.
1.3.5 Large quantities of milk production and secretion accompany lactation
Lactation involves the production and secretion of milk by the secretory epithelial celis.
Mammary epithelial proliferation continues into early lactation where it is estimated that
20% of total mammary growth occurs during the first 14 days of lactation. By the time
tlie mother is feeding lier pups, lier mamrnary glands are packed full of secretory
epithelium witli little fat, the complete opposite of the situation in the virgin or non
pregnant animal. The initiation of lactation is thouglit to be induced by the decrease in
estrogen and progesterone and several hormones such as prolactin, insulin and
glucocorticoids are involved in the maintenance of lactation. While the inner luminal
celis of the alveoli produce the milk, the outer contractile myoepithelial cells form a
basket-like network around the secretory alveoli and these cells are responsible for
squeezing the rnilk out of the alveolï and down the ducts and out of the nipple in
responsc to the hormone oxytocin.
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1.3.6 Apoptosis, regression and remodeling accompany involution after weaning
When lactation ceases after weaning, the mammary gland undergoes involution where
the entire mammary alveolar compartment is remodeled. This remodeling elicits a
dramatic change in the morphology of the mammary gland, restoring it to its pubescent
state. The process of involution commences with the suspension of milk production,
followed by the collapse of the mammary alveolar structures and removal of the
secretory epithelial celis through programmed ceil death and phagocytosis. The alveolar
structures collapse likely as a result of degradation of the extracellular matrix (ECM)
and apoptosis of secretory epithelial cells and surrounding myoepithelial cells. The
basement membrane and most of the epithelial cells are replaced with adipose tissue so
that the mammary gland changes from the epithelial rich lactational state to the epithelial
sparse non-parous state. After regressing to this state following weaning of the offspring
the fat pad contains only well spaced ductal structures within the adipose matrix. With
each subsequent pregnancy, a new cycle of lobulo-alveolar development occurs and can
be repeated several times during the life of an animal.
1.3.7 Mammary gland transplantation
An essential feature of the mouse mammary gland is the regenerative capacity of its
epithelium. Any portion of the epithelial tree can be transplanted into the mammary fat
pad of a syngeneic female, whose endogenous epithelial tree has been removed, and
reproduce a complete and functional mammary gland In a 3 week old female mouse,
the epithelial ductal system occupies little space in the mammary fat pad and is confined
to the most proximal portion of fat pad connected to, and in the vicinity of, the nipple
(Fig. 1.6). This area containing the prepubertal epithelial ductal system can easily be
surgically removed to generate a ‘cleared’ mammary fat pad into which cells or tissue
fragments from another female can be transplanted where it can develop under the
influences of a wildtype hormonal environment. In addition, endogenous epithelium can
be left intact, providing identical mammary fat pad conditions to enable in situ
comparisons between wildtype and transplanted epithelium.
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The deletion of a gene in the mouse genome can sometimes lead to the disruption of the
normal development and functïon of more than one organ. The absence of some genes
can influence ovarian function, which would obscure assigning direct or indirect effects
on marnmary gland development. Moreover, some homozygous deletions are flot viable
and postnatal mammary gland development cannot be studied directly. The above issues
can be overcome by transpianting mammary epithelial celis from such mutants into a
wildtype syngeneic host.
The ability to transplant portions of the mammaiy epithelium into the cleared fat pad of
a syngeneic host allows one to examine both the morphogenic and tumorigenic
capabilities of that particular marmnary epithelium. Ccli populations rcmoved from the
mammary gland and mainmary epithelial ceils grown in vitro can also be transplanted.
The 4 (inguinal) mammary gland is the most accessible and is the gland of choice in
most experimental manipulations (Fig. 1.4).
The ability to delete genes from the mouse genome, in conjunction with tissue
transplants to evaluate their physiologie role, has lcd to the identification of severai
genes invoived in mammary gland development. Experimental manipulation of
mammary tissue from wiÏdtype and knockout mice has shed light on distinct signaling
networks activated by systernic hormones that induce or are involved in mammopoiesis
whiie some of these signais act through reciprocal interactions between the mammary
epithelium and the adipose stroma. The mammary transplantation method has been
employed for decades to examine fundamental questions in mammary morphogenesis,
senescence and tumorigenesis. Such experiments examine the role of genes in the
context of a normal tissue environment with an endogenous hormonal milieu and can
determine the potential role of oncogenes in preneoplastic and neoplastic
transformations and the demonstration of oncogenic potential of unknown genes.
Daniel and colleagues used serial transpiantion studies to investigate the pattern of
senescence in mammary cells and demonstrated that the proliferation potential of normal
mammary celis declined with serial transplantation and was lost after 5-6 serial
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transplants ‘. The number of pnor ce!! divisions rather than chronological age of the
transplant donor was the rnost important determinant for the onset of senescence or lack
of division potential in the mammary gland. Moreover, they aiso demonstrated that
mouse mammary preneopiasias did flot senesce and were essentially immortal
populations.
1.3.8 Adult mammary epithetial stem ceits
The observation that marnmary epithelial fragments or celis from adult mammary glands
can generate a fuiiy differentiated mammary tree capable of lactating when transpianted
into the cieared fat pad of a prepubertal mouse led to the speculation that the mammary
epithelium must contain multipotential stem cells. Mammary epitheliai stem celis
(MSCs) have been the focus of much recent interest because they are also likeiy the cells
of origin of breast tumors. Some have suggested that the notion of breast stem ceils as a
resident ccli population in the aduit breast is an oversimp!ified view and that perhaps a
selective ce!! population has MSClike ability, possibly as a resuit ofits interactions with
its rnicroenvironment or stem ccli niche. No definitive identification has been made of
an adult MSC yet experimental evidence supports the notion that such an elusive stem
celi exists and would give risc to the distinct mammary epithelial cdl lineages within the
mammary gland and models of how these lineages might develop have been proposed
(Fig. 1 .7). Currently, at least four distinct mammary ccli populations are thought to exist.
One is the muitipotent MSC that is capable of self-renewal and recapitulating the entire
mammary ductal system, and these MSCs would gives risc to committed epithelial
precursor ce!ls (EPC5). The progeny of these EPCs give risc to two pre-committed
epithelial progenitors that become restricted to a ductal or alveolar fate j. The ductal
precursor celis (DPs) form myoepithelial ceils and iuminal celis, the two ccli types that
cxist in ductal structures. During pregnancy, the alveoli are thought to be generated from
alveolar precursors (APs), which give risc to myoepithelial celis and luminal ceils.
The pre-committed epithelial progenitors and the stem cclls that are capable of giving
risc to both ccli types, are thouglit to exist throughout the entire mammary epithelial tree
but may be enriched in TEBs 46• During the rapid expansion of the ductal system during
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puberty where the body ceils and cap ceils proliferate and differentiate to generate new
sections of the growing duct behind the active TEBs invading the underlying fat pad,
stem ceil-like activity is thought to reside in the TEBs. Since some of the cap ceils can
be seen to migrate into the body celi mass, the cap cells are the proposed stem ceils and
symmetric ce!! divisions of the cap ceils within the TEBs as they move through the fat
pad are thought to deposit MSCs in the growing ducts. In the mature virgin mammary
gland, the location of putative MSCs is thought to be suprabasal, at the base of the
luminal epithelial cell layer, adjacent to the myoepithelium and not contacting the lumen
or the basement membrane This proposed stem cell niche would contain
undifferentiated MSCs that do not express markers of either myoepithelial or luminal
epithelial ceils. Divisions of this MSC would generate progenitor cells that, at least in its
early stages, would be very difficuit to distinguish from its parental MSC until it
acquires both myoepithelial and luminal lineage rnarkers before becoming committed to
either the luminal or myoepithelial lineage In the proposed model, the ductal system
contains multipotent stem cells and committed ductal and luminal precursor ceils nestled
throughout the remodeled ductal system after involution (Fig. 1.7).
MSCs are conceivably the only celi population that would possess the replicative
potential that would be needed to maintain the routine tissue renewal, the massive
expansion in epithelial tissue that accompanies pregnancy and the cyclical process of
subsequent pregnancies in the mamrnary gland. Sucli candidate stem cells would be the
type that are quiescent until responding to physiological cues. In non-parous animals, a
less expansive but similar process occurs as the estrus cycle progresses, as evidenced by
the slight expansion and regression of the alveolar buds in response to the cyclic
hormonal influences. Conversely, MSCs in the postnatal mouse mammary gland may
also be involved in the replacement of luminal epithelial celis that are shed from the
inner lining of the ducts into the lumen during routine celI turnover. Evidence to support
this occurrence during lactation is provided by the fact that epithelial cells can be
recovered from milk. Cells that are shed into the lumen of the alveolar and ductal
systems must need to be continually replaced in order for the marnrnary epithelial tree to
maintain its structure and integrity. Candidate stem celis that would participate in this
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process would need to be continually active. Thus, there are two distinct potential roles
for MSCs in the aduit mammary epithelium but whether this infers that there might 5e
two or more distinct MSC populations, perhaps in a stem ccli hierarchy, or that one
MSC population lias the capacity to perform several functions depending on the
environmental cues it is given, remains to be elucidated.
The analysis of stem cell function can be complicated by the presence of progenitor celis
that have no seif-renewal capacity, unlike the parental MSC, but that undergo a
population expansion to increase the number of fully differentiated ceils that are
ultimately produced by the original MSC division event. Retroviral tagging and
transplantation experiments have provided an estimate of the number of potential stem
ceils in the mouse mammary epithelium that could generate epithelial structures when
transplanted into a cÏeared fat pad at approximately 1 in 2,500 cclls Since the number
of mammary epithelial ceils in a mature virgin mouse mammary gland lias been
estimated at 2—2.5x 106, each gland would contain roughly 1,000 stem celis
Freshly isolated mammary and breast epithelial ceils can 5e cultured in defined medium
conditions where the cells form nonadherent aggregates called mammospheres °. These
mammospheres can 5e disaggregated and the resulting ceils that are recovered can be
divided and cultivated in separate conditions to identify those that are capable of
forming secondary mammospheres and those that attach to the culture dish and
differentiate 50 Employïng lineage specffic markers, these studies have shown that
sphere forming ceils share several characteristics attributed to MSCs that can be assayed
in vitro, including a high proliferative potential and multipotentiality. These in vitro
stem celi assays are indirect and retroactive in that the existence and the properties of a
stem ceil population are inferred solely by the analysis of their mature celI progeny and
the only definitive way to reveal the existence of MSCs is by in vivo transplantation.
Analagous to the relationship between long-term culture initiating celis (LTC-IC) and
hematopoietic stem cells (HSC), mammospheres are not necessarily MSCs and may 5e
progenitor ceils which are stiil muftipotential in their differentiative capacity but have a
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significantly reduced seif-renewal ability, or they may even represent artifacts of ceil
culture.
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Fig. 1.7 The proposed and elusive rnarnrnaiy epithelial stem cell (MSC) would give rise
to distinct epithelial ce!! !ineages in the mammary gland. The mamrnaiy g!and is a
derivative of the ectodenn, which also gives rise to the skin and other appendages as
well as the neuroectodcrm. It is thought that the multipotent MSCs would give rise to
epithelial precursor cells (EPCs), the progeny of which dcvelop into either ductal or
alveolar structures. Ductal precursors (DP) give rise to basal myoepithelial cells and
luminal celis as the ducts arc generated postnatally, particularly during puberty. The
initiation of pregnancy coincides with alveolar precursor (AP) ce!ls giving rise to basal
myoepithelial and luminal epithelial cells. Afler lactation, the alveolar cells are subject
to programmed cell death during the process of involution. A simple ducta! system
containing multipotent (ye!Low) and committed ductal (green) and lumina! (orange)
precursor cells persists that will develop into a fully functiona! epithelium in subsequcnt
pregnancies. Figure reprinted from Hennighausen, L. and Robinson, G.W. (2005) Nat.
Rev. Mot CeliBiot 6:7l5-725.
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1.4 Role of Homeobox genes in the mammary gland
1.4.1 Homeobox genes have evolved to have roles in mammary gland development
Vertebrate homeobox genes are well known for their roles during embryonic
development, and new functions are continually being identified in embryogenesis, but
less attention lias been devoted to investigating tlieir potential roles in the aduit
vertebrate. The notion that such important regulatory proteins may exert additional
functions in aduit life has been supported by reports where mice lacking the function(s)
of one or several homeobox genes affected adult development processes such as the
solidity of hairs, tlie size of the prostate and the liematopoietic system 51 These reports
are slowly growing in number and suggest that complex processes in the aduit mammal
have evolved to employ genes wliose ancestral functions are unrelated.
For example, HoxalO, Hoxa]] and Hoxd]] are involved in the urogenital system of
adult mammals during pregnancy and in addition, their expression varies in response to
tlie estrous cycle and pregnancy 52• Based on their important functions during the
development of other organs, liomeobox genes are prime candidates for being involved
during the postnatal development of the mamrnary gland. lirimunohistochernical studies
and screens based on polymerase chain reaction (PCR) analysis first detected liomeobox
gene expression in several mammary epithelial celi unes and in the normal developing
mammary gland Several Hox members appear to exhibit developmentally regulated
expression patterns during postnatal development and their expression is found in either
the mammary epithelium or in the periductal stroma or both. During embryogenesis,
Hoxb9 and Hoxd9 are expressed in the condensed mammary mesenchyme surrounding
the marnrnary epithelial bud, suggesting roles in mesenchymal-epithelial interactions
during the formation of the rudimentary mammary gland M• Hoxd9 is expressed
throughout postnatal development in the mamrnary gland and is expressed at high levels
in the ductal epithelium and periductal fibrobÏasts in the virgin. Hoxd]O is expressed in
both the mammary epithelium and stroma during lobular differentiation before lactation
and targeted dismption of Hoxd]O leads to lactation failure in liomozygous mutants
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Mammary glands of female compound mutants lacking the function of Hoxa9, Hoxb9
and Hoxd9 do flot undergo the proper dcvelopment and differentiation during pregnancy
and after pregnancy, leading to a strong deficit in the ability to produce milk ‘.
Consistent with roles in regulating cellular proliferation in the adult mammary gland, the
extensive branching process in the compound mutants during pregnancy was
significantly reduced, leading to hypoplasia of the normally proliferative and expansive
pregnant mammary gland. Since these females have an abnonual lactational capacity,
they are subsequently unable to properly feed their young.
Homeobox genes Msx-] and Msx-2 are expresscd in reciprocal tissue compartments in
the postnatal mammary gland; Msx-] is expressed in the mammary epithelium while
Msx-2 is expressed in the periductal stroma. Interestingly, Msx-2 was also found to be
responsive to estrogen and may have a potential role in mediating hormone responses
Analysis ofMsx flmction in the postnatal mammary gland lias been hindered by the fact
that both homozygous mutations in Msx-1 and Msx-2 are embryonically lethal.
Given the large number of liomeobox genes in the genome and the small number whose
potential involvement in mammary gland development has been studied, much remains
to be answered with respect to homeobox gene expression and ftmction in mammary
tissue.
1.5 Role ofllomeobox genes in cancer
It is widely accepted that many of the molecular pathways that underlie carcinogenesis
represent aberrations of the normal processes that control embryogenic development.
There are many examples in which the aberrant expression of homeobox genes that
normally regulate growth and development have been implicated in carcinogenesis,
making them an ideal candidate gene family to study the relationship between
embryogenesis and oncogenesis. Despite numerous reports of deregulatcd expression of
homeobox genes in cancer, few studies have established direct causal links or functional
roles above a mere correlative expression profile, or whether their altered expression
promotes carcinogenesis. It was originally thought that homeobox genes were
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transcnptional activators that prornote oncogenesis through their aberrant upregulati on
in carcinoma ceils. Although deregulated homcobox gene expression was originally
associated with oncogenic activities, it is now apparent that homeobox genes might be
lost 56 as well as gained in cancer, and their corresponding activities might be tumor
suppressing as well as tumor promoting. Most cases of deregulated homeobox gene
expression in cancer conform to a simple rute: those homeobox genes that are normally
cxpressed during development in undifferentiated ceils are upregulated in cancer,
whereas those that are normally expressed in adulthood and/or in differentiated tissues
are downregulated in cancer
1.5.1 Homeobox genes are implicated in cancer
In addition to docurnenting homeobox gene expression in the normal mammary gland,
HOX gene expression was also detected in several primary breast tumor samples
There are many cases in which HOX genes are re-expressed in tumors and carcinoma
ccli unes that are derived from tissues in which HOX genes are normally expressed
dunng development. There are a few examples however, where the cancerous tissue that
ectopically expresses a homeobox gene is not a derivative of a tissue where that
particular homeobox gene is normally expressed during development. for example,
PAX5 is expressed in medulloblastoma, but it is flot normally expressed in the
cerebellum from which this tumor is derived ‘. The other case lies in homeobox genes
that are downregulated in tumorigenic celis that are derived from tissues in which that
particular homeobox gene is norrnally expressed during the differentiation ofthese celis.
The loss of expression ofNKX3.] in prostate cancer fits into this category . Homeobox
genes that are expressed in carcinoma are typically those whose normal expression
pattem is restricted to undifferentiated or protiferative celis. In contrast, homeobox
genes that are downregulated or lost in carcinoma are normally expressed in ftully
differentiated tissues.
1.5.2 Nlisexpression of homeobox genes in carcinoma
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In support of a causal role in carcinogenesis, gain of function of certain homeobox genes
lias been shown to promote the transformation of ceils in culture. Expression of HOX
genes in nontransformed fibroblast cell lines leads to an increase in proliferation, other
liallmarks of oncogenic transformation in celi culture and tumor growth when ceils are
injected into nude mice . For some horneoproteins, it is thought that the wi!dtype,
rather than a mutant forrn of the protein, produces these oncogenic activities. This
implies that the oncogenic activity of some homeoproteins is flot due to new or
alternative properties, but is a resuit of their normal functions being carried out in the
wrong cellular context. For example, MSX genes have been shown to inhibit
differentiation during deve!opment and purportedly upregulate cyctin D]. Cyclin Dl is
involved in regulating the G1-S transition so it lias been proposed that MSX genes block
terminal differentiation during embryogenesis by preventing ceils from exiting the ce!!
cyc!e 60 The oncogenic properties of MSX genes in cancer cel!s rnight reflect an
erroneous extension of their normal embryonic functïons, !eading to inappropriate
upregulation of cyclin Dl, thereby effecting cdl cycle regulation and promoting or
maintaining an undifferentiated state in breast ce!!s. Overexpression of cyclin D] is a
common occurrence in mammary carcinogenesis, suggesting a possib!e link between
MSX genes and cyc!in Dl in breast cancer. A!though MSX genes might be deregulated in
several types of epithelial cancer, their causal effects for inducing carcinogenesis miglit
be restricted to tumor types where their normal downstream target genes, such as cyctin
D], have a significant impact.
HSIX] is the human homologue of the Drosophila Six gene that was originally isolated
on the basis of its enriched expression during S phase. Whule flot significantly affecting
pro!iferation, ectopic expression of HSIX] in ce!! cultures abrogates the DNA-damage
induced G2 cell-cycle checkpoint. 0f particular interest, HSJXJ is upregu!ated in
primary and metastatic breast cancer, as well as in other tumor types, raising the
possibility that its activities in ce!! culture reftect a relevant role in tumorigenesis in vivo
61 These findings, !inking HSIX1 to the regulation of the G2 cieckpoint, raise the
possibi!ity that deregulation of homeobox genes in cancer miglit have adverse effects on
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the maintenance of genomic stability by allowing ceils to proceed inappropriately past
the DNA-damage-induced checkpoint.
1.5.3 Loss of homeobox gene expression in carcinoma
There are clearly examples that support the notion where mere ‘gains’ of expression of
certain homeobox genes in cancer ceils are oncogenic and that the functionai outcome
for oncogenesis might vary depending on the ccli type in which the particular homeobox
gene is expressed. However, there are a few examples where the loss of function of a
homeobox gene has been implicated in tumorigenesis. Most notably, methylation ofthe
H0X45 promoter, leading to loss ofHOXA5 protein expression was correiated with loss
ofp53 expression and the subsequent development of breast carcinoma, suggesting that
epigenetic silencing ofHOX45 facilitates breat tumorigenesis 56
The homeobox gene CDX2 is an example ofhomeobox expression in fuily differentiated
tissue where its expression is involved in maintaining the differentiated state within that
tissue. Expression of Cdx2 first occurs in the developing gut and continues into the adult
gut while its expression is lost in colorectal tumors and colon carcinoma ccli unes 62 Re
expression of Cdx 2 inhibits ccli growth and tumorigenicity in estabiished colorectal ccli
unes while it promotes differentiation of non-tumorigenic epithelial ccli unes 63
Moreover, mice heterozygous for a mutant aliele of Cdx2 frequently develop
adenomatous intestinal polyps 64 Additional genetic events must be required for
tumorigenesis since these pre-malignant lesions do flot typically progress to the
deveiopment of overt colon carcinomas. Similar to ciinicai colon cancer samples, where
expression of CDX2 is ftequently lost without a corresponding deleterious mutation, the
wiidtype Cdr2 allele remains intact in the precursor poiyps from Cdx2 heterozygous
mutant mice despite the loss of Cdx2 protein expression 64 Thus, epigenetic inactivation
of CDX2, leading to a loss of CDX2 expression, couid represent an event that
predisposes to, but is flot sufficient for, the deveiopment of overt colorectal cancer.
Analogous to CDX2, the homeobox gene NKX3.] is expressed during the formation of
the prostate and is requircd for the terminai differentiation of prostate epitheiium in the
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aduit whule its loss of function predisposes to cancer in a tissue-specific manner 65
Overexpression of NIcc3.1 in prostate carcinoma ceils in culture and in nude mice
inhibits proliferation and tumorigenicity 66 There is increased proliferative activity in
the prostate epithelium of homozygous and heterozygous Nkx3.] mutant mice which
subsequently develop prostatic intraepithelial neoplasia (PIN), pre-cancerous lesions of
the prostate epithelium that are presumed precursors of prostate cancer 67 The loss of
NKX3I function predisposes to, but is not sufficient for, prostate carcinoma 6$ Similar
to CDX2, the loss of NKX3.] expression, due to epigenetic inactivation of one or more
ofthe NKX3.1 alleles, is involved in human PIN as well as prostate carcinoma 6$
1.5.4 Homeobox genes promote tumorigenesis
Homeobox genes are global regulators of growth and differentiation, with specific
members of different classes of homeobox gene families acting at precise developmcntal
stages and in particular tissue types. In normal tissues, the combination of these
activities provides the ultimate balance between proliferation and differentiation.
Growing evidence supports the broad generalization that the gain and Ioss of homeobox
genes promotes tumorigenesis as a consequence of their inappropriate effects on growth
and differentiation, perhaps through an extension of their normal function. Homeobox
genes that are negative regulators of differentiation exhibit oncogenic activities when
misexpressed while those homeobox genes that are positive regulators of differentiation
promote transformation following their loss of function.
The deregutation of homeobox genes appears to promote rather than be sufficient for
tumorigenesis, and this deregulation occurs in specific tissues rather than displaying a
broad specificity in many tumor types. With the exception oftranslocations that involve
homeobox genes in leukemia ‘, deregulation of homeobox genes in solid tumors might
not involve mutations or altered functions. With the above charactenstics, homeobox
genes may be generally defined as positive or negative tumor modulators, rather than as
classical oncogenes or tumor suppressors. For many documented cases of perturbations
in homeobox expression, a precise or causal relationship between the individual
homeobox gene and the tissue-specific cancer phenotype to which it contributes has flot
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been established. The notion that tissue specificity might reflect the differential activities
of normal downstream target genes, as described for cycÏin D] as a downstream target of
M$X genes, is starting to emerge. future studies that will help define the sclcctive
functional outcomes of particular homeobox genes and their associated tumor types will
no doubt aid in understanding different cancer phenotypes.
1.6 Breast Cancer
Breast cancer is one ofthe most frequent human malignancies in the Western world. The
American Cancer Society estimates that close to 212,930 American women will be
diagnosed with breast cancer and that 40,870 women will die from breast cancer this
year aJonc (www.cancer.org). Breast cancer is the leading cause of death among women
bertveen 40 and 55 years of age and is the second overail cause of death among women
from cancer, exceeded only by lung cancer. Fortunately, the mortality rate from breast
cancer is slowly decreasing with an increased emphasis on early detection and more
effective trcatments. The pathogenesis of this disease is thought to involve multiple
genetic and epigenetic events. In spite of recent advanccs in the assessment of breast
cancer risk, through the identification of crucial susceptibility genes (BRCA]/2, PTEN,
P53), these account for less than 5% of all breast cancer cases and may not be associated
with the more commonly ocdurring sporadic breast cancers 69 Sporadic nonhereditary
breast cancer is recognized as the most common form of this malignancy.
Like most other cancers, it is thought that breast cancer originates in one cdl which
acquires numerous events and becomes malignant. Later additional events lead to the
development of different clones and with different characteristics. few genes have bcen
found to be mutated in breast tumors but several chromosome arms with yet identified
genes have been found to be involved. These aberrations include DNA amplifications
and deletions. Genetic abnormalities in breast cancer include amplification of
oncogenes, mutation of tumor suppressor genes and loss of heterozygosity (LOH) at
chromosomes 1, 3p, 6q, 7q, 8p, 9p, lOq, 11, 13q, 16q, 17, 18q, 22q and X 70• Some of
these genetic abnormalities exist in premalignant breast tissue and may have a causative
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role in breast tumor pathogenesis. Unike colon cancer, the sequential steps ofmolecular
lesions during breast cancer progression are poorly understood.
Oniy a few critical oncogenes have been identified in sporadic breast cancer and the
discovery of bona fide primary genetic lesions underlying sporadic breast cancer
deveiopment remains a major challenge. This is due, at least in part, to the marked
cytogenetic compfexity seen in advanced breast cancer, preciuding investigators from
readiiy identifying primary causative genetic events in breast ccli transformation 71 The
c-MYC gene is amplifled and/or overexpressed in a high proportion of human breast
cancer, although the frequency of these aiterations varies greatly 72• Erb32 is aiso
amplified and subsequently overexpressed in 20-30% of human breast cancers, and
overexpression of ErbB2 is correlated with a poor ciinical prognosis of both node
positive and node-negative tumors n• The CycÏil? D] gene is amplified in 15-20% of
human breast cancers ‘. As the oncogenes iocated at amplified chromosornal regions are
rareiy amp}ified in benign breast disease 1, they may represent later events in the
multistep progression associated with the development ofbreast cancer.
One couid argue that the only known and weÏl validated human breast cancer oncogene
is ErbB2 since it is the only gene that has been shown to strongiy correiate with human
breast cancer progression in studies of primary ciinicai samples, to be transforming in
human mammary epitheÏial celis in vitro, to cause mammary tumor development in
transgenic mice 76 and most importantiy, for which a targeted therapeutic has been
deveioped that has ciear efficacy in the ciinic ‘. Thus, ErbB2 is the strongest candidate
for a bona fide human breast cancer oncogene and is based both on correlative data and
convincing mechanistic data.
Evidence is accumulating that suggests the breast and ovarian cancer susceptibllity
genes BRCAJ and BRCA2 seem to be involved in sporadic cancer as well. Recent
evidence suggests that BRCA] methylation contributes to a small subset of sporadic
breast cancer and the resulting molecular and clinical phenotype is similar to that of
hereditary BRCAJ-associated breast cancers. A modei lias now been proposed where
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BRCAJ promoter methylation may serve as a ‘first hit’ in a fraction of sporadic breast
carcinogenesis, mucli like an inherited germ une mutation, which promotes tumor
progression . The BRCA2-interacting protein EMSY, miglit now also provide the iink
between the BRCA2 pathway and sporadic cancer. EMSY and BRCA2 have overlapping
functions and EMSY was found to be arnplified in 512$ (18%) brcast cancer ceil unes
and in 70/551 (13%) poor-prognosis node-negative breast cancer cases ‘. EMSY was
shown to inhibit the transcriptionai activation function of BRCA2, so it is conceivably
possible that BRCA2 deletion and EMSY amplification have sirnilar effects .
Breast cancer research in the past lias focused on identifying mutations in breast tumors
and then determining their role in manimary carcinogenesis. These efforts have clearly
shown that breast cancer is a genetic disease where changes in the genome can lead to
putative causative events in the development and progression of mammary
carcinogenesis. Recent studies like those above with BRCA1 and BRCA2 in sporadic
cases also clearly indicate that the phenotype of most breast cancers, if not ail cancers, is
probably due to an amalgamation of some mutated genes and some genes that are
functionally modified by epigenetic changes such as hypermethylation of DNA and
hypoacetylation of histones 80 Inactivation or silencing of the E-cadherin gene is
associated with increased tumor invasiveness and is often found in late stage carcinomas
81 Hypermethylation of the E-cadÏzerin promoter is the principal mechanism of its loss
in many types of cancer, and its occurence is thought to reflcct the stage of tumor
progression $1
The abundance of important genes identifted as being epigenetically inodified in cancer
lias led to the expansion of Knudson’s ‘two-hit’ hypothesis for loss of turnor suppressor
gene function in tumor development to include epigenetic mechanisms as bona fide
‘hits’. Whether a mutation or epigenetic event occurs first is unknown. It is known that
the development of sporadic breast cancer is driven by phenotypic changes due to both
genetic and epigenetic events. One type of event may suffice in initiating the disease but
however initiated, the heterogeneity of sporadic breast cancer suggests that the etiology
of each turnor may be specific to the individual.
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Epigenetic dysreguiation can also Iead to aberrant expression or overexpression. For
example, the lysosomal protease cathepsin D is a predictor of poor outcome in breast
cancer patients and the genes 5’ reguiatoiy region displays differences in chromatin
structure in hormone-dependent vs. hormone-independent breast cancer ccli lunes 82
Differences in cathepsin D expression in breast cancer may conceivabiy invoive changes
in chromatin architecture, which couid render its expression constitutive. The gene for
the intermediate filament protein vimentin is transcriptionally ectopically activated
during tumor progression and also dispiays differences in chromatin architecture in
vimentin-positive vs. vimentin-negative breast cancer ceils 83
1.6.1 Breast Cancer Stem Ceils
Stem ceils have a large replicative potential and a long life span, which makes them
excellent candidates for the ceils of origin of breast tumors. Not oniy will MSCs persist
in the body for long enough to accumulate the many mutations that are required to
change a normal ccli into one with neoplastic potential, they also have the proliferative
capacity to easily generate a tumor mass. It is generally accepted that most tumors are
clonai in origin and represent the progeny of a single cdl but it was unclear which cells
in the tumor had the capacity to maintain and regenerate tumor growth. Two theories
were proposed to explain why only certain celis within a tumor could initiate tumor
growth. The stochastic model predicted that the tumor is relatively homogeneous and the
genetic alterations that underlie tumorigenesis were operative and shared among ail celis
within the tumor and although each cdl is potentially tumor-initiating, the necessaiy
ently into the ccli cycle is govemed by low probability stochastic events 84 The
hierarchy moUd predicts functional heterogeneity among the cells that make up the
tumor and that there are distinct and rare tumor initiating cells within the tumor.
A major step towards identifying these latter breast cancer-initiating ceils was provided
by elegant studies that support the theoiy that breast cancer is functionally
heterogeneous and that only a rare breast cancer-initiating cdl type is capable of
establishing human breast cancer after being transplanted. These studies showed that a
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minor breast tumor stem ceil like subpopulation was found to have a 10-50-fold increase
in the ability to form tumors in xenografts compared with the bulk of breast tumor celis
. This subpopulation represents 2% of the unfractionated breast cancer ceils derived
from human breast tumor samples and Jacks differentiated breast epithelial ceil lineage
markers (Lineage-) and was isolated using specffic ceil surface markers; CD44 and
CD24 adliesion molecules and the epithella! specific antigen ESA. The expression of
these markers is lieterogeneous in breast cancer tissue but the breast cancer-initiating
tumor celis were found to reside in a distinct Lin ESA CD44 CD24%0v population
whicli can be isolated by ceil fractionation
Evidence supporting the existence of a breast tumor stem ce!! population lias further
fueled the search for the putative but elusive aduit mammary epithelial stem ccli in the
normal breast. Identifying the existence of these tumor-initiating cel!s within breast
tumors also lias enormous implications for liow we approacli tumor therapy as most
traditiona! cancer treatrnents target rapidly proliferating ceils. Ahliougli this miglit
eliminate the non-wmor-initiating cancer celis that make up tlie bulk of a tumor and
therefore !ead to remission, the re!atively quiescent tumor-initiating stem celis miglit be
resistant to traditiona! cliemotherapy, allowing the disease to relapse if they are not
eliminated.
Whetlier breast tumor stem cells originate from normal adult MSCs or represent a transit
or progenitor ce!! population in the normal breast that lias gained stem ccli like
properties througli the possible induction of ccli type de-differentiation remains to be
answered. If normal MSCs are the primary target in the process of tumorigenesis, the
resu!ting tumors could be poor!y dïfferentiated and highly aggressive whi!e tumors
arising from transit or progenitor cel!s may be relatively well differentiated and
noninvasive. Mucli of the proliferative capacity of normal stem ceils cou!d very well
reside in a progenitor ceil population however, since these daugliter cells could
conceivably maïntain replicative potential and long life by means of a slow rate of
division.
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1.6.2 Breast cancer stem ceils as therapeutic targets
The advantage of targeting breast cancer stem ceils is that tumors could be treated on the
basis of a characteristic property shared by ail breast tumor stem ceils, one that is absent
from normal mammary stem celis. Instead of dissecting each and every genetic defect
and customizing a treatment for each individual and turnor type, this type of treatment
could enable the elirnination of the ceils of origin of the tumor, and make promising
therapeutic targets since these celis are those that likely remain after most regimens and
lead to eventual relapses in some patients.
If breast tumor stem celis are derived from progenitor or differentiated ceils instead of
normal aduit MSCs, they are likely to stiil have phenotypic characteristics of normal
MSCs. Reversion of progenitor or differentiated celis to a more stem ceil like state is
thought to be one possible scenario leading to the neoplastic process 86• In this scenario,
the phenotypic characteristics of normal MSCs miglit still be effectively employed to
target breast tumor celis 86 Future and ongoing studies are aimed at identifying distinct
molecules that are involved in the regulation of MSCs and patterns of gene-expression
sets that are limited to and define MSCs, as well as genes that are potentialiy common to
ail stem celis.
1.7 Objectives
The objective of the researcli summarized in the present PhD thesis was to identify a
gene involved in mamrnary tumorigenesis and to investigate whether this gene was also
involved in normal mammary gland development. The work presented herein represents
a candidate gene approach, which focused on the Engrailed family of homeobox genes
because of the following motivations:
(i) EngraiÏed-] (En-]) and EngraiÏed-2 (En-2) genes are downstream targets of Wnt-]
signaling during mouse embryogenesis that have important roles in development.
Ectopic expression of Wnt-] under the control of the mouse mamrnary tumor vims
(MMIV) promoter leads to extensive mammary hyperplasia and the subsequent
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generation of the majority of MMTV-induced adenocarcinomas ‘. Although expression
of WNT] itself lias flot been reported in normal or neoplastic human breast tissue, other
WNT family members are expressed in a proportion of both normal human breast tissue
and breast cancer samples 88• Wnt-1 encodes a secreted growth factor that initiates a
signaling cascade, which resuits in transcriptional activation mediated by fl-cateninlTcf
complexes 40• J3-cateninllcf-rnediated transcription bas been implicated in several
human cancers, with some targets relevant to breast carcinogenesis identified such as c
MYC and cycÏin D] 89• Also at the time this doctoral reseach was initiated, the
observation that Wnt-1 is a mouse mammary oncogene and that the downstream
mediator fl-catenin is often stabilized in certain human malignancies fueled the ongoing
search for additional targets of this pathway, such as the EngraiÏed genes, that might
also be implicated in human breast cancer;
(ii) The mammary gland is established during embryogenesis but the majority of
mammary gland growth and development occur in the adult female. En genes are
homeodomain-containing transcriptional regulators that have been studied extensively in
embryonic development, but they are also part of a growing number of transcription
factors which have evolved to carry out additional fonctions in the aduit mammal. At the
time this thesis was initiated, reports were beginning to provide evidence that En-] had
indeed acquired a further role in postnatal limb development and thus it is a possibility
that these genes have evolved to carry out additional postnatal roles, such as in postnatal
mammary gland development;
(iii) Studies were being published at the time that reported, similar to several Hox
proteins, that Pbx is a co-operative DNA-binding partner of En-2 . In addition, several
homeodomain proteins have been irnplicated as causative oncogenes in cancer and
studies in the lab were showing that Pbx was enhancing the transforming ability of Hox
genes when overexpressed in vitro.
The researcli presented in this PhD thesis describes efforts towards investigating whether
En-1 or En-2 were expressed in normal breast tissue, irnmoiïalized rnammary epithelial
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cef I unes and primary breast tumors and whether they might be involved in regulating
critical aspects of mammary gland development and/or mammary tumorigenesis.
Chapter 2 summarizes the identification of a putative role for En-1 in postnatal mouse
mammary gland devclopment while Chapter 3 documents studies that suggest EN2 is a
candidate oncogene in human breast cancer. Chapter 4 summarizes the identification of
putative EN2 transcriptional targets by microarray analysis. Chapter 5 concludes with a
discussion of the relevance of the findings presented in this thesis and addresses
potential future studies that could provide further insight into the roles of En-1 and EN2
in the regulation of normal mammary gland development and breast cancer,
respectively.
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Chapter 2 describes a study which documents the unique spatio-temporal pattem of En-]
expression in the mammary epithelium of the prepubertal and early pubertal mouse
mammary gland and suggests a potential roTe for En-] in the initial growth and
morphogenesis ofthe epithelial ductal system during the onset ofpuberty. Nicole Martin
generated ail the resuits presented in this chapter and wrote the paper under the
supervision of Dr. Guy Sauvageau.
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Abstract
We have defined the developmentally regulated expression profile ofEngraiÏed-] (En-1)
and the putative ceit types which express this gene in the mammaiy epithelium of the
prepubertal and early pubertal mouse mammary gland. Using En-] mutant mice, we
provide evidence that loss of En-1 function in the female mammary gland results in
severely impaired ductal growth. Pubertal En-] nuil mammaiy glands revealed a
primitive ductal rudiment devoid of terminal end buds, reminiscent of a prepubertal
mammary gland, while a fully developed ductal system was seen in En-l heterozygous
and wildtype siblings. Moreover, En-] nul! mammary epithelium transplanted into
surgically cleared fat pads of wildtype syngeneic hosts displayed Iirnited ductal
outgrowth with reduced side branching. Together, these studies demonstrate a unique
spatio-temporal pattem of En-1 expression in mammary tissue and suggest a potential
contribution for this gene in the initial growth and morphogenesis ofthe epithelial ductal
system during the onset ofpuberty.
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Introduction
Although the marnmary gland ïs established during fetal development, most of its
expansion and development occurs postnatally At birth, the mammary epithelial tree
emanates from a central primary duct, which is connected to the nipple. Functional
development of the postnatal mammary gland proceeds in distinct stages. At roughly 3-4
weeks of age, ovarian hormones stimulate the accelerated and invasive ductal extension
and branching of the rnamrnary tree. The onset of puberty also coincides with the
appearance of large club-shaped terminal end buds (TEB5), highly proliferatïve
structures found at the tips of the growing ducts. It is the bifurcation of these TEBs
through the stromal fat pad that creates the branched pattern of the ductal system found
within the mature mammary gland. The TEB is a specialized structure composed of two
distinct and relatively undifferentiated ccli types. Cap celis make up the outermost layer
of the TEB and interact with the surrounding stroma as the subtending duct is formed
while body celis (about 6-10 layers), fiil the interior of the TEB. Cap cells are the
precursors of myoepithelial cells, which form an outer sleeve around the primary ducts
and become discontinuous around secondary and tertiary ducts. The inner body celis
give rise to luminal epithelial ceils. A single layer of luminai epithelial cells wiil line the
newly forming ducts, where the ducts will eventuaily serve as channels for milk
transport during lactation. Temporally, the ductai system reaches the central iymph node
around 4 ½ weeks and continues growing until the ducts have reached the limits of the
manunary fat pad around 8 weeks of age. At this point the mammary gland reaches
maturity, ductal elongation ceases and TEBs regress to leave a branched system of
differentiated ducts. Lobulo-alveolar development and proliferation occur during
pregnancy, and functional differentiation of the secretory epithelium coincides with
parturition and lactation. After weaning, the entire mamrnary alveolar compartment is
remodeled to eventually resemble that of a mature virgin gland. With cadi subsequent
pregnancy, a new cycle of lobulo-alveolar development occurs.
An essential feature of the mouse mammary gland is tic regenerative capacity of its
epithelium. Portions of tic epithelial tree can be transplanted into the mammary fat pad
of a syngeneic female whose endogenous mamrnary epithelium has been removed, and
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reproduce a complete and functional mammary gland 2 The ability to delete genes from
the mouse genome, in conjunction with tissue transplants to evaluate their physiologie
role, has lcd to the identification of several genes involved in mammary gland
development. One famiiy of genes that has been proposed to be capable of regulating
such developmental decisions in the growth and differentiation of this tissue is the
homeobox family.
We have recently shown that the homeobox gene EngraiÏed-2 (EN2) is flot expressed in
the normal mouse or human mammary tissue, but is aberrantiy expressed in a subset of
human breast cancer and induces mammary tumors in mice . In addition, RNA
interference studies showed the importance of EN2 expression in maintaining the
transformed phenotype of a human breast cancer ccli une . Aithough both En-2, and its
paralog En-1, readily transform mammary epithelial cdl lines, En-1 was not detected in
any of the primaiy breast tumors analyzed (n=$2). Both Eu-] and En-2 are required for
midbrain and cerebelium deveiopment and in addition, En-] plays a cmcial role in
dorsal/ventrai patterning ofthe limbs and skeleton .
The fact that EN2 has been shown to promote mammary tumorigenesis, combined with
evidence indicating that En-1 bas evoived to perform ftirther critical fimctions in
postnatal iimb devclopmcnt in addition to its essential rolc in embryonic devciopment,
promptcd us to investigate whether En-] has acquircd an additionai role in mammary
gland dcvciopmcnt. The roic of En-1 in ncural and iimb devclopment lias bccn studied
extensiveiy, yet the determination of a potentiai role in postnatal mammary gland
development has been hampered by the fact that En-1 null mutants die shortiy afier birth
with a large mid-hindbrain deiction and skcletal defccts of the limbs, 13th rib and
sternum . In the present study we employed En-T’’ (Lki, tacZ knock-in) transgenic
mice in which the bacteriai reporter gene ÏacZ is under the control of the En-1 promoter
and endogenous regulatory ciements, to demonstrate ccli type specific and
dcvelopmcntaliy rcguiated expression of En-1 in mammary epithelial celis during the
onset of puberty, corresponding to a phase of overt proliferation and morphogenesis in
the mouse mammary gland. The targeting of ÏacZ into the first exon of En-] produces a
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nuil allele in En-1, and rare surviving mutant En]’ femates revealed a primitive
ductal rudiment devoid of TEBs while a fully developed ductal tree was seen in the
heterozygous and wildtype siblings. Moreover, mammary epithelium from
females was transplanted into the cleared fat pads of syngeneic 3 week old recipients
wherc the resulting transplants displayed impaired ductal outgrowth and branching
morphogenesis. These observations suggest that En-1 may be involved in the initial
growth and expansion of the epithelial ductal system during mammary gland
development.
Resuits
Temporal expression of En-1 in the mouse mammary gland
An initial investigation of En-1 protein expression in the mouse mammary gland
revealed that while En-1 was not detectable in the mammary tissue derived from a
lactating mother, it was readily detected in the mammary tissue ofboth ofher 17-day old
suckiing female pups (lane 6-7 in Fig. 2.la). This observation was confirmed using RT
PCR analysis, which also detected very low levels of En-1 expression in the mammary
tissue of a 35-day old female, but not in any of the later pubertal tirnepoints, or at any
developmental stage during pregnancy, lactation or involution (data flot shown).
Mamrnary tissue isolated from additional prenatal and postnatal developmental stages
showed that En-1 was first detected in the mammary tissue of a 1 5-day old prepubertal
female and expression levels steadily increase until puberty commences around day 24-
28, and become undetectable again at day 35 during puberty (Fig. 2.lb, e). En-l protein
xvas flot detected in embiyonic mammary tissue, mammary tissue containing the entire
mammaiy epithelium from a 17-day old suckling male pup or in mammary tissue
isolated during pregnancy or involution (Fig. 2.lb, e). Moreover, En-l was flot
detectable in the fatty stroma isolated from a 24-day old early pubertal female gland in
which thc epithelial tissue was surgically removed, while the highest levels of En-1
protein were observed in the tissue portion which contained the mammary epithelial trec
(Fig. 2.lb, c: lane 7 and 4, for epithelial-enriched and -depleted tissue, respectively). 0f
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interest, this highly regulated expression of En-] in the prepubertal and early pubertal
rnammary gland coincides with the rapid expansion of the epithelial ductal system and
the appearance ofTEBs.
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fig. 2.1 En-1 protein is detected in the prepubertal and early pubertal female marnmary
gland. Western blot analysis of En-1 protein expression in rnammary tissue derived
from: (a) a nursing mother at lactation day 17 (Lactation d17), and two of the suckiing
17-day old female pups (Virgin d17) and, (b-c) female inguinal marnmary glands at the
following developrnental timepoints; ernbiyonic day 19 (Ed19), 10 to 35-day old
prepubertal and pubertal immature virgin glands (Day 10 to Day 35), 5 days of
pregnancy (Pregnancy Day 5), and 4 days after weaning (Involution). In addition,
protein was extracted from the entire mamrnary gland isolated from a 17-day old
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prepubertal virgin male (Day 17 Male). The portion of the fat pad beyond the lymph
node whcre the epithelial tree has flot yet penetrated was surgically removed and was
included to represent epithclial-free mammary fatty tissue (Day 24 Stroma). HC 11 and
C57MG mammary epithelial celis engineered to express En-1, the MCF-7 human breast
tumor derived ccli une that expresses endogenous EN2 and aduit mouse cerebellum
which expresses En-2 were included as specificity controls while the Pregnant and
Involution samples were included as negative controls. a Enhb-]; antisemm that
recognizes both En-1 and En-2, aFTF]D; protein-tyrosine phosphatase ID antibody, a
TubuÏin; recognizes 55 kDa bcta Tubulin.
En-1 is expressed in ceils lining the mammary epithelial tree during pnberty
To localize the spatial expression pattem of En-1 in thc early pubertal mammary gland,
the targeted mouse une, En-1, in which En-1 was fiinctionally replaced with the
bacterial ÏacZ reporter gene, was employed (Fig. 2.2a, b) . Although the targeting event
that brought the integrated ÏacZ sequence under the control of the En-1 locus also
introduced a nuil mutation in En-1, En1L heterozygous mice are viable phenocopies
of wiÏdtype littermates and females display nonnal mammary gland development, are
fertile and are able to nurse their young (data flot shown).
Immunohistochemical staining for fi-gal was performed on sections derived from entire
• • Lki/+inguinal mammary glands isolatcd from female En-1 transgemc mice, where ÏacZ
expressing ceils produce a red-brownish reaction product. Importantly, no lacZ
expression was detected in mammary glands derived from wildtype agc-matched
+/+pubertal En-1 females (Fig. 2.2c).
At 2$ d, where high levels of En-1 expression were observed by western analysis,
positive staining for fi-gal was most obvious in putative myoepithelial and/or periductal
fibroblast cells lining the extending ducts within mammary glands derived from En-1’’
females (sec black arrows in Fig. 2.2d-f’). LacZ expression was also dctected in the cells
presumably surrounding the tip of thc highly proliferative TEB structures (sec red
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arrows in Fig. 2.2e,f) and possibly in nearby solitary stromal celis (see * in Fig. 2.2e).
En-1 expression appears to be restricted to the outermost layer of the TEB, where cap
celis reside. At this early pubertal stage, where the growing epithelial tree is approaching
the central lymph node, fi-gal expression was neyer identified in the lymph node or in
luminal epithelial celis (Fig. 2.2d-f and data not shown). 0f interest, fi-gal expression
was no longer detectable in mammary tissue denved from 35-day old En-1’’ pubertal
females (data not shown). In accordance with the temporal expression pattem presented
in Fig. 2.1, ÏacZ expressing celis were neyer detected at timepoints earlier than day 15,
later than day 35 or in subsequent developmental timepoints (data not shown),
confirming the developmentally regulatcd expression of En-1 in the prepubertal and
early pubertal mouse mammary gland.
En-1 deficient mammary glands exhibit impaired ductal growth and TEB
formation
To overcome the neonatal lethality in En-1 nuli mutants, the En-l’” allele, which resuits
in the complete disruption of En-1 function, was backcrossed into the C57B1/6J
background where rare En-1’” nul! mutants have been reported to survive up to 3
weeks afier birth 6 The resulting Enl’” heterozygous mice were indistinguishable
+1+ . . Lki/Lkifrom wildtype En-1 C57B116J mice while En-1 null mutants were
morphologically distinguishable at birth by their abnormal forelimb phenotype . In
addition, although En-l” nul! mutants were roughly the same size and weight as their
siblings at birth, by 2-3 weeks of age they were noticeably smaller than their wildtype
and heterozygous littermates (data not shown).
To determine the possible contribution of En-1 fiinction to pubertal mammary gland
development, entire inguinal mammary glands were surgically removed from rare
surviving En-l’’’ nul! mutant females, wholemounted and compared to mammaiy
glands from wildtype or En-1’’ age-matched female littermates. Newbom and 21-day
old En_]L’ female mammary glands resemble En_lUt and En-1m female littermates
(data flot shown). At 28 days of age, TEBs are readily visible and the growing mammary
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tree is approaching the lyrnph node in the early pubertal wildtype gland while no TEBs
are visible and the gland does not appear to have grown as far into the underlying fat pad
in the 2$-day old En]’’’ nul! mutant littermate mammary gLand (f ig. 2.3a, b). The
TEBs are even more prominent and the ducts have now reached the central lymph node
in a 32-day old En]kt mammary gland while the mammary glands from two En-] nuli
mutant littermates are still devoid of TERs, the ducts have yet to even approach the
Iymph node and the ductal tree still resembles a prepubertal epithelial tree (fig. 2.3c-e).
fig. 2.2 En-] is expressed in duct-lining cells ofthe mouse marnmary gland.
Lki/+(a-b) E 8.5 and E12.5 dpc En-] ernbryos stained in toto with X-Gal. Strong ÏacZ
derived activity is detected in the rnidbrain-hindbrain junction region (E8.5) and in the
mid-hindbrain region, posterior hindbrain, spinal cord and somite-derived tissue (E12.5
embiyo). (c-f) Immunohistochernical staining for fi-gal expression on paraffin sections
where “positive” cells are identified by the presence of a brownish reaction product in
the presence of NovaRED substrate and sections are counterstained with hematoxylin
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which stains nuclei blue. (e) Mammary glands from a representative 2$-day old wildtype
female shows absence of/3-gal expression. (c-f) Mammary glands from 28-day old En
1Lki/+ pcibertal fernales show positive staining in epithelial cells surrounding the growing
ducts (black arrows), the outer layer of TEBs (red arrows) and possibly in isolated
stromal cells (see * in e). Images were captured at either IOx (d), 20x (c,e) or 40x (f).
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Fig. 2.3 Impaired ductal development in En-1 nul! mutant mammary glands.
(a) Wildtype En-1’ 28-day old mammary gland; mouse weight: 13.3 g. TEBs are
readi!y visible and the growing mammary tree is approaching the !ymph node at this
stage of early puberty (l.6x). (b) Mutant En-lu’ 28-day o!d littermate mammary
gland; mouse weight: 5.2 g. TEBs are flot visible and the gland resembles a prepubertal
gland (2x). (c) Control En-l’ 32-day old mammary gland; mouse weight: 15.3 g. The
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TEBs are visible and the ducts have reached the lymph node (Ï.6x). (d-e) Two mutant
EnlLk/ 32-day old littermate mammary glands; mouse weight: 6.1 and 5.3 g,
respectively. TEBs are not visible (2x). (f-g) Control En-l’” 42-day old mammary
gland (left and right gland); mouse weiglit: 18.8 g. Some TEBs are stili visible and the
mammary tree lias grown past the lympli node (O.8x). (li) Magnification of (g) showing
the TEBs at the peripliery of the growing ductal tree (2x). (i) Mutant En-I’”’ 42-day
old littermate mammary gland; mouse weiglit: 12.3 g. Ilie mammary tree resembles a
prepubertal tree and the TEBs are at best atrophic (O.8x). (j) Magnification of (j) (2x).
(k) Contralateral mammary gland from the same En-l’’’ mutant described in (j)
(1.6x). (1) Magnification of (k) (3.2x).
0f all tlie mice analyzed in this study, one female En-]” homozygous mutant
survived until 42 days of age and exhibited the most striking difference in mammary
gland development due to En-] disruption. Whule the extensive ductal tree lias grown
past the lympli node and will soon completely f111 the fat pad in the lieterozygous En
jLki/+ female sibling (Fig. 2.3f-h), the En-]’”’ homozygous null female revealed a
primitive ductal system devoid of TEBs (Fig. 2.3i-l), reminiscent of the rudimentary
mammary tree that is present upon birtli. Consistent witli the temporal expression pattern
of En-], where En-] is not expressed until day 15, these resuits suggest that while En-1
is dispensable for the specification of the rudimentary tree pfesent at birth, it may be
required for the formation of TEB structures and the extension of the epithelial ductal
system in preparation for sexual maturity. In addition, non-cell autonomous effects
andlor a possible delay in sexual maturity, may contribute to, or exacerbate, this
phenotype.
Reduced ductal morphogenesis in En-1 nuli mammary epithelial transplants
To gain insiglit into whether the observed mammary gland phenotype in the En-] nuil
mice was due to a ceil-autonomous function of En-1 in mammary epithelium, control
En-] En-l’ and mutant En-]’’’ mammary epithelium were transplanted into
wildtype syngeneic C57B1/6J mammary fat pads following the removal of endogenous
epitlielium. In tliese studies, each 3 week old female recipient received an
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mammary tissue transplant in one inguinal fat pad and a control En-]’ or En-J
transplant in the contralateral inguinal fat pad. Wholemount analysis of En-1m and En
1LkU+
mammary epithelial transplants harvested at $ weeks (Fig 2.4 a,c,d) and 12 weeks
(fig. 2.4b) post transplantation show that the ducts were able to repopulate the host fat
pad to full capacity and any remaining TEBs are located at the periphery of the fat pad
before they regress, reminiscent of the epithelial tree secn in a normal postpubertal
virgin mammary gland. In accordance with the fact that En]Lk1/+ heterozygous mice
have no mammary phenotype, En-]’ mammary epithelial transplants undergo
comparable ductal growth and morphogenesis as compared to the wildtype epithelium
transplant (fig. 2.4c-d). However, ductal growth and morphogenesis is severely affected
in the En-] nuli mammary epithelial transplants as compared to wildtype or En-]’”
littermate transplants (Fig. 2.4e-j).
In contrast to the En-]’” mutant mammary glands that resemble the primitive
mammary tree present at birth, some of the En-] deficient mammary epithelium
transplants, from 3 different homozygous En-l’”’ micc, were able to grow and
displayed impaired ductal outgrowth and branching morphogenesis to varying degrees
when implanted into a wildtype fat pad microenvironment, from severe (f ig. 2.4e-g) to
moderate (fig. 2.4h-j). Two ofthe resulting En_]ki/Lki transplants recapitulate the growth
quiescent primitive nidimentary system seen in the En-] null mammary glands (Fig.
2.4e, g). Although one En-] null transplant appears to now be capable of forming TEB
structures, the proliferative capacity of these structures is impaired since they fail to
even penetrate the host fat pad beyond that of the mammary trec seen in a normal early
prepubertal gland (Fig. 2.4f). Interestingly, some of the En-1 deficient mammary
epithelium transplants were able to expand into much of the fat pad but they show a
reduction in branching and no visible TEBs when compared to wildtype or
heterozygous reconstituted glands (e.g., compare fig. 2.4i to d). In contrast to the well
developed ductal network in the control En-1’ and En-l’” transplants, the ductal
branching that emanated from the En-] null transplants did not extend to the periphery
ofthe fat pad and failed to establish the same level ofoccupancy ofthe fat pad.
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Fig. 2.4 Abnorrnal ductal devcloprnent of transplanted En-J nuli mamrnary epithelium.
(a,c-j) Wholemount analysis of mamrnary epithelial transplants of the indicated
genotypes harvested at 8 or 12 (b) weeks post transplantation.
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In contrast to the paralog En-2, which is not cxpressed at any developrnental tirnepoint
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in the normal mammary gland, this study demonstrates the unique spatio-temporal
pattem of En-1 expression during mammary gland development in the young female
mouse. En-] expression is highly regulated and is limited to the prepubertal gland and
during the onset ofpuberty. Immunohistochemical analysis of En-1” mammary tissue
suggests that En-] is expressed in epithelial ceils lining the expanding ductal system and
in the proliferative cap celis of TEBs. Based upon wholemount analysis, mammary
gland development was equivalent at birth in En_lL and wildtype
littermates, suggesting that prenatal mammary development is normal in En-]
homozygous nuil mice. Rare mutant females that survived to different
pubertal stages revealed a primitive ductal rudiment with a dramatic reduction in TEBs
while a fully developed ductal tree was seen in the wildtype siblings. Interestingly, a
significant proportion of the En-] null mammary epithelium transplants were able to
expand into the wildtype fatty stroma but displayed limited ductal growth and reduced
side branching to different degrees in the normal microenvironment and hormonal
milieu ofthe wildtype host fat pad.
The phenotype observed in the En-1 homozygous null female gland is not entirely
reflective of a mammary epithelial autonomous defect since it was not consistently
recapitulated by transplantation into wildtype hosts. At least within the scope of this
limited analysis, the transplantation experiments show that the En-1 homozygous null
mammary epithelium undergoes ductal extension, albeit somewhat reduced, if given the
correct developmental eues from the wildtype stromal microenvironment. Given that the
rare En-] homozygous nuli mice that survive faiÏ to thrive, it is thus conceivable that the
hormonal milieu of these mice is far from optimal. Moreover, and not tested here, it is
possible that En-1 may respond to hormonal changes that occur at the onset ofpuberty.
The second possible non celI-autonomous defect in these mice could result from a
defective microenvironment. Indeed, we detected rare fi-gal positive non-epithelial cells
in the vicinity of the expanding pubertal mammary epithelial tree (sec * in fig. 2.2e).
However, western blot analyses identified En-1 protein expression only in portions of
mammary tissue that included mammary epithelial fragments, and not in the adjacent fat
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pad, suggesting that the stromal compartment does flot contribute to the observed
phenotype. Reciprocal experiments (i.e., transpianting wildtype celis into cleared fat
pads from En-1 mutant mice) could help clarify this possibility but, due to viability
issues, their feasibility is compromised in homozygous En-] nul! mice. Thus, the
significance of this observation (i.e., possible expression of En-] in rare non-epithelial
cells) remains unclear and may be best appreciated using experimental strategies that
will complement those exploited in our study. For example, conducting recombinant
epitheliumlstroma capsular kidney cultures as described by Wiesen et al. (1999) may be
very informative .
Although there is an obvious non-cell autonomous contribution to the observed
mammary gland phenotype, it is also likely that the consistent reduction in ductal
density in the subgroup of glands reconstituted with cells lacldng a functional En-] gene
also involves ceil-autonomous effects. Iii agreement with the predominant expression of
En-1 in cells lining the epithelial ducts, the reduction in ductal tree density observed in
the reconstituted glands more likely reflects the possibility that En-] expression in the
mammary epithelium is required for epithelial-mesenchymal interactions that condition
the stroma such that it allows or stimulates the mammary epithelium to grow. The
limited number of biological samples (n=3) precluded us from performing a meaningful
quantitative morphometric analysis of total mammary epithelial structures to stromal
area as performed by Wiesen et al. (1999) . Further studies, where the possible variable
of an overali delay in development is removed, would be most valuable. Based on the
present study alone, it remains difficuit to quantify the contribution of ceil-autonomous
versus non-celi autonomous effects.
It is possible that the modifying genes in the C57B1/6J strain that temper the normally
lethal brain phenotype also temper the capacity of mammary epithelium to grow upon
transplantation. This might explain why C57B1/6J En-] nuil mamniary epithelium is
able to form TEBs and grow when transplanted into a C57B1/6J recipient, a less severe
mammary gland phenotype than what is observed in the En-] nuli mammary gland. It is
also possible that compensatory ectopic expression of En-2 in En-]’’’ C57B1/6J mice
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may partially rescuc the mammary gland phenotype in these mutant mice, analogous to
the finding that En-2 expression is likely responsible for the less severe cerebellar brain
phenotype when the En-1 Lki knock-in gene is introduced into the C57B1/6J strain 6
Although we have determined that En-2 expression is neyer detected in mammary tissue
from both CD-1 and C57B1/6J strains (Fig. 2.1 and data not shown), En-2 expression
was neyer tested in the actual rare En_lLd mutants that arose.
Given that the loss of En-1 function in the mouse mammary gland leads to reduced
growth in the otherwise rapidly proliferating pubertal ductal system, it is interesting to
note that ectopic expression of EN2 in human breast tissue is associated with breast
cancer . Since the consequence of the loss of En-1 function in the mammary gland is
consistent with a role for En-] in regulating proliferation, combined with the fact that
ectopic expression of En-] in mammary epithelial celis promotes proliferation, it is
tempting to speculate it plays a similar role in normal mammary tissue and that the
aberrant expression of EN2 in mammary tissue leads to the inappropriate activation of
En-1 targets that promote celi proliferation . It will therefore be important to identif’y if
there are common key target genes that arc both regulated by En-1 in the normal
expansion of the mammary gland and activated by cctopic EN2 expression in human
breast cancer.
Materials and Methods
Transgenic mice
The generation ofEn-]’’ (Lki, lacZ knock-in) transgenic mice, where the bacterial gene
ÏacZ which codes forfl-galactosidase (fi-gal), was inserted into the En-1 locus, has been
reported previously . The insertion of the bacterial ÏacZ coding sequences into the first
exon of En-1 brought the resulting expression of fi-galactosidase 7-gal) under the
regulation of the En-1 promoter and endogenous regulatory elements. In En-]’ mice
heterozygous for the targeted allele, the profile offl-gal activity during embryogenesis
was shown to accurately recapitulate that of the corresponding En-1 transcripts, as
determined by double-labeling using X-gal to detect lacZ expression and an antibody to
6$
detect En-1 protein and thus serves as a faithful reporter of En-1 expression . The first
111 amino acids of En-] are deieted by the above insertion of ÏacZ, and the resuiting En
J Lki allele resuits in the complete disruption of En-1 function as the homozygous En
1Lki/Lki
mutants are morphologically identical to nuli mutants (hd, deletion of
the homeodomain, also resulting in the complete disruption of En-1 function) and En-1
protein expression is flot detected with anti-En antibodies . The CDY En-1’” ce
were backcrossed into and maintained on a C57B1/6J background where rare En-1’
mutants survive 3-4 weeks after birth 6 En-l’’ heterozygous mice were
indistinguishable from wildtype En-1 mice while En-l’’’ nuil mutants were
morphologically distinguishable by their forelimb phenotype ‘. En-1’” and En-l’’’
mice were genotyped by Southern biot analysis of EcoRI-digested tau DNA using a
2400-bp Xho i-Sst 1 fragment from the bacterial lacZ cDNA andlor PCR anaiysis.
Primers used for genotyping the En-1 wildtype aliele were 5’-GAA AAA AGA AAG
GCG AGC GTC-3’ and 5’-AGC CTA AAA GTC AGC GCG AC-3’, which produced a
209 bp product. Primers used for genotypÏng the En-1’’ ailele were 5’-AAT CCC GAA
TCT CTA TCG TGC-3’ and 5’-CAC TCG GGT GAT TAC GAT CG-3’, which
produced a 240 bp fragment. Ail animais were maintained and bred in ventiiated
microisolator cages, provided with steriiized food and acidified water in the specific
pathogen-free (SPF) animai facilities of the Clinicai Research Institute of Montreai
(RCM) and of 1IRIC.
Celi unes
The HCY 1 mammary epithelial celi une is a cionai derivative of the COMMA-iD ceii
le, derived from mammary tissue of a mid-pregnant BALB/c female o The C57MG
ceil une was derived from the glands of a 23 week oid retired C57BL/6 breeder “ The
MCf7 mammary epitheliai ceii une was derived from a human breast adenocarcinoma.
C57MG, HC1 1 and MCF7 unes were grown in RPMI 1640 medium supplemented with
10% fetal caif serum, 10 ng/mi of epidermai growth factor and 10 Jg/m1 of insuiin. The
generation of HC1 1 and C57MG mammary epitheliai celis engineered to express En-]
have been described previousiy .
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Western Blot Analysis
Total protein was extracted from frozen #4 (inguinal) mouse mammary glands, adult
mouse cerebellum and celi lines and 40 jig of each resulting sample was separated by
SDS-PAGE as described previously 12 En proteins wcre detected with aEnhb-] antisera
(which detects both 41 kDa mouse En-1 and human EN1, and both 55 kDa mouse En-2
and human EN2 proteïns) as described 13 As a control for loading, membranes were
stnpped and hybridized with cither aFTFJD (protein-tyrosine phosphatase 1D; P54420;
BD PharMingen, Mississauga, Canada) or aTubulin (mouse monoclonal to beta Tubulin;
ab7287; Abcam, Cambridge, MA).
fi-galactosidase staining of embryos and immunohistochemical detection of tacZ
expression
Embryos were removed from En-1’’ females, fixed in 4% paraformaldehyde (PFA)
ovemight on a rotisserie at 4°C, and stained in toto forfi-galactosidase (fi-gal) activity as
described For fi-gal detection within the mouse mammary gland, entire inguinal
mammary glands were removed from En]ki/+ females at the indicated ages and fixed in
chilled 2% PFA, 0.2% glutaraldehyde, 0.02% Nonidet P-40 in PBS for 2 hours and
subsequently thoroughly rinsed in 4 changes of chilled PBS before being dehydrated,
paraffin-embedded and sectioned at 5 im. Immunohistochemical detection of ÏacZ
expression was performed on the resulting dewaxed and rchydrated sections using the
Vectastain Elite ABC Kit (PK-6101; Vector Laboratories, Burlingame, CA). Tissue
sections were incubated with a rabbit anti-E.coli-fl-galactosidase polyclonal antibody for
1 hour in a moisture chamber at RI (1:500 dilution; ab616; Abcam Inc., Cambridge,
MA). After PBS washes, sections wcrc incubated with biotinylated goat anti-rabbit IgG
before incubation with ABC (avidin-biotinylated-enzyme-complex) conjugated horse
radish peroxidase (PK-6101; Vector Laboratories, Burlingame, CA). Peroxidase was
visualized by incubating sections with NovaRED substrate (SK-4800; Vector
Laboratories, Burlingame, CA) and slides were counterstained with hematoxylin.
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Wholemounts and mammary gland transplantation
For wholemount analysis, entire inguinal mammary glands were surgically removed at
the indicated timepoints and spread flat on glass siides. After fixation in Camoy’s
fixative for 2 hours, the glands were defatted in ethanol and acetone washes and then
rehydrated and stained in Carmine Alum Stain ovemight. The glands were then
dehydrated, cleared with xylene and mounted with Permount. For En-1 nuil mammary
gland transplantation smdies, rare surviving En-1’’ mutant female C57B1/6J mice
were identified shortly afier birth by their limb phenotype and were left to thrive with
their female En-1 ‘ and/or En_]L littermates until 3 weeks of age. At 3 weeks of age,
the entire prepubertal mammary epithelial tree within the inguinal mammary gland (the
portion of the mammary gland comprising the main duct, rudimentary ductal system and
the surrounding fatty stroma from the nipple until the middle of the lymph node) was
removed from En_]L1 mutant females, En-1m andlor En-]’’ female littermates and
wildtype 3 week old syngeneic En-]’ C57B1/6J female mice. Using scissors, a small
incision was made in the remaining epithelial-free fat pad portion of the age-matcbed
En-1’ C57B1/6J recipient gland. Using dissection tweezers, the excised fat pad portion
from the En-l’’’ female was placed into this incision within the cleared fat pad ofthe
syngeneic host, just above the lymph node. The surgical procedures for clearing the
endogenous mammary epithelium from the inguinal fat pads of 3 week-old female mice
and implanting tissue fragments into cleared mammary fat pads have been described 2
Each recipient female carried an En-l’’ mutant mammary tissue transplant in one fat
pad and a control En-1’” or En-1m transplant in the contralateral fat pad. Wholemount
preparations of the excised portion of the host mammary gland were generated and
examined to ensure that only those En-1’ transplant recipients where the entire
mammary epithelial tree was removed were included in the study. Tissue was resewed
from each sacrificed animal to confirm the genotype of mutant En-l’’’ transplants,
+1+ Lki/+ .
. +1+female En-1 or En-1 littermate transplants and recipient En-1 C57B116J
females. The female hosts were sacrificed 8-12 weeks post-transplantation and the
chimeric mammary gland transplants were surgically removed and examined by
wholemount analysis.
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Chapter 3 is a co-authored article which documents the ectopic expression of EN2 in
human breast-tumor derived ceil unes and primary human breast cancer samples. Most
impoilantly, this work was the first to investigate a possible role of EN2 in mammary
tumorigenesis and describes in vitro and in vivo studies which suggest that EN2 indeed
behaves as an oncogene in mammary tissue.
Dr. Marc Saba-El-Leil, a Research Associate in the laboratory of Dr. Sylvain Meloche at
the time, contributed to this work by performing the transfections of synthetic siRNA
using a transfection procedure developned in the laboratory of Dr. Meloche. Dr.
Svetlana Sadekova, who heads the Breast Cancer Functional Genomics Group within the
Oncology Group at McGill University, contributed to this work by provding the 11
frozen primary normal human reduction mammoplasty breast tissue samples presented
in Figure 3.2, the frozen primary human infiltrafing ductal carcinoma, inftammatory type
sample represented by T4 in Figure 3.3 and the additional 59 primary human breast
tumor samples tested (data flot shown). The paper was written by Nicole Martin under
the supervision of Dr. Guy Sauvageau.
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Abstract
OnIy a few critical oncogenes have been identified in the more commonly occurring
cases of sporadic brcast cancer. We provide evidence that EN2 is ectopically expressed
in a subset of human breast cancer and may have a causal roic in mammaiy
tumorigenesis. Non-tumorigenic mammary celi unes engineered to ectopically express
En-2 have a marked reduction in their cycling time, lose celi contact inhibition, become
sensitive to 17-AAG trcatment, fail to differentiate when exposed to lactogenic
hormones and induce mammaiy tumors when transplanted into cleared mammary glands
of syngeneic hosts. RNA interference studies suggest that EN2 expression is required for
the maintenance of the transformed phenotype of a human breast tumor ccli une.
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Introduction
Breast cancer is one ofthe most frequent human malignancies in the Western world. The
pathogenesis of this disease is thought to invoive multiple genetic and epigenetic events.
In spite of recent advances in the assessment of breast cancer risk, through the
identification of crucial susceptibility genes (BRCAJ/2, FTEN, F53), these account for
less than 5% of ail breast cancer cases and may not be associated with the more
commonly occurring sporadic breast cancers . The discovery of bona fide primary
genetic lesions underiying sporadic breast cancer development remains a major
challenge. This is due, at ieast in part, to the marked cytogenetic complexity seen in
advanced breast cancer, precluding investigators from readily identifying primary
causative genetic events in breast ceil transformation 2
A number of oncogenes and tumor suppressors have been associated with breast cancer.
The c-MYC gene is amplified and/or overexpressed in a high proportion of liuman breast
cancer, although the frequency of these alterations varies greatly . Erb32 is also
amplified and subsequently overexpressed in 20-30% of human breast cancers, and
overexpression of Erb32 is correlated with a poor clinical prognosis of both node
positive and node-negative tumors ‘. The CycÏin Dl gene is amplified in 15-20% of
human breast cancers . As the oncogenes located at amplified chromosomal regions are
rarely amplified in benign breast disease 6 they may represent later events in the
multistep progression associated with the development of breast cancer.
In rodents, it lias been possible to identify severai breast cancer-initiating oncogenes by
tlie characterization of proviral integration sites of the mouse mammary tumor virus
(MMTV). One such locus is Wnt-1 which, when overexpressed, leads to mammary
hyperplasia and subsequent generation of adenocarcinomas . Although expression of
WNT-1 itself has flot been reported in normal or neoplastic human breast tissue, other
WNT genes have been detected in subsets of human breast cancers . Wnt-l encodes a
secreted growth factor tliat initiates a signaling cascade which resuits in transcriptional
activation mediated by /J-cateninlTcf complexes . 16-cateninlTcf-mediated transcription
has also been implicated in human cancer, witli some targets relevant to breast
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carcinogenesis identified such as c-MYC and cvcÏin DI 10.11 The observation that Wnt-1
is a mouse rnammary oncogene and that the downstream mediator B-catenin is often
stabilized in certain human malignancies fuels the ongoing search for additional targets
of this pathway, such as the Engrailed genes, that might also be implicated in breast
cancer.
The mouse En-l and En-2 genes encode horneobox-containing transcription factors that
are the murine homologs of the Drosophila segment polarity gene engraileL En-1 is
first expressed in the presumptive miWhindbrain around 8.0 dpc and continues to be
expressed, together with En-2, in overlapping pattems dunng midbrain development 12
En-2 expression is restricted to the central nervous system and branchiolar arches during
embryogenesis and En-2 nuli mutants are viable but harbor reductions in cerebellar size
13,14
En and other homeobox-containing genes clearly occupy a prominent position in the
developmental regulatory hierarchy, yet they have received little attention with respect
to mammary gland organogenesis and cancer. In the present study we show that EN2
(but not EN]) is ectopically expressed in a subset of human breast cancer and in a large
proportion of breast cancer cdl lines and that its ectopic expression readily transforms
mamrnary epithelial cells in vitro and promotes adenocarcinoma formation in vivo. We
also provide evidence ofits critical fiinction in a breast cancer cell line.
Resuits
Engrai!ed genes are rarely activated in Wnt-1-induced rnammary tumors
As Engrailed-1 (En-1) and Engrailed-2 (En-2) are firnctional targets of Wnt-1 in mouse
embryogenesis and several different groups of homeodomain proteins have been
implicated as causative oncogenes in cancer 15 we initially sought to determine whether
En-] or En-2 were impÏicated in Wnt-1-induced mouse mammary hyperpiasia observed
in MMTV-Wnt-1 transgenics 16 Neither En-] nor En-2 were detected by western blot or
RT-PCR analyses in hyperplastic mammary glands derived from nulliparous
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hemizygous MMTV-Wnt-1 transgenic females (n=4; Fig. 3.la, lane 2,3,5,7). In addition,
only one of three tumors arisïng from the MMTV-Wnt- 1 transgenics expressed En-]
(flot shown), whilc no expression of En-2 was detected in these primary tumors (fig.
3.la). Thus, while En-1 and En-2 are downstream and responsive to Wnt-1 signaling in
embryogenesis, it seems unhikely that they contributed to tumor formation.
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Fig. 3.1 Expression of En-1 and En-2 in the mouse marnmary gland. ta) Semi
quantitative RT-PCR analysis of globally amplified cDNA derived from hyperpiastic
mammary glands (MG) and tumors of MMTV-Wnt-1 transgenic mice. (b) RT-PCR
analysis was used to investigate En-2 expression at several different developmental
stages in the mouse mammary gland. HC11 mammary epithelial ceils engineered to
express En-] or En-2, E 12.5 dpc embryonic bodies without heads (Ed12.5 Body), where
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En-1 is exclusively expressed, and aduit mouse cerebellum, where En-2 is exclusively
expressed, were included as specificity controls.
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fig. 3.2 EN2 is not detectable in epithelial structures within normal human breast tissue.
(a) EN2 expression in total amplffied cDNA obtained from consecutive 2.5 fold dilutions
of MCF7 ceils (which express EN2) with HC1 1 Neo celis (EN2 negative). (b) RT-PCR
analysis of 11 normal human breast tissue samples. Keratin 18 was used to show the
epithelial content in each sample. (e) H&E sections from the corresponding 11 samples
in (b) were taken both above and below the section used to isolate RNA (20x).
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Although En-] shows a specific temporal expression pattem in the normal adult mouse
mammary gland (NM and GS, manuscript in preparation), En-2 expression was not
detectable in the normal mouse gland (fig. 3.1 b). With a detection sensitivity nearing
0.01% of the celis (F ig. 3.2a), EN2 was also flot detected in normal human mammary
tissues derived from reduction mammoplasty (n= li; Fig. 3 .2b and e). As detailed below
however, the presence of EN2 protein in the human breast cancer ceil line MCF7 (fig.
3.3a) lcd us to investigate its expression in pnmary human breast tumors.
EN2 is ectopically expressed in human breast cancer samples
Using semi-quantitative RT-PCR analysis, we found that EN2 expression was flot
limited to MCf7 celis since a large proportion (7/12 or 58%) of cstablished breast
carcinoma cdl lines expressed this gene (f ig. 3.3b). 0f the EN2-positive cdl lines, four
were derived from adenocarcinomas (MDA-MB-435S, BT-20, MDA-MB-436 and
MCF 7), one from ductal carcinoma (BT-474), and two were designated as fibrocystic
breast tissue (MCF 1OA and MCF-12A). The latter two unes, although originally
derived from hyperplastic breast tissue and flot carcinomas, have evolved from the initial
immortalized normai cdl line as they now form colonies in soft agar, a characteristic
frequently associated with transformed cells (data not shown). Western blot analyses
confirmed the presence ofEN2 and the absence ofENi in ail ofthese cdl unes (data not
shown).
To determine whether EN2 was also expressed in primary human breast tumors, semi
quantitative RT-PCR analysis was performed on RNA derived from frozen breast
biopsies. Two of the 23 primary tumors initially analyzed expressed EN2 at levels
comparable to that observed in MCF7 cells (Fig. 3.3c). Importantly, the normal tissue
adjacent to these two tumors did flot express EN2 (Normal 3 and 4; Fig. 3.3e, lane 1 and
16, respectively). These observations were confirmed by immunohistochemistry which
revealed strong EN2 nuclear staining in the neoplastic epithelial ceÏls within the tumors
only and flot in the normal adjacent tissue (Fig. 3.3d, compare T3 and T4 to N3 and N4,
respectiveiy). Histologically, these 2 tumors were defined as adenocarcinoma (T3) and
$2
infiltrating ductal carcinorna, inflamrnatory type (T4). Our analysis of human breast
tumors and normal adjacent samples was expanded to better define an estimated
frequency of EN2 expression in breast cancer. WhiÏe EN2 was flot detected in any of the
normal samples analyzed (n=19 total), 4/59 of the additional tumors expressed EN2 (flot
shown). AlI four additional EN2 positive tumors were infiltrating ductal carcinomas.
Thus, EN2 is ectopically expressed in a subset of human breast cancer representing
approximately 7% in the population tested.
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fig. 3.3 EN2 is ectopically expressed in human breast carcinomas. (a) Western blot
analysis shows the presence ofEN2 in the human breast cancer cell line MCF7. aEnhb
1; antiserum that recognizes EN1 and EN2, aPTFJD; protein-tyrosine phosphatase ÏD
antibody. (b) RT-PCR analysis of RNA isolated from hurnan breast tumor-derived cdl
unes. (c) RT-PCR analysis of RNA derived from primary breast tumor biopsies shows
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ectopic EN2 expression in two tumors (Tumor 3 and 4), whule EIV2 expression is flot
detected in the normal adjacent tissue to each tumor (Normal 3 and 4). Quantitative
phosphoimager analysis of the EN2 / Actin ratio in Tumor 3 (T3), Tumor 4 (T4), MCf7
(M), and endogenous levels in the aduit mouse cerebellum (Cer) in the figure are shown.
(d) Immunohistochemistry using aEnhb-1 antisera on sections denved from Tumor 3
(20x); in the normal adjacent tissue to Tumor 3 (20x); in the Tumor 4 section (40x); and
in the normal adjacent tissue to Tumor 4 (40x); En-2 expression in the adult mouse
cerebellum has been documented and was used as a positive control (40x).
Ectopic expression of En-2 readily transforms mammary epithelial celi unes
To investigate the possible oncogenic role of En-2 in normal breast epithelial ceils, we
first engineered, by retroviral gene transfer, its ectopic expression in two immortalized,
non-transformed, anchorage-dependent mammary epithelial celi unes, HC1 1 and
C57MG. HC1 1 cells were chosen as they have retained both the ability to differentiate in
vitro upon stimulation with lactogenic hormones and to generate epithelial outgrowths
when transplanted back into the cleared (gland-free) fat pads of syngeneic hosts, as
observed with primary mammary epithelial ceils Additionally, both HC11 and
C57MG cells have been shown to acquire anchorage independent growth when
transduced with oncogenes involved in breast cancer (c-erbB-2 in HC1 1:18; Wnt-1 in
C57MG:19). The resulting levels of En-2 expression in HCY1 selected polyclonal
populations transduced with En-2-containing retrovirus were comparable to levels of
EN2 seen in MCF7 and endogenous levels seen in the cerebellum (Fig. 3.4).
HC1 1 and C57MG cells ectopically expressing En-2 proliferated significantly faster
when compared to parental untransduced cells or Neo-transduced ceils (Fig. 3.5a and b).
Furthermore, ectopic En-2 expression conferred anchorage independent growth to both
ceil lines (Fig. 3.5c). En-2--dependent loss of cell contact inhibition was also observed in
HC1 1 cells (Fig. 3.5d). Ail of the above effects produced by En-2 expression, were
reproduced, albeit to a lesser extent, with the paralogous gene En-1 (Fig. 3.5).
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Fig. 3.4 HC11 and C57MG ceils engineered to ectopically express En-2 by retroviral
gene transfer. ta) Schematic representation of the retroviral constrncts carrying the fui
length cDNA for En-1, En-2 or PBXJb. The expected sizes of the LTR driven viral
transcripts are shown. (b) The integrity and expression of the En-1, En-2, FBX]b and
Neo-containing proviruses within the selected polyclonal transduced populations were
confirmed by Southem (DNA), northern (RNA) and western blot analysis (Protein). The
genomic DNA was digested with either Kpn I or Nhe I to release the integrated En-liEn-
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2 (4.2 kb), FBXJb (4.3 kb) and Neo (2.7 kb) viruses where Neo- and Furo-specific
cDNA probes detect the En-]/En-2 and Neo, and FBX]b proviruses, respectiveiy. En
]/En-2 and FBX1b transcripts are detected in total RNA from the same celi populations.
Autoradiographs were exposed 14 hr at -70°C. Western blot analysis using ciEnhb-1
antisernm confirms that both En-1 (55 kDa) and En-2 (41 kDa) are present at the protein
level in cells transduced with either En-1 or En-2-containing retrovims. (c) Western blot
analysis and the corresponding En / PTPID ratio of En-1 (Hi) and En-2 (H2) protein
leveis achieved by retroviral gene transfer in comparison to that documented in MCf7
(M) and endogenous levels seen in the adult mouse cerebellum (Cer).
Similar to Hox proteins, Engrailed proteins can bind target DNA as a heterodimer with
Pbxlb, another homeodomain-containing protein 20 21 Studies in our lab have shown
that Hox-induced proliferation of fibroblasts is dependent on its interaction with Pbx 22
Consistent with the ability of Pbx to enhance the DNA-binding affinity of En, the co
overexpression of FBX1b enhanced ail of the En-1 and En-2-induced effects, beyond
those determined for ceils transduced with En-] or En-2 alone (Fig. 3.5). These results,
like those seen with several Hox genes in fibroblasts, suggest a genetic collaboration
between En and Fbxlb in enhancing cdl proliferation.
Ectopic En-2 expression inhibits differentiation of mammary epithelial ceils and
renders them sensitive to 17-AAG treatment
Also restricted to HC1 1 ceils was a noticeable morphological change upon En-2
expression (and also with En-1, data not shown). 15±4% of the En-2-transduced
heterogeneous population showed larger nuclei and reduced cytoplasm compared to the
parental cells (data not shown). This morphological change is not due to the induction of
a differentiation program as RT-PCR analysis shows that neither WAF (whey acidic
protein) nor /3-casein, differentiation markers that are rapidly induced upon hormone
stimulation, are detectable in HC1 1 En-2 celis (data not shown). Moreover, HCY 1 cells
engineered to express En-2 failed to acquire a cuboidal appearance when exposed to the
lactogenic hormone cocktail (DIP; dexamethasone, insulin and prolactin, Fig. 3.5e, top
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panel) but rather maintain an elongated phenotype (fig. 3.5e, lower panel). Consistent
with this observation, control HC1 1 celis synthesize /3-casein transcripts in response to
DIP stimulation, while /3-casein remains undetectable in NC 11 cells expressing En-2
(Fig. 3.5f). Ectopic expression of En-2 thus inhibits the DIP-induced differentiation
program of HC 11 ceils in vitro.
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Fig. 3.5 Ectopic expression of En-2 readily transforms HC1 1 and C57MG celi tines.
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(a, b) Proliferation curves for HCÏ Ï and C57MG ceils transduced with En-] and En-2
+1- FBX]b. (c) Colony formation of the transduced cells after 21 days in soft agar. (d)
HCÏ Ï En-] and En-2 +1- PBX]b transduced ceils show loss of celi contact inhibition. Ail
experiments were performed immediately after selection in G41$ and/or puromycin.
Results in panels a-d represent the mean value ± s.e. of three separate experiments
repeated in triplicate each time, with two independently infected and selected polyclonal
populations. (e) HCÏ 1 parental cells stimulated with the lactogenic hormones
dexamethasone (D), insulin (I) and prolactin (P) for 4 days show the characteristic large
round cells undergoing differentiation which arise from a typical cuboïdal epithelial-like
morphology. HCÏ 1 ceils expressing En-2 maintain a more elongated fibroblastic-like
morphology after the same treatment. Magnifications of both cell populations in culture
were lOOx. (f) RT-PCR analysis of total RNA from HCÏ Ï parental cells and HCÏ Ï cells
transduced with En-2 following 3, 6 and 9 days of treatment with DIP.
We also examined the effect of 17-AAG, an inhibitor of Hsp9O which selectively kilis
cancerous celis, on the growth of these mammary epitheiiai cell unes 23 Proliferation of
both non-transformed HC1 1 and C57MG cell lines was not significantly affected by 17-
AAG treatment yet the proliferative advantage conferred by En-2 expression in these
two celi unes is abrogated by Ï7-AAG exposure (Fig. 3.6a and b). Interestingly, in the
case of En-2-expressing C57MG cells, exposure to Ï7-AAG did not only reveil the
proliferative advantage conferred by En-2, but further inhibited proliferation of these
cells to leveis that are now below those measured in the untransduced parental ceils (Fig.
3.6b). Since Hsp9O found in tumor cells has a much higher affinity for 17-AAG than the
Hsp9O found in normal cells, this supports the observation that En-2 behaves as an
oncogene in vitro and readily transforms these mammary epithelial celis.
Transplanted En-2-transduced HC11 ceils generate adenocarcinomas that
metastasize
HC1 1 mammary celis introduced into surgically cleared fat pads of female hosts, under
endogenous hormonal influences and within the natural microenvironment, will generate
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mammary epithelial outgrowths 17 Using this technique in an initial cohort, we observed
that the majority (14/16) of mammary glands reconstituted with either En-2 or En-2 +
PBX]b transduced HC1 I celis developed palpable adenocarcinomas at 14 weeks while
those receiving control HC 11 cells (either Neo-transduced or parental celis) produced
reconstituted glands but remained tumor-free (Fig. 3.7a).
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Fig. 3.6 The proliferative advantage that accompanies ectopic En-2 expression in
mammary epithelial celis is lost afier exposure to 17-AAG. (A,B) Selective in vitro
antiproliferative activity of 17-AAG in En-2-transduced HC11 and C57MG mouse
mammary cdl lines. Proliferation cuwes were generated from total cdl counts taken 3
and 6 days following the addition of either DM50 or 5 .tm 1 7-AAG.
To test for tumor progression in this in vivo tumor model a second cohort of mice were
generated and sacnficed at 21 weeks post transplantation. Once again, the control groups
remained tumor-free. The En-2 and En-2 + PBX]b groups developed large
adenocarcinomas (32/34) with extensive fibrosis and neo-vascularisation (Fig. 3.7a and
b). Macroscopic metastases were observed in multiple sites with regional nodes and
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Ïungs being preferentiaÏly targeted by the ceils initiating metastatic growth (n=6/32 mice
or 19%). Metastases were also detected in the spleen and the mesenteric lymph nodes in
certain cases (hollow diarnonds around black diarnonds indicate mice with metastases in
Fig. 3.7b).
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Fig. 3.7 Mammary glands reconstituted with either En-2 or En-2 + PBXJb transduced
HCY1 celis develop adenocarcinomas. ta) Carmine Red-stained whole mounts and
subsequent sections of the reconstituted inguinal mammaiy glands. (a) Mamrnary gland
reconstituted with Neo transduced HCI 1 celis after 21 weeks (5x). (b, c) Subsequent
sections derived from the whole mount (lOx, 20x). (cl) Mammary gland reconstituted
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with En-2 transduced HCÏ 1 celis showing one of the smaller palpable tumors afier 14
weeks (5x). (e) H&E-stained histologicai section of a representative small palpable
lesion in an HC1 1 En-2 recipient after 14 weeks. The lesion resembles carcinoma in situ
and is composed ofhyperplastic epithelium within a thick, coilagenous fibrosis (lOx). (J)
Magnification of an occluded duct seen throughout many of the recipients of En-2-
transduced HC1 1 cells (40x). (g) Mammary gland reconstituted with En-2 + FBXJb ceils
shows one of the larger tumors arising in the proximal region of the inguinal gland afier
14 weeks (5x). (h, i) H&E-stained sections of representative lesions in recipients
receiving HCY1 cells transduced with En-2 + FBX]b after 21 weeks. The tumors are
large, poorly differentiated, predominantiy soiid nests with extensive fibrosis and
surrounding angiogenesis (20x). (b) Approximate tumor volumes in the recipients afier
21 weeks (volume width2 x length x 0.52). Ail the control groups (HC 11 untransduced
parental celis, Neo or FBX]b-transduced HCÏ 1 celis) were tumor-free. (e) Clonai
dnalysis by Southem hybridization of DNA isolated from the resulting tumors and
different regions of the reconstituted mammary gland shows the contribution of En-2-
provirally-marked cells to three ofthe HC11 En-2 recipients; 2.1, 2.2 and 2.3. The DNA
is digested with BglII, which cuts only once within the provirus, and hybridization with
a Neo probe allows the identification of different integration events and distinct clones.
Exposure time was 3d at —70°C. LN, iymph node, L; lung, S: spleen, M: mesenteric
iymph node, LT; left tumor, RT; right tumor, RP; right proximal, RD; right distal, LD;
Ïeft distal; LT.4 lefi tumor in the #4 inguinal gland, LT.5; left tumor in the adjacent #5
mammaiy gland.
The clonai composition of the tumors and of adjacent portions of the reconstituted
glands was investigated using Southem blot analysis. Proviral integration analysis
showed that during the progression to tumorigenesis, typically 1-2 distinctive clones
contributed to the population of the celis comprising the tumor. Such clones are
distinguished by different autoradiographic signais visible at distinct sizes in different
tumors (e.g., see 2 different signals in lane 7, Fig. 3.7c). From the five different tumors
shown here, at ieast five distinct clones were identified (see clones “a” to “e” in Fig.
3.7e) indicating that there were no prominent clones in the initiating population.
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Interestingly, clone “a”, confirmed to be the same clone wïth a second digest (not
shown), was found in 2 different hosts (2.1 and 2.3 in Fig. 3.7c). The presence ofthis
clone in two different recipients could reflect a selective event which occurred in vitro
prior to transplantation. Our inability to detect this clone in the polyclonal population
from which it is derived (lane 1 Fig. 3.7e) suggests that a different selective process
occurs in vivo versus in vitro and that additional genetic events were required for the
development of overt mammary carcinomas in this model.
Interestingly, clones that contributed to tumor formation were different from the clones
that contnbuted to non-hyperplastic mammary outgrowths in the more distal region of
the same mammary gland (Fig. 3.7c, see 2.2 LT versus 2.2 LD). Glands transplanted
with control Neo’-transduced HC1 1 cells also tended to display clonai reconstitution
(data flot shown). Together, these results suggest that reconstitution of typical epithelial
breast structures by HCI 1 cells depends either on the selection of a subset of “stem”
ceils in this population (heterogeneity), or altematively, that these ceils require
adaptation to grow in vivo.
The clonal composition of metastases was generally identical to that of the dominant
clone present in the tumor (data not shown). Importantly, metastases mostly occuned in
mice that harbored large (>4 cm3) tumors (sec Fig. 3.7b). This suggests that fiirther
genetic events were needed for the tumor celis to acquire the ability to metastasize and
validates En-2 as a candidate oncogene that fosters conditions required for tumor
progression in vivo.
siRNA-mediated suppression of EN2 inhibits proliferation of human breast cancer
ceils
We next sought to determine the effect of knocking down EN2 expression in one of the
human breast cancer-derived ceil lines using an RNA interference (RNAi) approach.
The small interfering RNAs (siRNAs) appear to mimic intermediates in the RNAi
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Fig. 3.8 EN2 expression is required for proliferation of MDA-MB-435S ceils. (a)
Western blot analysis ofthe resulting transfected celis shows that siEN2 leads to specific
and complete suppression of EN2 leveis for up to 9 days post transfection. (b)
Transfection of siEN2 leads to a change in ceilular morphology as seen here 9 days post
transfection. Magnifications of the ceil populations in culture were 40x for 435S and
1 OOx for both siEN2 and siCTRL. (c) Proliferation curves where total celi counts were
taken at day 3 and 6 (6 and 9 days post transfection, respectively). (d) Ccli cycie-DNA
2O0O1
435S sCTRL EN2 435S &CTRL siEN2
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content analysis and Annexin V staining performed 3 days post transfection. Cer;
cerebellum, Tf CTRL; mock transfection control with 23mer ds DNA, siCTRL;
scrambled control siRNA.
pathway and can silence genes in somatic ceils without activating non-specïfic
suppression by double-stranded RNA-dependent protein kinase 24 MDA-MB-435S
ceils, which express higli levels of EN2 (Fig. 3.3b), were chosen as it was possible to
achieve more than 90% transfection efficiency in these ceils. Transient transfection of
the synthetic siRNA directed against EN2, resulted in a reproducible and complete
ablation of the protein within 48 hours which lasted for up to 12 days (Fig. 3.8a and data
not shown). Microarray analysis comparing parental MDA-MB-435S celis and siEN2-
transfected-MDA-MB-435S showed that siRNA exposure did not activate interferon
genes such as MHC class I, oligoadenylate synthetase or enolase and that off target
effects are unlikely since there was very little difference in the global transcriptome in
response to siRNA treatment (data not shown).
siEN2-transfected-MDA-MB-435S ceils uniquely exhibited a more flattened and
retractile morphology while ceils transfected with a control scrambled siRNA displayed
littie observable change in their transformed morphology (Fig. 3.8b). Jmportantly, the
suppression of EN2 in these cells also resulted in a reproducible and significant decrease
in their proliferation rate when compared to controls (those transfected with the
scramble siRNA or mock transfected cells, Fig. 3.8c). In line with these results, celi
cycle analysis revealed a 2-fold reduction in the proportion of siEN2 transfected cells in
S phase when compared to controls (30% vs 16% respectively, P<0.01, Fig. 3.8d). This
reduction in proliferation is flot accompanied by an increase in apoptosis, as revealed by
Annexin V staining and the lack of an increasing sub-G1 population (right panel; Fig.
3.$d). Persistent expression of EN2 is thus required even in this well-established breast
cancer cell une.
Discussion
We have shown that EN2 is expressed in the majority of human breast tumor-derived
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ccli lunes and that it is ectopically expressed in 7.3% of primary breast cancers. We
have also shown that ectopic expression of En-2, at levels similar to those observed in
primary tumors, readily transforms HC 11 and C57MG celis and inhibits a differentiation
program in HC1 Ï celis that is normally induced by lactogenic hormones. En-2 thus
enhances proliferatïon and inhibits differentiation of mammary epithelial celis.
furthermore, our in vivo studies and clonai analysis of mammary adenocarcinomas
ocdurring with En-2-transduced HC 11 ceils generated a unique model of breast cancer
progression from selection of long-term repopulating cells to tumor development and to
metastasis. RNA interference-mediated down-regulation of EN2 in a human breast
tumor-derived ccli une ieads to a dramatic reduction in ccli proliferation and loss of
transformed morphological characteristics.
To our knowledge, EN2 is the first candidate oncogene identificd in breast cancer which
is not normally cxpresscd in breast epithelium. Southem blot analysis of genomic DNA
isolated from the seven different EN2-positive human breast cancer ccli unes studied
herein failed to reveal any anomaly, suggesting that neithcr rcarrangemdnt nor
amplification are responsible for ectopic EN2 expression. Although the basis for
overexpression of MYC, CycÏin D] and ErbB2 is ofien amplification of the gene,
overexpression is also obscrvcd in the absence of amplification 25 Epigenetic
modification of the EN2 locus remains a real possibility. Vcry littie is known about
upstrcam rcgulators of En, in addition to Wnt, and our studies suggest that the activation
of one Wnt mcmber, Wnt- 1, is flot involvcd since En-2 expression is not found in mouse
mammary tumors induced by Wnt- 1 and this oncogenc is not cxpressed in human breast
carcinomas. It will therefore be challenging to identify the exact mechanism(s)
underlying the ectopic expression ofEN2, but standard epigenetic tests will likely revcal
that the locus is rendercd transcriptionally active. It will be interesting to discriminate
whether EN2 is activated in preneoplastic breast lcsions as both MCF 1 OA and MCf
12A express EN2 and are derived from womcn with cpithelial hyperplasia of the breast.
This is in contrast with other oncogenes (e.g., ErbB2) which are rarely detected within
early lesions or benign brcast disease 26 and may indicate that ectopic EN2 expression
occurs carly in brcast cancer.
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The reasons for the high incidence of EN2 expression in breast cancer ceil unes (as
opposed to primary tumors) are not clear. Perhaps a selection process (proliferation,
independence of stroma, etc.) favors the emergence of cancer ccli unes which express
this gene. As the notion of breast cancer stem ceils is emerging 27 it will become
interesting to investigate whether EN2 determines the proliferative activity of these
tumor stem ceils, as we recently showed for Bmi-] in leukemic stem celis 2$
0f interest, EN2 was also detected in SAGE libraries derived from human brain
glioblastoma, colon and ovarian carcinoma (Library numbers NCI CGAP Bm23, NCI
CGAP Co16 and CL ES2-1, respectively, http://www.ncbi.nim.nih.gov/UniGene). It wiIi
be essential to anaiyze whether EN2 is also ectopicaily expressed in other epithelial
tumors as the observations described herein may be generaiized to other carcinomas.
Importantiy, it wili be critical to determine an even more accurate frequency of EN2
ectopic expression in breast cancers using a iarger number of specimens and to assess
whether its expression coi-relates predominantly to infiltrating ductal carcinomas.
Similar to the current rationale that herceptin and 1 7-AAG, in combination, will increase
the taxol response even further in HER-2 overexpressing breast and prostate cancers, the
combination of 1 7-AAG and siRNA against EN2 may constitute a strong assault against
EN2-positive breast tumors. Although siRNA directed against EN2 offers great
specificity in cancerous iesions detected early, as we have shown that EN2 is ectopically
expressed in breast cancer, the addition of 17-AAG may also affect those tumors that
have evolved to evade the toxic effects of single molecuiarly targeted agents. This
approach could have great clinical benefit as if it does not kiil the cancer ceils, it might
leave them sufficiently debilitated and more sensitive to chemotherapy and radiotherapy
23
Materials and Methods
Transgenic mice
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The generation of MMTV-Wnt-l transgenic mice has been reported previously 36 and
were purchased from The Jackson Laboratory (FVB/N hybrid background, stock #
002934). MMTV-Wnt-1 mice were genotyped by Southem blot analysis of Bam HI
digested tau DNA using a 904-bp Kpn l-Sph 1 fragment of SV4O poly(A) DNA. BALB/c
mice were acquired from Harlan Labs (Indianapolis, IN). Ail animais were maintained
and bred in ventilated microisolator cages, provided with sterilized food and acidified
water in the specific pathogen-free (SPF) animal facility of the Clinical Research
Institute ofMontreal (IRCM).
Ceil unes
The HC1 1 rnammary epithelial ccli une is a clonal derivative of the COMMA-iD celi
une, dcrived from marnmary tissue ofa mid-pregnant BALB/c fernale 29.30 The C57MG
ccli une was derived from glands of a 23-week-old retired C57BL/6 breeder MCF7,
MDA-MB-231, SK-BR-3, MDA-MB-46$, MDA-MB-435S, MDA-MB-436, and BT-20
human epithelial cell lines were derived from breast adenocarcinomas. T-47D and BT
474 human epithelial cdl lines were isolated from ductal carcinomas. MCF 1OA and
MCF-12A human epithelial celi unes were derived from fibrocystic breast tissue and
both lines have been reported to form colonies in soft agar. The HBL 100 human
epithelial cell une was originally derived from breast milk, yet aiso forms colonies in
soft agar. CS7MG, HC 11, T-47D, HBL 100, and MCF7 lines wcre grown in RPMI 1640
medium supplementcd with 10% fetal caif serum, 10 ng/ml of epidermal growth factor
and 10 ig/ml ofinsulin. MDA-MB-435S, MDA-MB-436 and MDA-MB-46$ lines were
grown in Lebowitz-L 15 medium supplcmented with 10% fetal caif serum. MCF 1 OA
and MCF-12A unes were grown in f12 HAM:DMEM (1:1) medium supplemented with
5% fetai calf serum. The BI-20 une was grown in cLMEM medium supplemented with
10% fetal calfsemm.
Generation of recombinant retrovïruses and infection of mammary ceil unes
Thc entire coding regions of thc mouse En-I (nucleotides 274-157$; Accession no.
112703, #552) and En-2 (nucleotides 1-13 15; Accession no. L12705, #547; the mouse
97
En-2 protein shares 90% amino acid sequence identity with the human EN2 protein)
cDNAs were introduced into the Hpa I and Hpa 1-Bgl 11 sites, respectively, downstream
of the retroviral promoter contained within the 5’ long terminal repeat (LTR), of the
MSCVneoEB retroviral vector which confers G4 18 resistance under the control of the
phosphoglycerate kinase (PGK) promoter. The MSCV-human PBX1b-PGK-PAC
retroviral vector (which confers puromycin resistance) was described previously 22
High-titer helper-free recombinant retroviruses were produced from BOSC-23 viral
packaging ceils and tested as previously reported 22 HC1 1 and C57MG ceil unes were
infected by exposure to filtered (0.2 tm, low-protein binding filter, Millipore, Bradford,
MA) viral supematant in the presence of 6 tg/ml polybrene (Sigma). Transduced ceils
were selected and maintained in 220 and 260 tg/ml of G418 for HC11 and C57MG
lines, respectively, or 2.5 jig/ml puromycin, or both drugs concurrently, as appropriate
for selection of virus encoded selectable markers.
Southern, Northern and Western Blot Analysis
To assess proviral integration, Southem hybridization analyses were performed as
previously described 32 10 tg of genomic DNA was digested with Kpn 1 or Nhe 1 which
cleaves in both flanking LTRs to release the provims. Membranes were hybridized with
Neo- or Furo- specific probes labeled with 32P-dCTP by random primer extension as
described Following autoradiography, blots were stripped and hybridized using a
probe specific to HoxA9 (1.1 kb Hind III fragment) to assess loading. For Northem blot
analysis, 10 jig total RNA isolated with TRizol (GIBCO) was separated on a 1%
formaldehyde-agarose gel as described ‘ and hybridized with a 1 86-bp Bgl II En-1
cDNA (#552) probe, a 254-bp Bgl II-Sst I En-2 cDNA (#530) probe and a 1.6-kb Bgl II
Eco RI PBX]b cDNA (#448) probe. After autoradiography, the blots were stripped and
rehybridized with an oligonucleotide complementary to 1 8S rRNA for western blot
analysis, total and nuclear extracts were prepared as reported previously 100 ig total
and 40 jig nuclear aliquots of protein were separated by SDS-PAGE as described 36 En
proteins were detected with ŒEnhb-1 antisera (which detects both 41 kDa mouse En-1
and human EN1, and 55 kDa mouse En-2 and human EN2 proteins) as described
PBX1b proteins were detected with an anti-PBX1 polyclonal antibody (P-20; cat# sc
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889; Santa Cruz Biotechnology mc, Santa Cruz, Calif.). As a control for loading, ail
membranes were stripped and hybridized with ŒPTP 1 D (protein-tyrosine phosphatase
1D; P54420; BD PharMingen, Mississauga, Canada).
cUNA generation, amplification and analysis
Total RNA was isolated from aduit mouse cerebellum, mouse mammary glands, cdl
unes, frozen human primary breast tumors, adjacent normal breast samples and frozen
human reduction mammoplasty tissue using TRIzol. Reverse transcription and
amplification of 0.1 jig of the resulting total RNA were performed as described
previously 38• Single-copy probes corresponded to a 436-bp fragment of the mouse fi
casein cDNA (nt 4871-5307; Accession no. M26940 X13484, #1051) and Actin, isolated
as described in The amplification ofActin was used as a control for both quality and
quantity of templates in each sample. To demonstrate that the amplification was solely
from cDNA and flot from DNA contamination, a control which contained RNA but no
reverse-transcriptase (No RT) was included in cadi experiment.
Immunohistochemistry
Frozen sections were cut at 5 jim and were subsequently fixed briefly in
paraformaldehyde. Immunohistochemistry was performed using a three-step
streptavadin-biotin peroxidase method and antigen retrieval was carried out by
microwave heating in citrate buffer. Primary antibody rabbit anti-mouse polyclonal
aEnhb-1 was used at a final dilution of 1/500. Biotinylated goat anti-rabbit IgG
secondary antibody (Vector Laboratories, Burlingame, CA) was used at a final dilution
of 1/150, and revealcd using Streptavidin-Horseradish Peroxidase (NEL 750, NEN) at
1/1000. Siides were counter-stained with Methyl Green.
Soft agar colony formation, contact inhibition and proliferation assays
For proliferation assays, the selected HCÏ 1 and C57MG polycional transduced ceil
populations were trypsinized and replated at 3x105 and 5000 cells per 10 cm2 dish in
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RPMI 1640 with 5% FBS, for 3 and 6 days of growth respectively, and subsequently
starved, serum stimulated and counted as previously described 22 For colony assays, the
celis were grown for 3 days in the absence of antibiotic selection and then 2x104 celis
were plated in RPMI 1640 medium supplemented with 10% fetal calf serum, 10 ng/ml
of epidermal growth factor and 10 ig/m1 of insulin containing 0.3% Agar Noble into 35
Petri dishes containing a layer of solidified 0.6% agar. Colonies were scored 21
days afler being plated using a surface area that corresponded to 1/8 of the 35mn12 dish
using an inverted microscope. For the contact inhibition assay, selected HC1 1 polyclonal
transduced celi populations were trypsinized and replated at near confluence in 10 cm2
dishes in RPMI 1640 with 10% FBS. Total ceil counts were taken 7 days later when
dense foci were readily visible in the cultures that no longer displayed contact inhibition
and continued to grow.
Lactogenic hormone stimulation of fiCh mammary epithelial celis
HC1 1 cells and HC1 1 cells expressing En-2 were grown to confluency in 10 cm2 dishes
and maintained for 3 days in normal media. Confluent cultures were washed and
incubated for 18 hr in serum-free media (RPMI 1640 containing 1 mg/mJ fetuin and 10
tg/m1 transferrin) followed by 3, 6 and 9 days of treatment with induction medium
(RPMT 1640 containing 1OE6 M dexamethasone, 5 ig/ml insulin, and 5 Ig/m1 ovine
prolactin /luteotropic hormone; Sigma) as described 40 Parallel unstimulated controls
were subjected to the same regimen but were kept in RPMI 1640 with 5% FCS after
serum-free staiwation. The morphological changes in HC1 1 cells expressing En-], En-
1+ PBXJb, En-2 and En-2 + FBX]b were scored on cytospin preparations containing
150,000 cells (n=4 siides for each population).
Transplantation of HC1 Transduced Celis into Syngeneic Hosts
Selected polyclonal populations of HCY 1 celis transduced with En-2, En-2 + FBX]b,
PBXJb, Neo and untransduced HC1 1 cells were collected from 10 cm2 dishes and
resuspended in normal growtli medium at a final concentration of 5 x i0 cells/10 t1.
Using a beveled syringe, the celis were injected into the cleared fat pads of female
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BALB/c syngeneic hosts, just above the lymph noUe, in a volume of 10 t1. The surgical
procedures for clearing the endogenous mammary epithelium from the #4 (inguinal) fat
pads of 3-week-old female mice have been described In each case, whole-mount
preparations of the excised host mammary epithelium were generated to verify complete
removal. Two cohorts of mice were sacrificed at 14 and 21 weeks post transplantation,
respectively, and the glands were surgically removed. Whole-mount preparations and
subsequent sections were produced from the reconstituted glands in the first cohoiï. In
the second cohort, the majority of the resulting tumors, different portions of the
reconstituted glands, and potential sites of metastases were either fixed in paraffin and
subsequently sectioned, or used for DNA extraction.
Whole Mounts and Tumor Histology
Inguinal mammary glands were resected and flatten fixed in Camoy’s fixative, defatted
in ethanol and acetone, rehydrated and stained in Carmine Red. The manmiary whole
mounts were reprocessed for paraffin embedding and 5 tm sections were prepared.
Tumors and potential sites of metastases (brain, lung, femur, spleen, lymph nodes, and
the #5 mammary gland) were fixed O/N in 4% PFA, embedded in paraffin, sectioned at
5 jim and stained by H&E.
RNA Interference Studies
The 21-nt human EN2 target sequence used to design the synthetic siRNA was 5’-AAC
TTC TIC ATC GAC AAC ATC-3’. The selected sequence was subjected to a BLAST
search against the human genome sequence to ensure that only EN2 would be targeted.
The 21-nt sequence constituting the control scrambled siRNA (siCTRL) was 5’- AA
GCG CGC ITT GTA GGA TTC G -3’. Synthetic siRNA oligonucleotides were
purchased from Dharmacon (Lafayette, CO). MDA-MB-435S ceils were regularly
passaged to ensure exponential growth and were passaged the day before transfection.
Subconfluent MDA-MB-435S celis were transfected witli 150 nM siRNA / 6 cm2 disli
and fresh media was provided 36 h after (details of the transfection procedure are
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available upon request to S.M.). Whole-cell extracts were prepared 3, 5, 7, 9 and 12 days
after transfection, separated on a 10% SDS-PAGE and immunoblofted to reveal EN2
protein. The same membrane was immunoblotted with antibody against ,6-Tubulin as a
control for loading. Celis were harvested for flow cytometry and plated for proliferation
assays 3 days afier transfection in at least three independent experiments.
Ccli Cycle Analysis and Annexin V Staining
MDA-MB-435S ceils were trypsinized three days post-transfection, washed twice with
PBS, and incubated for 30 min on ice in hypotonic DNA staining solution (0.1% Sodium
citrate, 0.3% NP-40, 0.02 mg/mL RNase A, 50 ug/mL Propidium Iodide). Stained nuclei
(10 000/sample) were analysed by flow cytometry. Parallel 6 cm2 dish were trypsinized,
washed twice with PBS, and incubated 15 min on ice in Aimexin V binding buffer (10
mM Hepes pH 7.4, 150 mM NaC1, 5 mM KC1, 1 mlvi MgC12, 1.8 mM CaC12, 2.5 1g/ml
Annexin V-FlIC; 556419 BD PharMingen, 50 jtg/ml Propidium Iodide). Stained cells
(10 000/sample) were analyzed by flow cytometiy to detect phosphatidyl serine
exposure and damaged ccli membranes.
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CHAPITRE 4
Identification of Putative EN2 Transcriptional Targets
by Microarray Analysis
Nicole Martin, Richard Le Blanc & Guy Sauvageau
(Manuscript in preparation)
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Chapter 4 summarizes the experimental data obtained thus far in identifying putative
EN2 transcriptional targets in human breast cancer ceil unes by microarray analysis. Dr.
Richard Le Blanc, a Clinician Scientist affihiated with the laboratory at the time,
conducted the statistical analysïs of the microarray data and generated Figure 4.2, Table
4.3 and the Materials and Methods section entitled ‘Expression Profiling Data Analysis’.
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Introduction
Evidence has accumulated that supports the notion that homeobox genes, when
dysregulated, are involved in tumorigenesis, yet the precise mechanism(s) involved are
largely unknown. The molecular mechanism(s) through which EN2 mediates breast
tumorigenesis have flot been elucidated and would require the identification of
downstream target genes. Although Drosophila en has been implicated in the regulation
of several pathways, few target genes have been shown to be under its direct regulatoiy
control. Methodologies used for the isolation of target genes and for the analysis of
putative targets wiIl be beneficial in establishing the genetic pathways controlled by EN2
within breast tissue.
Transient transfection of the synthetic siRNA directed against EN2 resulted in a
reproducible and complete reduction of EN2 protein levels in the human breast cancer
derived celi line MDA-MB-435S . The specificity of siEN2 was confirmed using a
control-scrambled siRNA that failed to suppress EN2 expression. Not only was this
approach more successful than anticipated, but the complete knockdown mediated by
siEN2 was maintained for up to 12 days post transfection. MDA-MB-435S ceils
transfected with siEN2 quickly vary to exhibit a more cuboidal flattened morphology,
reminiscent of non-transformed ceils, while the control ceils displayed littie or no
observable change in their transformed morphology. The suppression of EN2 in MDA
MB-435S celis also resulted in a reproducible and significant decrease in proliferation
rates when compared to controls. Importantly, this reduction in proliferation was not
accompanied by an increase in apoptosis. With the overt phenotypical changes seen
upon suppressing EN2 protein levels in MDA-MB-435S ceils, it is likely that there are
key expression profile changes that take place.
We reasoned that comparing the original MDA-MB-435S cancer ceil une, which
expresses high levels of EN2, and the siEN2-transfected ceils where EN2 has been
completely knocked-down, serves as an invaluable source to identify key targets that are
either up- or downregulated in response to EN2 suppression. The recent sequencing of
the human genome provides a foundation for studying global pattems in gene
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expression. The simultaneous measurement of the relative abundance of thousands of
mRNAs allows characterization of the cellular transcriptome under various experimental
conditions. Oligonucleotide arrays have been used extensively for mRNA expression
analysis and the exemplar of this technology is the Affymetrix Gene Chip.
Results
Employing s1RNA to e]ucidate potential downstream targets of EN2
Comparing the gene expression profile of the original MDA-MB-435S cancer ceil une,
which expresses high levels of EN2, with the transcriptome of the same MDA-MB-435S
celi une, transfected with siEN2 to knock-down EN2 protein levels, should serve as an
invaluable source to identify key targets that are either up- or downregulated in response
to EN2 suppression. To further enhance this experimental design, the reciprocal
approach of ectopically expressing EN2 in T-47D celis, another human breast
adenocarcinoma ceil une, was carried out. This should allow one to better discern
transcriptional programs that are truly relevant to breast cancer rather than those that are
unique to one specific celi une or the consequence of one specific manipulation (i.e.
transfection of siRNA vs retroviral transduction). RT-PCR analysis of the resulting RNA
confirms that the expected experimental system was indeed attained whereby EN2 is
completely suppressed in MDA-MB-435S celis and EN2 is ectopically expressed in T
47D ceils (Fig 4.1). Moreover, the level of ectopic EN2 expression achieved in T-47D
ceils was comparable to that documented in parental MDA-MB-435S celis, so we could
presumably rule out dosage responsive targets found only at non-physiological elevated
levels.
Although the Affymetrix HG-U133A array contains approx 22 000 probesets, only a
small proportion of transcripts showed a significant change in expression after
normalization. The majority of these transcripts were upregulated, suggesting that
although EN2 is capable of acting both as a transcriptional activator and repressor,
inducing gene expression seems to be more prevalent in breast cancer celis (Table 4.1).
Many genes that were significantly differentially expressed in one ce!! une were flot
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significantly differentiaily expressed in the second ceil une or did flot even respect the
same trend of either upregulation or downregulation in response to EN2 (Table 4.1).
Employing two breast cancer celi lines not only affords an increased chance of finding
bona fide targets that are common to both cdl lines while excluding targets that are
specific to one ccli une, but also points out how expression studies which use one ccli
une or tissue system will give risc to many context-specific targets.
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Fig. 4.1 RT-PCR analysis ofthe same total RNA which was used in the microarray
analysis. EN2 is succcssfiully ectopically cxprcssed in the T-47D human breast
adeonocarcinoma ccli une 3 days post infection (T-47D EN2 lanc) and complctcly
supprcsscd in the MDA-MB-435S human breast adenocarcinoma ccli line 3 days post
transfection (435S siEN2 lane). NT, non transfectcd; GFP, infected with Enhanccd
Grccn fluorescent Protein; siCTRL, transfcctcd with control scrambled siRNA; No RT,
no reverse transcriptase.
Importantly, siRNA exposure did not activate interferon genes such as MHC class I,
oligoadenylate synthetase or enolase in MDA-MB-435S cells and thc cctopic expression
of EN2 in T-47D cells did flot activate altemate cell-specific transcriptional programs.
The first 50 common ranked differentially expresscd gcncs that were identified are listed
with their corresponding ID idcntifiers (fig 4.2). A large proportion of the genes found
to be commonly upregulated (or induced fiirther) in the presence of EN2 in both ccli
lines have chaperone and/or heat shock activity (Table 4.2). Gene Ontology (GO)
Mining Tool provided by the NetAffyx Analysis Center predicted that 1.01 genes wouÏd
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Fig. 4.2 Heat map cluster diagram of the first 50 top-ranked differentially expressed
filtered putative EN2 transcriptional targets whose expression cotTelates positively with
the presence of EN2. Each column represents a single microarray experiment, and each
row represents a single gene, where the corresponding ID identifier is listed beside each
row. The color of each square in this image represents the measured expression ratio of
each gene in question. The color saturation is also directly proportional to the magnitude
of the measured gene expression ratio where bright red squares represent the highest
RJG ratio, bright green squares represent the lowest RIG ratio of gene expression in the
experimental samples and black squares represent a ratio of approximately 1.
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be associated with heat shock protein activity and 4.25 genes with chaperone activity
among the first 477 probesets which were significant at thc nominal 0.001 level ofthe
univariate two-sample t-test (Table 4.3) 2,3 The actual numbers exceeded these
predictions as 7 genes with heat shock protein activity and 22 genes with chaperone
activity were observed in this subset, representing an observedlexpected ratio of 6.92
and 5.17, respectively, over the predicted values (Table 4.3). These ratios are likely
underestimated as P5, the top-ranked upregulated gene in our analysis (with 3 probesets
amongst the first 13 top-ranking probesets), has only recently been ascribed chaperone
activity . Genes such as Hsp9Oa, Hsp9O/3 Cainexin, DnaJ (Hsp4O), NucÏeophosmin,
hP5, Hsp7O and Tumor rejection antigen (‘gp96) ail have chaperone activity or associate
with chaperone proteins. 0f particular interest was the dramatic induction of Hsp9O, a
molecular chaperone which has been implicated in the survival of cancer celis .
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fig. 4.3 RT-PCR analysis of the five most differentially expressed transcriptional
targets identified by microarray analysis. The above induction trends for Hsp9Oa,
Hsp9O/i Caïnexin and DnaJ A] and the repression trend for HOXC6 reflect the
induction and repression found in the microarray data.
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To validate some of tlie targets acquired by our microarray analysis, RT-PCR analysis
was performed on the remaining RNA that was prepared for microarray hybndization.
Five of the most differentially expressed transcriptional targets identifled by microarray
analysis were confirmed (Fig 4.3). The same induction trend was seen for Hsp9Oa,
Hsp9O/ Caïnexin and DnaJ A] while documentation of the same repression trend as
that seen in the microarray data was found for HOXC6 (Fig 4.3). RT-PCR results also
verified that these five genes are regulated by EN2 expression in both T-47D and MDA
MB-435S human breast cancer celi unes.
The upregulation of genes with chaperone an&or heat shock activity in response to EN2
expression is flot a non-specific effect as the observed upregulation is only seen in the
presence of EN2 and is not induced by the stress of either siRNA or retroviral
manipulation alone in the control ceils. The exact mechanism by which EN2 expression
leads to a further induction of these genes and whether they are direct targets remains to
be determined, but this initial observation is potentially interesting and fitting as
molecular chaperones have been implicated in the survival of cancer cells and one
chaperone in particular, Hsp9Ou, has recently been shown to function in tumor invasion
6,7,8 Ongoing clinical trials unexpectedly found that 1 7-AAG, an inhibitor of Hsp9O,
selectively kiils cancerous ceils . This selectivity occurs because Hsp9O found in tumor
ceils lias a much higher affinity for 17-AAG and higher ATPase activity, required for its
chaperone function, than the Hsp9O found in normal celis 10 17-AAG also inhibits the
proliferation of human cancer cells and has shown antitumor activity in several
xenograft models, including breast
We previously examined the effect of 1 7-AAG on the growth of mammary epithelial
cell lines engineered to ectopically express EN2. The proliferation of both non
transformed HC11 and C57MG ccli lines was not significantly affected by 17-AAG
treatment yet the proliferation advantage conferred by EN2 expression in these two cdl
unes is abrogated by 1 7-AAG exposure Interestingly, in the case of EN2-expressing
C57MG celis, exposure to 17-AAG did not only revert the proliferative advantage
conferred by the oncogene, but fiirther inhibited proliferation of these ceils to levels tliat
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are now beIow those measured in the untransduced parental celis . Since Hsp9O found
in tumor celis bas a much higher affinity for 17-AAG than the Hsp9O found in normal
celis, this supports the observation that EN2 behaves as an oncogene in vitro and readily
transforms these mammary epithelial ceils. In addition, the proliferation ofboth T-47D
and MDA-MB-435S celis expressing EN2 was significantiy further reduced in
comparison to the decrease in proliferation seen in both ccli unes when EIV2 is not
expressed (data flot shown). This observation likeiy reflects the increased chaperone
protein expression, inciuding 1-Isp9O, in the two ceil unes wherc EN2 is expressed, which
renders the ceils more sensitive to 1 7-AAG.
Discussion
Expression profihing employing two breast tumor ccli unes where EN2 was up and down
regulated highuighted a large group of chaperone and heat shock proteins, including
Hsp9O, whose expression arc coordinately upreguiated by EN2. The large number of
differentially expressed genes that were found to be specific to each ccli une also
highuights the caveat of studies employing only one ccli lune or tissue in microanay
analysis. The exact molecular mechanism(s) by which EN2 fosters tumorigenicity stiil
nccd to be elucidated, but this is the very first glimpse into potential mammalian targets
that may convey the transcriptional signal from EN2 and identification of putative genes
rcgulated by EN2 was a pivotai next step to providing some insight into how EN2 may
contribute to the pathogenesis ofbreast cancer.
Expression profihing technologies offered by microarrays facilitated the identification of
transcriptionally responsive genes to EN2 and the experimental design added a icvel of
confidence that we would be more likely to identify truc targets. Two physiologically
relevant breast cancer ccli unes were employed so wc could discem targets that were
ccli une specific. This was key as there were numerous differentiaiiy expressed genes
that were unique to each cdl une. Additionaliy, the leveis of ectopic EN2 expression
were comparable to that documented in MDA-MB-435S cells, so we could mie out
dosage responsive targets found only at non-physiological elevated levels.
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Interestingly, several molecular chaperone family members were induced in response to
EN2 expression and these proteins fittingly play a key role in promoting survival and in
maintaining the malignant phenotype in tumor ceils. Heat shock proteins and their co
chaperones have recently been shown to regulate both apoptosis and celi death. Hsp7O,
found to be highly expressed in response to EN2, prevents apoptosome formation,
diminishes Apaf-l-independent apoptosis and inhibits caspase-dependent events that
occur later in apoptosis 12 Both Hsp9O and Hsp7O bind and stabilize the survival protein
Akt 11,13 The induction of Hsp4O/DnaJ, another key regulator of apoptosome formation
12
also coincided with EN2 epression in our microarray study. Although molecular
chaperone proteins are consistently expressed at higher levels in tumor ceils, they are not
aiways found to be further induced in transcription profiles of other microarray studies
using oncogenes (http://c1arke1abs.georgetown.edu/BreastStudies), suggesting that they
are functional EN2 targets and flot a mere consequence of the transformed phenotype in
our study.
One chaperone in particular, Hsp9O, is found at elevated levels in cancer ceils where it
regulates the function and stability of key proteins that protect cancer celis from the
stress of chemotherapy, hypoxia and their own inherent genetic instability . The up
regulation of such protective proteins would be most advantageous for cancer ceils to
thrive and suggests that EN2 may promote mammary hyperplasia and tumorigenesis by
providing both a proliferative and survival advantage. Mammary epithelial cells that
express EN2 are quite sensitive to 1 7-AAG and the cessation of proliferation, following
exposure to 17-AAG in vitro, is accompanied by ce!! death. This observation implies
that EN2 is truly an oncogenc that transforms these celis, in part through the
upregulation of Hsp9O, rendering them more sensitive to 17-AAG.
In addition, molecular chaperones have recently been shown to be required for GR and
PR nuclear mobility and the Hsp9O inhibitor, Geldanamycin, inhibits their rapid nuclear
trafficking and function 14 Hsp9O has been shown to stabilize ‘client proteins’ such as
HER2, AKT, stcroid receptors, mutated p53 and p210BcrAbl which are ofien exp!oited
by cancer ceils for growth anWor survival advantages . It would be fitting if EN2 is
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another oncogenic Hsp9O client protein and/or Hsp9O enhances its localization and
activity, as we have clearly shown that EN2 provides a proliferative advantage to ceils.
The downregulation of HOXC6 is worthy of note but exactly how this could be an
oncogenic mechanism for EN2 is flot clear. HOXC6 is oflen overexpressed in human
leukemia yet Hoxc6 transcripts were found to decrease during pregnancy when the
mammaiy gland is highly proliferative and HOXC6 is expressed at low levels in human
precancerous tissue and not expressed in breast cancer tissue 15 Another study reports
that Hoxc6 expression in mammary epithelial celis appears to promote adult mammary
gland expansion while Hoxc6 expression in the mammary stroma appears to promote
regression and involution of the gland 16 If aberrant EN2 expression represses the latter
activity of HOXC6, EN2 may supersede the normal growth program and restraints of the
mammary gland and allow for immense expansion.
Unlike a screen involving primary breast tissue, the cancer celI unes that the targets were
identified in are immediately accessible for further genetic studies. This provides a faster
path from gene identification to functional validation and the precise role of a target and
its relative contributions to EN2-regulated tumorigenesis can be explored initially in
these celis. The exact molecular mechanism(s) by which EN2 fosters tumorigenicity still
need to be elucidated, but this is the very first glimpse into potential mammalian targets
that may convey the transcriptional signal from EN2 in human breast cancer. To our
knowledge, not only have there been no reports of EN2 targets that are relevant to
cancer, but there has not been a single EN2 target identified in any human adult tissue. A
recent study using chromatin immunoprecipitation with DrosophiÏa engrailed however,
pulled out direct targets such as Wnt2, frizzÏed 2, arrnadiÏÏo (beta-catenin), EGfR,
EGFR ligand, Gsc (goosecoid), and 17 Similar to other homeodomain-containing
proteins, the remarkable conservation of the homeodomain makes it difficult to
understand how transcriptional specificity can be attained. A probable explanation for
homeoprotein specificity is their association with co-factors. Clearly, homeoproteins
have been shown to associate with numerous proteins, including members ofthe same or
divergent homeoprotein family and non-homeodomain proteins. Several En-2 co-factors
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have recently been identified and belong to several classes oftranscriptional regulators;
181920Groucho, Fbx, Meis, foxa2
Materïals and Methods
Celi unes
The MDA-MB-435S human mammary epithelial cell line was derived from a ductal
adenocarcinoma and was grown in RPMI 1640 medium supplemented with 10% fetal
calf semm (FCS), 10 ng/ml of epidermal growth factor (EGf) and 10 tg/m1 of insulin.
The T-47D human mammary epithelial cdl une was isolated from a ductal
adencarcinoma and was grown in Lebowitz-L15 medium supplemented with 10% FCS.
The techniques used to engincer T-47D ceils to ectopically express EN2 and EGFP, the
techniques employed to suppress EN2 protein levels in MDA-MB-435S celis, and the
steps involved in RT-PCR analysis have been described previously
RNA Isolation and Oligonucleotide Array Hybridization
Total RNA was isolated from MDA-MB-435S cells 3 days post transfection with either
siEN2 or siCTRL and from T-47D celis 3 days post infection with concentrated and
filtered VSV supematant possessing EN2- or GFF-containing retroviruses, when the
ceils were >95% GfF-positive, with the RNeasy mini kit (Qiagen). Triplicates of RNA
for each experimental sample were provided for hybridization. Total RNA quality was
assessed by running 1 00 ng of total RNA on the Agilent Bioanalyzer. Target labeling
was performed as specified by the Affymetrix protocol EukGe Ws2v4 with 10 jig of
total RNA. After IVT, 15 ng of the resulting cRNA was used for the fragmentation
reaction and 10 tg of the ftagmented reaction was hybridized onto the HG-U133A
expression microarray (Affymetnx). The quality of the cRNA amplification was also
assessed by running 1 .i1 of the cRNA reaction on the Agilient Bioanalyzer. Staining,
washing and scanning were carried out in accordance with Affymetrix protocol EukGe
Ws2v4.
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Expression Proflllng Data Analysis (written by Dr. Le Blanc)
B ackground-corrected batch-normalized Jog2-valued probeset summaries were obtained
from probe raw signais using the RMA subroutine 21 We used the RMA version
impiemented in R and freeiy available from the Bioconductor website at
www.bioconductor.org/. Gene expression level variance across sampies in a given
experiment is a function of the experimental design. Since the present design involves
two different biologicai systems which necessarily would impart a higher level of gene
variance whenever ail samples would be considered at once for gene variance
estimatation, we chose to normalize unlogged gene expression leveis in a two-step
procedure in order to better account for the higher degree of gene variance inherent to
the experimentai design and better uncover parallel patterns of up- or downreguiation
across the bioiogicai systems. First, in vectorial notation, we refer to a given gene
expression profile across ail samples of either 435S or T47D biological system as 43g
or
T47Dg
respectively. These expression profiles were centered and normalized such that
the scalar product Bg1.Bg, between any two genes in either biological system B = 4355
or T47D directly yields their Pearson correiation in that system. Next, a normaiized gene
expression profile g across ail samples of the experimentai set-up was defined in terms
of the outer product g=(4355g ® T47Dg )/ When defined this way, the scalar product
between any two genes
g1.g2=(43SSg1.4355g2 + T47Dg1.T47Dg2)/2
simply amounts to the Pearson correiation as averaged over the two independent
biological systems. Two genes with sirnultaneously strong positive or negative
correlations across both biological systems will therefore retain a high correlation in the
combined system.
Biological sampies were spiit into two ciasses (EN2+ or EN2-) as defined by the
presence or absence of BN2. After gene normalization and fiitering, differentialiy
expressed genes were identified by first computing their two-sample Welch t-statistics.
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where BE2 denotes the gene class average in the bïological system B and
‘3SEN2+ the
corresponding gene class standard deviation. When gene expression profiles are
normalized as above and when there is an equal number n of samples in each class of
each biological system B, it is relatively straightforward to prove that
B
— (n)(B
\ EN2+
where
f(fl)(B)2(l)
B
J(1_B G2÷)
and B
=
-f n gEN2+• For the combined system, one finds
t
A gene with high Bt_score, that is, B —* ±1 across both biological systems
simuitaneously will therefore retain a high t-score in the combined system. Note that
BJ
—> ±1 if and only if the normalized gene expression profile across ail samples
approaches the idealized downlup expression pattem
whenever samples are ordered according to the layout (EN2- samples, EN2+ samples).
Statistical significance was assessed by computing t-score associated p-values, adjusted
for multiple comparisons. These adjusted p-values were estimated by permutation
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following Westfall and Young’s step-down maxT adjusted p-value procedure 22 using
the mt.maxT subroutine from the mulftest R package availabie at the Bioconductor
repository web site 23 A subset of analyses, namely observed vs expected frequencies of
Gene Ontology (GO) classes, were performed using BRB-Array tools v3.1 developed by
Dr. Richard S imon and Amy Peng Lam (http ://linus .nci.nih. gov/BRB-ArrayTools.htrnl).
In order to obtain clusters of a manageable size, a filter was applied in order to select
genes with pre-determined changes in the presence or absence of the oncogene EN2. We
elected to filter genes for which the unlogged RMA values increased or decreased by at
least 2=32 units on average in presence of the oncogene EN2 when compared to a
baseline where EN2 is either not expressed or its mRNA is interfered with to dismpt
protein translation. Note that this filter does not specify a pre-determined multiplicative
fold-change threshold. Rather, it reflects the fact that currently favored background noise
models for Affimetrix oligonucleotide microarrays assume an additive contribution of
noise (N) to signal (S), and that N will mostly affect signais in the low intensity range,
that is, signals for which log2 S 5-7. 1417 out ofthe 22215 probesets passed the filter.
The list ofall 1417 probesets that passed the filter along with their expression values and
adjusted p-values are available as Supplemental Data in the Sauvageau lab server.
Hierarchical clustering of the first 50 ranked differentially expressed filtered genes was
performed using Cluster 3.0 (http://bonsai.irns.u-tokyo.ac.ip/--mdehoon!software/cluster)
and the resulting clusters were visualized using Mappie Tree 24
(http://sourceforge.net/projects/mapletree).
Acknowledgements
We thank Dr. Alexandra Joyner (NYU, NYC) for the En-2 cDNA; Dr. Peari Campbell
(OHRI, Ottawa) for performing the Affymetrix hybridization; and Dr. Morag Park
(McGill University, Montréal) for the MDA-MB-435S cell une. This work was
supported by ftmnds from the NCIC (15064) to G.S. N.M. is a recipient of a CIHR
research award, G.S. is a scholar of the Leukemia and Lymphoma Society of USA.
122
Table 4.1 Siibset ofgenes that were significantly (P <0.05) up-regulated ? 2 fold or down
regulated 0.5 fold in response to EN2 expression in either MDA-MB-435S or T-47D ceit unes
with the corresponding fold change observed in the other ceil une indicated. Bold font indicates
transcripts which were induced at comparable levels in both celi lines.
Fold change
in MDA-MB-435S Gene description
FoId change
in T-47D
0.90 heatshock 7ûkDapratein 6 (HSP7OB’) 33.45
2.02 prostate differciitiatiotifactor 7.19
2.02 protein kinase HIl 3.97
2.02 tumor necrosisfacror, alpha-inducedprotein 3 3.84
1.10 DNA-daniage-indtcible transcript 3 3.81
1.30 crvsiallin, alpha B 3.79
0.90 BCL2-associated athanogene 3 3.65
1.10 heatshock lOSkD 3.48
3.39 cvclin BI 0.84
1.10 8100 calcium binding protein P 3.33
3.26 baculovirallAP repeat-containing 5 survivin,.) 0.9]
0.90 heat shock 70kDaprotein lA 3.22
3.20 basic leucine zipper ana’ W2 do,nains 2 1.11
1.20 glvcoprotein (trans,ne,nbrane mnb 2.94
1.10 fe,-ritin, light polypeptide 2.92
0.90 homocysteine—inducible, ubiquitin—like domain menber 1 2.86
1.00 ESTs, Highly similar ta fRIL HUMAN ferritin light chain 2.79
2.66 protein disulfide isoinerase-relatedprotein I .44
1.00 kvnurenine 3—monooxvgenase (kvnurenine 3—hydron’Iase) 2.51
1.20 solute ca,7-ierfamilv 3, member 2 2.48
0.90 solute carrier jinnily 7 member 11 2.48
2.42 hvaluronan-mediated motili’ receptor (RHA MM.) 0.83
0.90 H4 histanefa,nily, ,nemberH 2.41
2.40 protein regulator ofcvtokinesis I 0.96
2.33 tunwr rejection antigeiz (gp96) 1 2.04
1.00 Rczg D protein 2.35
2.34 inunediate early response 3 I .03
1 .00 putative transmembrane protein 2.29
2.27 topoisomerase (DNA) II alpha 1 7OkDa 0.86
2.26 RAB6 interacting, kinesin-like (rabkinesin6 0.84
2.22 V-A TPase C2 subunit 1.46
2.21 staufen, RNA binding protein (Drosophila,) 1.17
2.20 heatshock 7OkDaprotein S (7SkDa,) 1.99
2.19 sorting nexin 4 III
2.15 hypothetical protein fUI 0540 0.77
2.14 Bcl-2-associated transcription factor 1.39
1.10 lnpothetical protein fU20059 2.13
1.40 dual specificity phosphatase 1 2.12
2.11 epithelial cdl transforming sequence 2 ancogene 0.81
1.40 DnaJ (Hsp4O,) homolog, subfinailv B, member] 2.10
1.20 ornithine clecarboxvlase 1 2.09
2.08 cukaotic translation initiatianfactor 3, stibunit 6 48kDa 1.01
2.06 Drosophila discs large-1 tumor stipressor-like 0.79
0.90 3-hvdroxy-3-inethvlghaan’l-Coenryine A synihase 2 2.06
1.00 heat shockprotein (‘hspllofamiiv,) 2.05
1.00 SF13 domain binding glutamic acid-rich protein 2.05
1.00 activating transcriptionfactor 3 2.04
2.01 palmitoyl-protein thioesterase 1 (‘ceroid-hpofiiscinosis 1.33
1.00 Inenmgiolna expressedantigen 5 (hvahironidase) 2.01
0.49 ADP-rihosvlationfactor 3 0.74
0.48 HI ltisionejami/v, member 2 I .60
0.47 immunoglobulin supe,fitnily, member 3
0.47 ubiqiunol-cylochrome c redzictase bindingprolein
0.45 hypotheticalprotein fUi 1848
0.43 secretory carrier membrane protein I
0.43 hypothetical protein FUJi 1193
0.43 protein tyrosine phosphatase type IVA, member 2
0.42 $TARTdomain containing 7
0.40 actin relatedprotein 2/3 complex, subunit 2, 34kDa
0.40 fasciculation and elongalion protein zeta 2 (zvgiu II)
0.40 huntingtin interaclingprotein 2
0.39 hvpothetical geIe supported In’ AF038182; 3C009203
0.37 conservedgene amplified in osteosarco,na
0.70 serine (or cvsteine,) proteinase inhihiior
0.33 inethylene tetrahvdrofolate dehydrogenase
0.32 APG]2 autoptiagv 12-like (‘S. cerevisiae)
0.27 PAl-1 ,nRNA-binding prolein
0.27 senun-inducibte kinase
FoId change
in MDA-MB-435S Gene description
FoId change
in T-47D
1.1$
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1.12
1.3]
1.01
1.26
0.90
109
0.87
1.16
1.08
1.62
0.94
0.34
1.15
1.07
1.05
1.22
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Table 4.2 Subset of regulated transcripts common to both ce!! unes with significant induction or
repression in response to EN2 expression with adjusted P values less than 0.05.
207668 xat
208639x at
202655at
200599sat
221 923_s_at
20069! sat
212510at
200666 s at
221577_x _at
202934at
21 6640sat
202636at
21 6450xat
202] 3Oat
2023 82sat
209694at
21 8088 sat
21 $574sat
201 952at
214328 sat
200825 sat
204255 sat
209295at
20 1925 sat
20916]at
202302 sat
204266sat
209238at
208852 sat
200598 sat
200068sat
2!8145at
210275 sat
200732sat
208813at
22169 Ixat
21 8358at
21250] _at
20324] _at
21 1969at
203534at
212724at
200790at
209180at
203! 59at
20858]xat
2] 084 9s at
21 1936at
209681 _at
21 2434at
202106at
22184]sat
2035] Isat
P5
P5
ARMET
TRi!]
NPMI
HSPA 9B
KIAA 0089
DNA]BI
PLAB
HK2
P5
NEDf
IRAI
RIOK3
GNPJ
PTS
RRA GC
LMCDJ
ALCAM
HSPCA
HYOUI
VDR
INfR
DAF
PRPF4
fLJ1IO2I
CHK
STX3A
CANX
IRA]
CANX
C20orJ97
ZNf2]6
PTP4A]
GOT]
NPMJ
MGC11256
CEBPB
UVRA G
HSPCA
LSMI
ARHE
ODCJ
RABGGTB
GLS
MT]X
VPS4]
HSPA5
SLCI9A2
GRPEL]
GOLGA3
KLF4
BET3
0.0022
0.0043
0.0065
0.0087
00087
0.0087
0.0087
0.0087
0.0087
0.0087
0.0087
0.0087
0.0087
0.0108
0.0108
0.0152
0.0173
0.0173
0.0173
0.0173
0.0173
0.0173
0.0238
0.0238
0.0238
0.0238
0.0238
0.0238
0.0238
0.0260
0.0260
0.0260
0.0260
0.0260
0.0281
0.0281
0.0281
0.0281
0.0325
0.0325
0.036$
0.036$
0.036$
0.036$
0.036$
0.0390
0.0390
0.0390
0.0411
0.0411
0.0411
0.0411
0.0433
Affy ID Gene Gene Description (Genes upregu]ated in response to EN2) P value
protein disufide isomerase-relatedprotein
protein disti(flUe isotnerase-relatedprotein
arginine-rich, mutated in earlv stage tiimors
tumor rejection antigen (gp96) J
nticleophosmin (nucleolar phosphoprotein B23, ,nmtatrin,)
heat .çhock 7OkDa prolein 9B (mortatin-2)
KJAA 0089 protein
DnaJ (J-Isp4O) homolog, sub/inaiit’ B, member 1
prostate differentiationfactor
hexokinase 2
protein disu(flde isomerase-relatedprotein
.incfingerprotein 103 homolog (mouse)
Imnor rejection anhigen tgp96,) I
sudD suppressor o! bimD6 homolog (A. nidulans
glucosamine-6-phosphate isoiflerase
6-pyrtivoyltetrahydropterin synthase
Rag C protein
LIMand cysteine-rich domains]
actiuated leukocyte ce!! adhesion molecule
heat shock 9OkDa protein 1, alpha
hvpoxia upregzilated I
vitainin D (1,25- dihydrosyvitamin D3) receptor
lumor necrosisfr’ctor receptor superfamllv, inember 10h
decay acceleratingfactorfor complement
PRP4 pre-mRNA processingfactor 4 ho,nolog (veast)
hypotheticaiprotein FJJ1102] simitar ta splicingfactor
choline kinase
st’ntaxin 3A
cainexin
tumor rejection antigel? (gp96) 1
calnexin
chromosome 20 open readingfra,ne 97
zincfingerprotein 216
protein tyrosine phosphatase type IVA, member 1 /PRL-1
glutamic-oxaloacetic transaminase 1,)
nucleophosmin ‘nttcleolar phosphoprotein B23, manatrinj
hvpotheticalprotein MGCI 1256
CCAA T/enhancer binding protein (c/EBP,), beta
UV radiation resistance associated gene
heat shock 90kDaprotein 1, alpha
Lsm] protein
ras homolog genefami/v. member E
ornithine decarbosylase]
Rab geranvlgeranvltransferase, beta subunit
glutaninase
inetallothionein iX
vacuolarprotein sorting 4] (yeast)
heat shock 7OkDa protein 5 (ghicose-regtilatedprotein, 78kDa)
sainte carrierfa,niiv 19 (ihiamine transportetj, member 2
GipE-like protein cochaperone
golgi autoantigen, golgin subfa,nily a, 3
Kntppel-likefactor 4 (gut)
similar ta yeast BET3 (S. cerevisiae
20869 lat
209366xat
209154at
200809xat
217776at
TfRC
CYB5
TIP-]
RPLI2
RDHI 1
0.0476
0.0281
0.0238
0.0173
0.0173
Observed in Expected in
.
. Observed/GO id GO classification selectcd selected Expected
subset subset
0003773 [heat shock protein activity 7 1.01 [6.92
[0003754 [chaperone activity 22 [4.25 [5.17
0016860 jintramoiecuiar oxidoreductase activity s i.i -
0015078 [hydrogen ion transporter activity
- [3.38 [2.96
0015077 [monovalent inorganic cation transporter activity io [3 75 [267
j0003925jsmall monomeric GTPase activity Iii [4.34 2.53
[0004197 [ysteine-type endopeptidase activity [.oi [2.42
[0003924 [FPase activity 13 [5.52 2.36
0016616 oxidoreductase activity\, acting on the CH-OH group ofdonors\, 6 2.67 2.25NAD or NADP as ace eptor
0050800 [j ydrolase activity\, acting on acid anhydrides\, acting on GTP\, 1496 2.22involved in cellular and subcellu]ar movement
[0008248 [pre-mRNA splicing factor activity
- 6 [2.71 12.21
[0003714 [1nscription corepressor activity 7 [3.19 [ï
[0016614 [oxidoreductase activity\, acting on Cl-l-OH group ofdonors 6 2.76 [2.18
[0008324 [cation transporter activity 13 [6.23 [2.09
[0005525 GTP binding 12 [5.84 [2.06
[0019001 [guanyl nucleotide binding
- 12 5.93 [2.02
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Affy ID Gene Gene Description (upregulated in response In EN2 cool) p value
21021 1 HS?CA heat shock 90kDa protein 1. alpha 0.0455
21 8233 sat C6orJ49 over-expressed breast tumorprotein 0.0476
208638 al ATP6VIC2 V-ATPase C? subunit 0.0476
208726 sat E1f2S2 eukarvotic translation initiation factor 2 0.0476
21921 2at HSP70-4 ortholag ofmazise heat shockprotein, 70 kDa 0.0476
201453 xat RHEB Ras honwlog enriched in brain 2 0.0498
Affy ID Gene Gene Description (Genes downregulated in response to EN2) P value
transfen-in receptar ‘p9O, C’D 71)
cytachrorne h-5
Tax interaction protein I
ribosomal protein L12
androgen-regulated short-chain Uehydrogenase/reductase]
Table 4.3 Gene Ontology (GO) Mining Tool provided predictions that 1.01 genes would be
associated with heat shock protein activity and 4.25 genes with chaperone activity arnong the
first 477 probesets which were significant at the nominaI 0.001 level ofthe univariate two
sample t-test.
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CHAPITRE 5
Conclusions, Perspectives and Future Directions
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Chapter 5 is a discussion of the relevance of the findings presented in this thesis and
adresses potential future studies that could be performed to further understand the roles
of En-I and EN2 in the regulation of normal mammary gland development and breast
cancer, respectively.
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En-1 in mouse mammary gland development
Our findings provide some initial insight as to which developmental stage coïncides with
En-1 expression and where En-1 expressing celis appear to reside with respect to the
actively growing ductal tree. We have shown that there are some clear candidate ccli
populations which might express En-], while ruling out others such as the inner most
body cells of the TEB and the luminal epithelial celis of the ducts. Our
immunohistochemical studies document En-1 expression in putative cap cells,
myoepithelial cells, periductal fibroblasts and in a few stromal cells. As one can
appreciate from Fig. 5.1 however, we cannot conclude with confidence, from our intial
immunohistochemistry data, whether En-1 is expressed in the myoepithelial cells, the
thickened basal lamina, or both. In addition, it is possible that the En-1 expression that
we perceive as arising solely from the cap ceil layer of the TEB, may aiso arise from
some of the body celis in the TEB and/or the thin basal lamina surrounding the TEB
(Fig. 5.1).
Given the small window of En-] expression and the putative cell types it is exclusively
found in, one possibility is that En-1 expressing cap celis are those progenitors that give
rise to myoepithelial celis in the newïy forming ducts. Since primary progenitor cells
represent one daughter ccli of a stem ccli division and divide repeatedly before
becoming committed to a given lineage, one possibility is that En-1 may be expressed in
the secondary progenitors arising from the primary progenitors that have made the
decision to continue along the myoepithelial lineage in the rapidly growing pubertal
ductal system. There are no reports of proteins upstream of En-], or known targets of
En-1 signaling, that are invoived in the specification of the myoepithelial lineage from
cap cells within the growing ductal system, but similarly, there are few upstream
regulators and even fewer direct targets of En-1 signaiing that have been identified in
mammalian cells. Interestingly, studies have suggested that Wnt-signaling is involved in
myogenic specification In addition, chromatin immunoprecipitation (ChIP) studies
have shown that potential target genes of DrosophiÏa engrailed are involved in muscle
development pathways 2 To investigate thïs possibility, the specific cdl type(s) that
express En-] must first be clearly defined.
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Fig. 5.1 Longitudinal section of a TEB from a 5-week old virgin Balb/c mouse. The
TEB within the pubertal mouse mammary gland contains two ce!! types: body & cap
cel!s. The cap celis at the tip of the growing TEB are highly proliferative and
differentiate into the myoepithe!ial celis, which surround the mature duct. The body celis
are the most prominent celis in the TEB and differentiate into the ductal epithelial ceils.
Tissue section image reprinted from http://mammary.nih.gov/atlas/structures.
To achieve a clearer picture, it will be necessary to perform precise co-localization
experiments at different developmental stages and also in available models with
impaired ductal developrnent during puberty. Immunohistochemistry employing several
markers, in addition to fi-gal, ail with unique detection agents, will allow for co
localization of En-l protein with definitive marker expression. Attempts have been made
to correlate celI type specific cytokeratins and ceil surface markers with in vitro
differentiative capacity, to identify particular ceil lineages and to further determine
which cells have stem cell-like properties based on patterns of marker expression.
Isolated primary mammary cells expressing En-] can be divided into either luminal or
myoepithelial/hasal populations and the in vitro differentiative capacity of these cells in
tissue culture can then be tested in an attempt to define multipotential cells such as cap
thickened basal lamina around
the neck with numerous fibroblasts
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ceils. Epithelial-specific antigen (ESA), mucin 1 (MUC1) and cytokeratin $ (K$) are
surface markers of luminal epithelial celis while CD1O, u6-integrin and K14 are surface
markers that are specific to myoepithelial celis. Keratin 6 (K6) is normally expressed in
the body ceils of TEBs during ductal morphogenesis but not in MECs from mammary
ducts . These and other markers can be utilized to characterize the celi fraction that
expresses En-1 to determine if they are indeed myoepithelial, stromal, fibroblast,
adipocyte and/or cap celi in origin.
Transplant experiments were performed to determine if the mammary gland phenotype
documented in En-T’ females is intrinsic to mammary epithelial ceils or due to systemic
defects in the En-T’ mutant mice. The resulting transplants were able to grow to varying
extents, some of them were able to form TEBs and/or were able to, albeit more sparsely,
fill the marnmary fat pad. Several possibilities may account for these observations,
including a systemic hormonal deficiency in the En-T’ mutant mice, the loss of En-1
affecting a particular organ which influences the mammary gland, andlor the mutants
suffer from a mere delayed puberty.
The fact that En-1 expression coincides with the onset of puberty also raises the
possibility that En-1 may be produced in response to estrogen to carry out the hormonal
stimulation of the mammary epithelium. No defects were apparent in whole mounts
derived from En-T’ mutant mice before 3 weeks of age, demonstrating that En-1 is
dispensible for the development of the ductal tree preceeding puberty. However, when
analyzed at 3 ½ weeks of age, mutant glands displayed delayed ductal outgrowth and
TEB formation. Another possibility is that En-1 may regulate hormone production.
Initial expression of En-1 commences at day 15, which slightly precedes the onset of
puberty, and the retarded growth seen in the En-1 nuil mutant mouse mammary gland
may be a resuit of the lack, or reduced production, of hormones that normally initiate
this growth phase. This will also need to be addressed. The link between hormonal
signais and En-] expression may come from immunohistochemistry experiments that
colocalize En-1 and estrogen R expression in mammary epithelial ceils. If this is the
case, it wili be interesting to see if En-1 expression can be induced by estrogen in
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ovariectomized animais and whether En-] is reduced in EW’ epithelium. Although this
miglit establish whether estrogen activates En-] expression, it would remain to be
established whether this occurs as a direct or indirect mechanism. In this respect, it will
be important to determine whether the En-] promoter contains binding sites for estrogen
that mediate estrogen-induced transcriptional activation.
Jnterestingly, studies in normal mammary tissue have shown that progesterone induces
Wnt-4 expression in the mouse mammary gland and that Wnt signaling is the likely
mediator of the progesterone signal during pregnancy, a very proliferative stage in
postnatal mammary gland development . It is presently thought that Wnt signais also
have an important role in the maintenance of stem ceil compartments . The reported
expression of other Wnt members in unique temporal and spatial patterns during the
normal development of the mouse mammary gland provides several candidate upstream
regulators of En-] expression in non-cancerous breast tissue 6 Although we showed that
En-] expression was not consistently activated by etopic Wnt-] expression in the mouse
mammary gland, future studies will need to address whether En-] is downstream to any
of the rernaining Wnt family members that are expressed in the normal pubertal
mammary gland.
It is also possible that compensatory ectopic expression of En-2 in the C57B1/6J
mammary gland may partially rescue the mammary gland phenotype in En-l’”
mutant mice, analogous to the finding that En-2 expression is likely responsible for the
less severe cerebellar brain phenotype when the En-] Lki gene is introduced into the
C57B1/6J strain “. Although we have looked at En-2 expression in mammary tissue from
both CD-1 and C57B1/6J strains, En-2 expression was neyer tested in the actual rare En
jLki/Lk hornozygous mutants that arose. This is something that should be tested to either
further suggest or rule out this possibility.
Our studies show that En-] is expressed in the mammary epithelium. Although we
observed En-] expression in what appeared to be periductal fibroblasts and some
outlying solitary stromal ceils, these results are less convincing and preliminary and will
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need to be extended. In addition, we have not verified whether stromal celis expressing
En-J ai-e only found in the vicinity of the growing ductal tree or whether they are also
found in the distal portion of tlie fat pad wliere the ductal tree lias not yet penetrated.
Altliough this epithelial-free portion of the early pubertal female fat pad did not express
detectable levels of En-1 protein by western blot analysis, this technique may flot be
sensitive enough to detect a small number of solitary stromal ceils expressing En-]. If
we consider that the preliminary western analysis resuits are indeed reflective of a few
En-J expressing stromal cells residing adjacent to the mammary epithelium only, this
would support tlie scenario wliere nearby En-] expression in the mammary epithelium
could be involved in the crosstalk between the stroma and the epithelial compartments.
Homeodomains and homeoproteins can be internalized by live ceils, and a small
proportion of Engrailed lias been found to associate with membrane regions implicated
in signal transduction and secretion and suggest tliat Engrailed miglit act as a secreted
polypeptidic messenger . These studies suggest the possibility that En-1, a IF, can be
converted to a secreted signal, tliat could control tlie fate of adjacent cells in a paracrine
fashion. Perliaps a portion of En-1 protein produced in the rnanimary epitlielium is
secreted and affects the nearby strornal ceils and fosters a microenvironment that
regulates tlie ductal expansion during puberty.
Paracrine interactions between individual mammary epitlielial ceils andlor tlie adjacent
stroma can by investigated by tlie introduction of a tag that can be visualized in one of
the epithelial cell components in a marnmary epithelial transplant so it is possible to
distinguish the origin of individual ceils in mixed epithelial transplants, wliere
transplants contain a mixture of epithelial celis from different origins. If En-J expressing
celis express a tag, these mammary epitlielial celis can be mixed with En-] nuli
epithelial celis. If Eu-J is flot required in the stromal compartment and tlie stroma does
not contribute to tlie regeneration of manurlary epithelial structures, this is indicative of
a pararine mechanism, confined to marnmary epithelial cells, of En-1 action. The
reciprocal experirnent, where En-1 nuli ceils express a tag, could also be generated.
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Although the evidence suggests that En-1 may be involved in ductal growth and
morphogenesis during pregnancy, littie is known about direct or indirect downstrearn
mediators. Not only should future studies identify and investigate some of these En-1
targets that are specific to normal marnmary gland development, but it will be interesting
to identify what targets are connnon to ectopic EN2 expression during breast
tumorigenesis.
EN2 in breast tumorigenesis
Epigenetic activation, where an alteration in gene activity influences the breast tissue
phenotype without affecting the genotype, is one plausible explanation for the ectopic
expression of EN2. Changes in prornoter methylation may be involved. Another
possibility is that a suppressor of EN2 (ex. Groucho), which norrnally serves to maintain
repression of EN2 in certain tissues, may be inactivated and cause the misexpression of
EN2 in breast tissue. Another possible mechanism of ectopic EN2 expression would be
the resuit of an increase in fl-catenin. fl-catenin forms a complex with the transcription
factor TCf, converting TCF from a transcriptional repressor to an activator of
downstream targets and could thercby stimulate the expression of Eu-2 without any
changes being evident at the genetic level such as realTangement. TCF lias already been
shown to activate c-Myc in breast tumorigenesis and EN2 may be activated in addition.
Like other homeobox genes, the ectopic expression of wildtype EN2, rather than a
mutated or altered form, may be involved in the onset of breast carcinogenesis.
Although many studies have reported the deregulated expression of homeobox genes in
cancer, relatively few have established direct functional roles for particular homeobox
genes in oncogenesis. It is conceivable that in sorne of these reported cases, the
deregulated expression of horneobox genes might be consequential, rather than
functionally relevant, for carcinogenesis. The ectopic expression of EN2 was flot merely
found to correlate with the progression of breast cancer and with celi lines derived from
breast tumors. Its transforming properties in vitro, the ability to induce adenocarcinomas
in vivo and the growth suppressive effect when its expression is knocked down by RNA
interference in a breast tumor derived ceil line ail support a bona fide role for EN2 in
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promoting transformation and carcinogenesis. Whether the ectopic expression of EN2 is
an initial andlor causal event in the progression of breast cancer, a downstream and low
penetrance event resulting from the initiation of carcinogenesis and/or a resuit of the
genetic instabiiity that occurs, or whether it is pivotai in a later stage sucli as metastasis,
remains to be elucidated. Similar to other homeobox genes, although EN2 lias clear
oncogenic properties, its precise function in carcinogenesis in specific tumor types lias
flot been identified. EN2 may be more fittingly described as a tumour modulator rather
than an oncogene at this stage.
A comprehensive anaiysis of the expression pattern of EN2 in several types of breast
cancer classifications, as weii as in other solid tumors sucli as brain cancer is warranted.
Ectopic expression of EN2 in brain carcinoma would fit the notion of other liomeobox
genes that are re-expressed in the tissue where they play a pivotai role during embryonic
development. EST data lias indeed shown tliat EN2 expression has been documented in
meduiloblastoma .
Our initial studies looked at 23 primary human breast tumor samples. 0f tlie two EN2-
positive tumors, one was an adenocarcinorna whuie tlie second was an infiltrating ductal
carcinoma, inflammatory type. 0f the seven EN2-positive human ccli unes, four were
derived from adenocarcinomas, one was derived from a ductal carcinoma, and two were
designated as liyperpiastic fibrocystic breast tissue. Furtlier studies documented EN2
expression in 4/59 additional tumor sampies, au four EN2-positive tumors being
ciassified as infiitrating ductai carcinomas. Thus, EN2 was shown to be ectopically
expressed in a subset of liuman breast cancer representing approximately 7% in the
population tested. A more precise frequency of ectopic EN2 expression in a much larger
sampie pool of breast tumors and any possible correiation with a specific subset(s) of
tumor phenotypes wili need to be screened. Employing a technique of larger scaie that is
mucli faster than the RT-PCR/Southern hybridization approach used in tliese studies wilJ
aliow one to screen far more samples in a shorter turne. Any positive samples can be
further analyzed by immunohistochemistry to confirm that the relevant celis within the
iesion show nuclear EN2 staining. To this end, tlie specificity of tlie antibody that
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recognizes botli mouse En-1/human ENI and mouse En-2/human EN2 lias been sliown
extensively in the literature.
Infiltrating ductal carcinoma (IDC), also known as invasive ductal carcinoma, is the
most common type of breast cancer, accounting for 80% of breast cancer diagnoses.
IDC begins in the milk ducts of the breast and penetrates the wall of the duct, invading
the fatty tissue of the breast and eventually other regions of the body. Inflammatory
breast cancer, on the other hand, is quite rare, accounting for only 1% of breast cancer
cases. It is associated with the appearance of inflamed breasts with dimples andlor thick
ridges caused by cancer celis blocking lymph vessels or channels in the skin over the
breast, is extremely aggressive and is associated with poor prognosis. It will be
important to explore whether EN2 expression is found in more of these latter samples,
potentially providing an early detection marker of this aggressive form of breast cancer,
or whether its ectopic expression represents an occurrence that is common to most forms
ofthe disease.
Researchers involved with the Breast Cancer Functional Genomics Group at McGill
have been using Laser Capture Microdissection (LCM) to dissect tumor cells from
amidst the beterogeneous tumor section. They have agressively been building this tissue
bank and the samples contained within would be invaluable to truly ascertain which celis
express EN2 afier its expression is linked to a specific subset ofbreast cancer.
Isolating MSC and progenitor celi-specific promoters and using them to direct
expression of EN2 will enable answering the question of whether EN2 activity is
required in stem celis or progenitor cells for EN2-positive breast tumor formation. It will
lie interesting to sec if EN2-induced tumors contain celis that have myoepithelial, as well
as luminal, differentiation, indicating that they might originate in a pluripotent stem or
transit cell. Disrupting EN2 and EN2 target genes of interest within tumor models using
RNA interference will allow the potential cffects of anti-EN2 therapy to be tested in
various mammaiy tumor moUds.
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Perspectives
There are many examples in which the aberrant expression of homeobox genes that
normaliy regulate growth and deveiopment have been implicated in carcinogenesis. For
some homeoproteins, it is thought that the wildtype, rather than a mutant form of the
protein, produces these oncogenic activities. This implies that the oncogenic activity of
some homeoproteins is not due to new or alternative properties, but is a resuit of their
normal functions being carrïed out in the wrong celiular context. The finding that En-1 is
expressed during the expansion that takes place in pubertal deveiopment in the normal
mouser mammary gland, combined with the observation that wiidtype EN2 is
ectopically expressed in human breast cancer fits into this latter category. Interestingly,
both En-1 and En-2 behave like oncogenes when expressed in mamrnary epithelial celis
and both inhibit differentiation, yet expression of En-2 consistently elicited higher
measurements in ht vitro transformation assays compared to En-1. Non-transformed
mammary epithelial ceils that have been engineered to ectopicaily express wiïdtype En-
2, form mammary adenocarcinomas when injected into the cleared fat pads of syngeneic
hosts, further supporting the above notion, where the wildtype protein expressed in the
wrong ceilular context can have oncogenic activity. A key distinguishing feature is that
while only En-1 is expressed in the normal mammary gland, its paralog EN2 is found to
be ectopically expressed in breast carcinogenesis, rather than the re-expression of En-].
However, the two paraiogs share many conserved functions during deveiopment, with
En-2 being able to rescue ail but one of the En-] nuii phenotypes, and En-2 actually
appears to exhibit more oncogenic activity in cuiture and in tumor growth compared to
En-1.
Importantly, the above findings raise the intriguing possibility that the oncogenic
properties of EN2 in breast tissue might reflect an erroneous extension of the normai
postnatal functions of En-1 in the mamnlary giand, where EN2 aberrantiy mimics the
proliferative effects of En-1, the natural inductive signal in mammary epithelium and
perhaps leads to the maintenance of an undifferentiated state in breast celis. These
observations prompt questions about the basis of En signaling specificity. It wiIl be
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instructive to determine which downstream targets are affected by En-1 and EN2 as the
two paralogs may have distinct targets in addition to several common targets.
Altematively, the two paralogs could activate different signaling pathways or the same
signaling pathways to different extents through differential interactions with co-factors,
thereby eliciting unique cellular responses. A genetic understanding of En-1 and EN2
signaling and how they regulate mammary epithelial growth and morphogenesis wilÏ
improve our ability to manipulate these processes and thus allow us to define strategies
for the prevention and treatment ofbreast cancer.
Conclusion
In summary, the research described in this thesis documents the expression ofEngraiÏed
(En) genes in the mouse mammary gland and breast cancer tissue and provides evidence
that suggests they play a role in both regulating mammary gland development and
mammary epithelial ceil proliferation in breast carcinogenesis. Hence, these studies
reveal that En genes have flot only acquired a role in the postnatal development of the
mouse mammary gland, but in addition, they have evolved to contribute to breast
tumorigenesis. These above findings have broad implications in the fields of
developmental biology and cancer.
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